Document:

Disney Savings and Investment Plan As Amended and Restated Effective 1/1/2010

 Exhibit 10.1 

DISNEY 

SAVINGS AND INVESTMENT PLAN 

As Amended and Restated 

Effective 

January 1, 2010 

 DISNEY SAVINGS 

AND INVESTMENT PLAN 

TABLE OF CONTENTS 
  

					
	 	  	 	  	Page
		
	 Preamble
	  	v
		
	 ARTICLE 1 Definitions
	  	1
			
	 1.01
	  	 “ABC Employee”
	  	1
	 1.02
	  	 “Adjustment Factor”
	  	1
	 1.03
	  	 “Affiliated Employer”
	  	1
	 1.04
	  	 “After-Tax Account”
	  	1
	 1.05
	  	 “Aggregate Account” or “Account”
	  	2
	 1.06
	  	 “Alternate Payee”
	  	2
	 1.07
	  	 “Authorized Leave of Absence”
	  	2
	 1.08
	  	 “Beneficiary”
	  	2
	 1.09
	  	 “Board” or “Board of Directors”
	  	3
	 1.10
	  	 “Break in Service”
	  	3
	 1.11
	  	 “Code”
	  	4
	 1.12
	  	 “Committee”
	  	4
	 1.13
	  	 “Company”
	  	4
	 1.14
	  	 “Company Stock”
	  	4
	 1.15
	  	 “Company Stock Fund”
	  	4
	 1.16
	  	 “Company Stock ESOP Fund”
	  	4
	 1.17
	  	 “Company Stock Non-ESOP Fund”
	  	4
	 1.18
	  	 “Compensation”
	  	5
	 1.19
	  	 “Covered Employee”
	  	5
	 1.20
	  	 “Effective Date”
	  	9
	 1.21
	  	 “Eligibility Computation Period”
	  	9
	 1.22
	  	 “Eligible Employee”
	  	9
	 1.23
	  	 “Employee”
	  	9
	 1.24
	  	 “Employer”
	  	11
	 1.25
	  	 “Employment Commencement Date”
	  	11
	 1.26
	  	 “Enrollment Date”
	  	11
	 1.27
	  	 “ERISA”
	  	11
	 1.28
	  	 “Highly Compensated Employee”
	  	11
	 1.29
	  	 “Hour of Service”
	  	12
	 1.30
	  	 “Income”
	  	14
	 1.31
	  	 “Investment Fund”
	  	14
	 1.32
	  	 “Leased Employee”
	  	14
	 1.33
	  	 “Matching Account”
	  	15
	 1.34
	  	 “Matching Contribution”
	  	15
	 1.35
	  	 “Maximum Compensation Limitation”
	  	15
	 1.36
	  	 “Participant”
	  	15
	 1.37
	  	 “Plan”
	  	15

  

 i 

					
	 1.38
	  	 “Plan Year”
	  	16
	 1.39
	  	 “Qualified Domestic Relations Order”
	  	16
	 1.40
	  	 “Reemployment Commencement Date”
	  	16
	 1.41
	  	 “Rollover Account”
	  	16
	 1.42
	  	 “Rollover Contribution”
	  	16
	 1.43
	  	 “Roth Account”
	  	16
	 1.44
	  	 “Roth Contributions”
	  	16
	 1.45
	  	 “Rule of Parity”
	  	16
	 1.46
	  	 “Section 402(g) Limit”
	  	17
	 1.47
	  	 “Special Account”
	  	17
	 1.48
	  	 “Special Contribution”
	  	17
	 1.49
	  	 “Spousal Consent”
	  	17
	 1.50
	  	 “Spouse”
	  	17
	 1.51
	  	 “Statutory Compensation”
	  	18
	 1.52
	  	 “Tax-Deferred Account”
	  	18
	 1.53
	  	 “Tax-Deferred Contributions”
	  	18
	 1.54
	  	 “Trust Agreement”
	  	18
	 1.55
	  	 “Trust Fund”
	  	19
	 1.56
	  	 “Trustee”
	  	19
	 1.57
	  	 “Valuation Date”
	  	19
		
	 ARTICLE 2 Eligibility and Participation
	  	20
			
	 2.01
	  	 Eligibility
	  	20
	 2.02
	  	 Participation
	  	20
	 2.03
	  	 Reemployment of Former Employees and Former Participants
	  	20
	 2.04
	  	 Special Rules Relating to Veteran’s Reemployment Rights Under USERRA
	  	20
	 2.05
	  	 Transferred Participants
	  	25
	 2.06
	  	 Termination of Employment and Termination of Participation
	  	26
		
	 ARTICLE 3 Contributions
	  	27
			
	 3.01
	  	 Tax-Deferred Contributions
	  	27
	 3.02
	  	 Matching Contributions
	  	28
	 3.03
	  	 Special Contributions
	  	29
	 3.04
	  	 Deductibility Limitations and Form of Contribution
	  	30
	 3.05
	  	 Rollover Contributions
	  	30
	 3.06
	  	 After Tax-Contributions
	  	32
	 3.07
	  	 Catch-up Contributions
	  	32
	 3.08
	  	 Roth Contributions
	  	33
		
	 ARTICLE 4 Allocations to Participants’ Accounts
	  	34
			
	 4.01
	  	 Individual Accounts
	  	34
	 4.02
	  	 Account Allocations
	  	34
	 4.03
	  	 Limitation on Allocations
	  	35
	 4.04
	  	 No Guarantee
	  	36
	 4.05
	  	 Statement of Accounts
	  	36

  

 ii 

					
	 ARTICLE 5 Vesting
	  	37
			
	 5.01
	  	 Nonforfeitability
	  	37
		
	 ARTICLE 6 Investment Elections and Voting of Company Stock
	  	38
			
	 6.01
	  	 Investment Options
	  	38
	 6.02
	  	 Voting of Company Stock
	  	47
		
	 ARTICLE 7 Participant Loans
	  	50
			
	 7.01
	  	 Loans to Active Participants
	  	50
	 7.02
	  	 Repayment of Loans
	  	51
		
	 ARTICLE 8 Distributions to Participants and Beneficiaries
	  	54
			
	 8.01
	  	 Withdrawals from After-Tax Account and Rollover Account
	  	54
	 8.02
	  	 Hardship Withdrawals
	  	54
	 8.03
	  	 Distributions on Account of Termination of Employment
	  	57
	 8.04
	  	 Restrictions and Requirements on Distributions
	  	59
	 8.05
	  	 Method of Payment for Eligible Rollover Distributions
	  	61
	 8.06
	  	 Recapture of Payments
	  	64
	 8.07
	  	 Age
59 1/2 Withdrawals
	  	64
	 8.08
	  	 Required Minimum Distributions
	  	65
		
	 ARTICLE 9 Administration of Plan
	  	71
			
	 9.01
	  	 Plan Administrative Committee
	  	71
	 9.02
	  	 Duties of Committee
	  	72
	 9.03
	  	 Meetings
	  	72
	 9.04
	  	 Actions By the Committee
	  	72
	 9.05
	  	 Compensation and Bonding
	  	72
	 9.06
	  	 Establishment of Rules and Interpretation of Plan
	  	73
	 9.07
	  	 Service in More Than One Fiduciary Capacity
	  	74
	 9.08
	  	 Limitation of Liability
	  	74
	 9.09
	  	 Indemnification
	  	74
	 9.10
	  	 Expenses of Administration
	  	74
	 9.11
	  	 Claims Procedures
	  	75
	 9.12
	  	 Limitation on Actions
	  	81
	 9.13
	  	 Class Action Forum
	  	82
		
	 ARTICLE 10 Management of Funds
	  	84
			
	 10.01
	  	 Trust Agreement
	  	84
	 10.02
	  	 Exclusive Benefit Rule
	  	84
	 10.03
	  	 Committee Power and Duties
	  	84
		
	 ARTICLE 11 Assignments and Liens
	  	86
			
	 11.01
	  	 Nonalienation
	  	86
	 11.02
	  	 Qualified Domestic Relations Orders
	  	87
	 11.03
	  	 Facility of Payment
	  	88
	 11.04
	  	 Information
	  	88
	 11.05
	  	 Construction
	  	88

  

 iii 

					
	 11.06
	  	 Proof of Death and Right of Beneficiary or Other Person
	  	89
	 11.07
	  	 Failure to Locate Recipient
	  	89
	 11.08
	  	 Electronic Transmission of Notices to Participants
	  	89
		
	 ARTICLE 12 Amendment, Merger and Termination
	  	90
			
	 12.01
	  	 Amendment of Plan
	  	90
	 12.02
	  	 Merger or Consolidation
	  	90
	 12.03
	  	 Additional Participating Employers
	  	91
	 12.04
	  	 Termination of Plan
	  	92
	 12.05
	  	 Distribution of Assets on Plan Termination or a Complete Discontinuance of Contributions
	  	92
	 12.06
	  	 Notification of Termination
	  	92
		
	 ARTICLE 13 Top-Heavy Provisions
	  	94
			
	 13.01
	  	 Priority Over Other Plan Provisions
	  	94
	 13.02
	  	 Definitions Used in this Article
	  	94
	 13.03
	  	 Minimum Allocation
	  	97
		
	 ARTICLE 14 Limitations on Contributions and Allocations to Participants’ Accounts
	  	99
			
	 14.01
	  	 Definitions Used in This Article
	  	99
	 14.02
	  	 Actual Deferral Percentage Test
	  	101
	 14.03
	  	 Contribution Percentage Test
	  	104
	 14.04
	  	 Additional Discrimination Testing Provisions
	  	106
	 14.05
	  	 Maximum Annual Additions
	  	108
	 14.06
	  	 Return of Contributions
	  	110
	 14.07
	  	 Contributions in Excess of Section 402(g) Limit
	  	111
		
	 ARTICLE 15 General Provisions
	  	113
			
	 15.01
	  	 No Contract of Employment
	  	113
	 15.02
	  	 Severability
	  	113
	 15.03
	  	 Scrivener’s Errors
	  	113

 APPENDIX A - Transfer of Assets from
the Jumbo Pictures, Inc. 
 APPENDIX B - Transfer of Certain Assets to or from the Go. Com Plan 

APPENDIX C - Recognition of Service with Acquisitions or Predecessor Employers 

APPENDIX D - Transfer of Assets from the Fox Plan 

APPENDIX E - Transfer of Assets from the Miramax Plan 

APPENDIX F - Transfer of Assets from the Dream Quest Plan 

APPENDIX G - Transfer of Assets from the Mammoth Records Plan 

APPENDIX H - Transfer of Assets from the ABC, Inc. Savings & Investment Plan 

Schedule of Effective Dates 
  

 iv 

 PREAMBLE 

DISNEY SAVINGS AND INVESTMENT PLAN 

The Disney Salaried Savings and Investment Plan (the “Plan”) was originally adopted, effective May 1, 1984, by The Walt
Disney Company (“Company”) by authorization of the Board of its predecessor, Walt Disney Productions, to provide a retirement savings vehicle for certain salaried employees of the Company and such other participating companies as approved
by the Company as described in Section 12.03. The Plan was amended thereafter from time to time and was renamed the Disney Savings and Investment Plan effective February 1, 2007. 

The Plan, as set forth herein and as amended and restated effective January 1, 2010 (the “Effective Date”), is intended to
qualify as a profit sharing plan with a cash or deferred arrangement under Sections 401(a) and 401(k) of the Internal Revenue Code (“Code”). Although the Plan is intended to qualify as a profit sharing plan, employer contributions
hereunder may be made without regard to profits. In addition, (a) before October 5, 2010, the ESOP component of the Company Stock Fund and (b) on and after October 5, 2010, the Company Stock ESOP Fund are intended to qualify as
an employee stock ownership plan, within the meaning of Section 4975(e)(7) of the Code. 
 Pursuant to Article 12, the
Company shall have the right to amend or terminate the Plan at any time without notice to the Participants or Beneficiaries if the Company so decides in its sole and absolute discretion. 

Except as specifically provided otherwise in this document, the provisions of this restatement of the Plan shall apply only to an
employee who terminates employment with the employers on or after the Effective Date. A former employee’s eligibility for benefits and the amount of benefits, if any, payable to or on behalf of a former employee shall be determined in
accordance with the provisions of the Plan in effect on the date his employment terminated. The benefit payable to or on behalf of an employee included under the Plan in accordance with the following provisions shall not be affected by the terms of
any amendment to the Plan adopted after such employee’s employment terminates, unless the amendment expressly provides otherwise. Notwithstanding the Effective Date of this restatement of the Plan: 

 

	1.	 Article 4 (Allocations to Participants’ Accounts), Article 6 (Investment Elections and Voting of Company Stock), Article 9
(Administration of Plan), Article 10 (Management of Funds), Article 11 (Assignments and Liens), Article 12 (Amendment, Merger and Termination) with the exception of Section 12.03 (Additional Participating
Employers), and Article 15 (General Provisions) shall apply to all employees and former employees (to the extent appropriate) who are Participants on or after the Effective Date; 

 

 v 

	2.	 An employee’s or former employee’s eligibility for and amount of contributions allocated with respect to Plan Years beginning before the
Effective Date shall not be affected by the provisions of this restatement of the Plan, except as expressly provided herein; 

  

	3.	 The provisions of Section 8.05 (Method of Payment for Eligible Rollover Distributions), 8.06 (Recapture of Payments), and 8.08
(Required Minimum Distributions) shall apply, as appropriate, to distributions that occur under the Plan on or after the Effective Date; and 

  

	4.	 Plan provisions necessary to comply with changes in applicable law effective since the enactment of the Economic Growth and Tax Relief
Reconciliation Act of 2001 are effective as of such earlier dates as are set forth in the “Schedule of Effective Dates” attached to this restatement of the Plan. Amendments to the Plan that are not identified in such Schedule (including
amendments that are not required to comply with changes in applicable law) shall be effective as of the dates set forth in the prior instruments adopting the amendments (including any prior restatement of the Plan) or in the particular provision of
this restatement of the Plan affected by such amendment, and otherwise as of the Effective Date. 

 To the
extent applicable, beneficiary designation forms, qualified domestic relations orders, and any other administrative forms or orders on file with the Committee with respect to Participants and Beneficiaries under the Plan as in effect before the
Effective Date shall continue in full force and effect under the Plan on and after the Effective Date, subject to the right of such Participants to change such designations and elections in accordance with Plan terms. 

 

 vi 

 ARTICLE 1 

Definitions 
  

	1.01	 “ABC Employee” means an Employee who is employed by ABC, Inc. or any subsidiary or affiliate of ABC, Inc. that is an Employer.

  

	1.02	 “Adjustment Factor” means any of the cost of living adjustment factors prescribed by the Secretary of the Treasury under
Section 415(d) of the Code applied to such items and in such manner as the Secretary shall provide. 

  

	1.03	 “Affiliated Employer” means any company not participating in the Plan that is: 

 

	 	(a)	 a member of a controlled group of corporations as defined in Section 414(b) of the Code (determined under Code Section 1563(a) without
regard to Code Sections 1563(a)(4) and (e)(3)(C)) with the Company; or 

  

	 	(b)	 any trade or business under common control (as defined in Code Section 414(c)) with the Company; or 

 

	 	(c)	 a member of an affiliated service group (as defined in Code Section 414(m)) that includes the Company; or 

 

	 	(d)	 any other entity required to be aggregated with the Company pursuant to Treasury regulations under Code Section 414(o).

 Notwithstanding the foregoing, for purposes of Section 14.05, the definitions in
Sections 414(b) and (c) of the Code shall be modified by substituting the phrase “more than 50 percent” for the phrase “at least 80 percent” each place it appears in Section 1563(a)(1) of the Code.

  

	1.04	 “After-Tax Account” means the account maintained for a Participant to record his after-tax contributions made to the Plan prior to
January 1, 1987 and adjustments relating thereto. 

	1.05	 “Aggregate Account” or “Account” means the records, including subaccounts, maintained by the Committee in the
manner provided hereunder to determine the interest of each Participant in the assets of the Plan and may refer to any or all of the accounts that a Participant may have under this Plan, namely a Tax-Deferred Account, a Matching Account, a Rollover
Account, a Special Account, an After-Tax Account or a Roth Account. 

  

	1.06	 “Alternate Payee” means any Spouse, former Spouse, child or other dependent of a Participant who is recognized by a qualified
domestic relations order as having a right to receive all, or a portion, of the benefits payable under the Plan with respect to a Participant. 

  

	1.07	 “Authorized Leave of Absence” means an absence authorized by an Employer or an Affiliated Employer under its standard personnel
practices as applied in a uniform and nondiscriminatory manner to all persons similarly situated, provided that the Employee resumes employment with the Employer or an Affiliated Employer or retires within the period specified in the Authorized
Leave of Absence. An Employer or an Affiliated Employer is not required to authorize any absence due to a strike, a walkout or a lockout as an Authorized Leave of Absence. An absence due to service in the Uniformed Services of the United States
shall be considered an Authorized Leave of Absence provided that the Employee complies with all of the requirements of federal law in order to be entitled to reemployment and provided further that the Employee returns to employment with an Employer
or an Affiliated Employer within the period provided by such law. 

  

	1.08	 “Beneficiary” means any person, persons or entity named by a Participant by written designation filed with the Committee to receive
benefits payable in the event of the Participant’s death, provided that if the Participant is married and he designates someone other than his Spouse as the Beneficiary, the Participant must file a Spousal Consent with the Committee. If any
Participant fails to designate a Beneficiary, or if the Beneficiary designated by a deceased Participant dies before the Participant, then the Beneficiary shall be deemed to be the Participant’s surviving Spouse or, if none, then the benefits
shall be paid in accordance with the following order of priority: 

  

	 	(a)	 the Participant’s children (equally), or if none 

 

 2 

	 	(b)	 the Participant’s parents (equally), or if none 

 

	 	(c)	 the Participant’s brothers and sisters (equally), or if none 

 

	 	(d)	 the Participant’s estate. 

  

	1.09	 “Board” or “Board of Directors” means the Board of Directors of The Walt Disney Company.

  

	1.10	 “Break in Service” means an Eligibility Computation Period during which an Employee is credited with less than 501 Hours of
Service. Solely for the purpose of determining if an Employee incurred a Break in Service, Hours of Service shall also include hours granted, on the basis of forty-five (45) hours per week, for periods during which an Employee is on an
Authorized Leave of Absence. 

 Notwithstanding the foregoing and solely for the purpose of
determining whether a Break in Service has occurred, an Employee shall be credited with up to 501 Hours of Service during a period of absence by reason of: 
  

	 	(a)	 The Employee’s pregnancy; 

  

	 	(b)	 The birth of a child of the Employee; 

  

	 	(c)	 The placement of a child with the Employee in connection with the Employee’s adoption of such child; 

 

	 	(d)	 The caring for such child for a period beginning immediately following such birth or placement; or 

 

 3 

	 	(e)	 The Employee’s own illness or caring for his Spouse or a member of his immediate family pursuant to the Family and Medical Leave Act of 1993
and regulations thereunder. 

 Hours of Service credited by reason of the above period of
absence shall be credited in the Plan Year in which the absence occurs if those Hours of Service are needed to prevent a Break in Service in that year; otherwise, they shall be credited in the immediately following Plan Year. Such Hours of Service
shall be equal to the normal number of Hours of Service that would have been credited to the Employee but for the above period of absence; however, in no event shall more than 501 Hours of Service be credited. The Committee may require that an
Employee file a written request to receive credit for Hours of Service under this paragraph. Unless otherwise determined by the Committee or an Employer’s personnel practices, an Employee who is absent from work for the reasons described in
this paragraph shall be deemed to have terminated employment for all purposes of this Plan other than the special Break in Service rule in this paragraph. 
  

	1.11	 “Code” means the Internal Revenue Code of 1986, as amended. 

 

	1.12	 “Committee” means the Investment and Administrative Committee of The Walt Disney Company Sponsored Qualified Benefit Plans and Key
Employees Deferred Compensation and Retirement Plan. 

  

	1.13	 “Company” means The Walt Disney Company and its successors. 

 

	1.14	 “Company Stock” means common stock of the Company. 

 

	1.15	 “Company Stock Fund” means the Investment Fund established and maintained before October 5, 2010 pursuant to
Section 6.01(a)(i)(A)(I), which consists of an ESOP component and a Non-ESOP component. 

  

	1.16	 “Company Stock ESOP Fund” means the Investment Fund established and maintained on and after October 5, 2010 pursuant to
Section 6.01(a)(i)(A)(II). 

  

	1.17	 “Company Stock Non-ESOP Fund” means the Investment Fund established and maintained on and after October 5, 2010 pursuant to
Section 6.01(a)(i)(A)(III). 

  

 4 

	1.18	 “Compensation” means an Employee’s base pay (excluding overtime, bonuses, relocation reimbursement, stock options, incentive
compensation, profit participation, compensation for extended work week, or other extraordinary payments, as determined by the Committee) and an ABC Employee’s commissions and sales bonuses paid during the calendar year by the Employer in
return for the Employee’s services. Except, for an ABC Employee who is represented by a collective bargaining representative, “Compensation” means the amount of covered compensation prescribed by the collective bargaining agreement
with the Employer pursuant to which he is treated as a Covered Employee. Compensation does not include: 

  

	 	(a)	 Employer contributions to any pension plan other than contributions caused by an Employee’s salary deferral reduction pursuant to
Section 401(k) of the Code; 

  

	 	(b)	 Employer contributions to this Plan or any other plan of deferred compensation maintained by an Employer other than Tax-Deferred Contributions;

  

	 	(c)	 Fringe benefits not taxable to the Employee (other than an elective qualified transportation fringe arrangement described in Code
Section 132(f)(4)); 

  

	 	(d)	 Payments to or on behalf of an individual after he is no longer an Employee; 

 

	 	(e)	 Imputed life insurance and all other forms of imputed income (for example, but not by way of limitation, income based on the value of health care
coverage for the Employee’s domestic partner, regardless of whether the Employee is permitted to exclude such amount from taxable gross income); and 

 

	 	(f)	 back pay. 

Except as provided otherwise in Article 3, Compensation shall not, for Plan purposes, exceed the Maximum Compensation
Limitation. 
  

	1.19	 “Covered Employee” means: 

  

	 	(a)	 For an Employee who is not an ABC Employee, an Employee who receives Compensation in the form of a salary (as distinguished from hourly-paid

  

 5 

	 	 
Employees), whether or not such Employee is exempt for wage-and-hour-law purposes. Notwithstanding the above, an Employee as described in any of the following paragraphs shall not be a Covered
Employee, except to the extent the Company elects, by written notice, to extend Plan participation to such Employee: 

  

	 	(i)	 an Employee who is represented by a union unless the union and the Employer entered into a collective bargaining or other agreement that provides
that the individual may participate in the Plan; 

  

	 	(ii)	 an Employee who is employed by an Employer pursuant to an oral or written agreement that provides that the individual shall not be eligible to
participate in the Plan; 

  

	 	(iii)	 an Employee who is a “Leased Employee” (determined, for this purpose, without regard to the requirement that services be performed for at
least one year); 

  

	 	(iv)	 an Employee who is a non-resident alien with no United States source income; and 

 

	 	(v)	 an Employee designated by an Employer as employed in a division or group, or at a site that the Employer determined, on a nondiscriminatory basis,
shall not be eligible to participate in the Plan. 

  

	 	(b)	 For an ABC Employee, an Employee who is a regular Full-Time Employee or a regular Part-Time Employee and who is remunerated in U.S. currency, except
that an ABC Employee described by any of the following paragraphs shall not be a Covered Employee: 

  

	 	(i)	 an Employee who is represented by a union unless the union and his Employer have entered into a collective bargaining or other agreement that
provides that the Employee shall participate in the Plan; or 

  

	 	(ii)	 an Employee if at the time of the adoption of the Plan by his Employer, or thereafter, the Employer elects to exclude some or all employees
described in Section 410(b)(3)(C) of the Code and the Employee is excluded from the Plan by reason of such election; or 

  

 6 

	 	(iii)	 an individual who is employed as a “daily hire” which means, for purposes of this paragraph (iii) and subject to the provisions of
applicable collective bargaining agreements, an Employee who is hired by his Employer on a day to day basis, usually for a one-day assignment; or 

  

	 	(iv)	 an individual who is hired for what is intended by his Employer to be a temporary period for a position in connection with a special event, such as
Olympics coverage or Presidential election coverage; or 

  

	 	(v)	 an individual who is hired in a position for a specific prime time program or series produced by the Entertainment Division of the ABC Television
Network; or 

  

	 	(vi)	 an individual who is employed pursuant to an agreement that provides that the individual shall not be eligible to participate in the Plan; or

  

	 	(vii)	 an individual who is not classified as an employee by the Employer, but who is treated as an Employee by reason of being treated as a “common
law” employee of the Employer pursuant to the standards prescribed by Internal Revenue Service Revenue Ruling 87-41 or any successor thereto; or 

  

	 	(viii)	 an Employee who is an Employee by reason of being treated as a Leased Employee (determined, for this purpose, without regard to the requirement that
services be performed for at least one year); or 

  

	 	(ix)	 an Employee whose basic compensation for services on behalf of the Employer is not paid directly by the Employer; or 

 

	 	(x)	 an Employee of any division, unit, or department designated by the Employer to be a non-participating division, unit, or department.

  

 7 

 Notwithstanding the provisions of paragraphs (iv) and (v) above,
an ABC Employee described in either of said paragraphs shall be treated as a Covered Employee to the extent that the terms of a collective bargaining agreement to which his Employer is a party require the Employee to be treated as a Covered
Employee. Expiration of a collective bargaining agreement shall not by itself affect an Employee’s status as a Covered Employee pending execution of a new collective bargaining agreement. For purposes of this subsection (b), a “Full-Time
Employee” means an ABC Employee who is designated as full-time by his Employer under standards uniformly applied to similarly situated employees and a “Part-Time Employee” is an ABC Employee who is not a Full-Time Employee, including
an ABC Employee who is designated as “casual” by his Employer. 
  

	 	(c)	 For purposes of this definition of “Covered Employee,” and notwithstanding any other provisions of the Plan to the contrary, individuals
who are not classified by the Company, in its discretion, as employees under Code Section 3121(d) (including but not limited to, individuals classified by the Company as independent contractors and non-employee consultants) and individuals who
are classified by the Company, in its discretion, as employees of any entity other than the Company or an Affiliated Employer do not meet the definition of Covered Employee and are ineligible for benefits under the Plan, even if the classification
by the Company is determined to be erroneous, or is retroactively revised. In the event the classification of an individual who is excluded from the definition of Covered Employee under the preceding sentence is determined to be erroneous or is
retroactively revised, the individual shall nonetheless continue to be excluded from the definition of Covered Employee and shall be ineligible for benefits for all periods prior to the date the Company determines its classification of the
individual is erroneous or should be revised. The foregoing sets forth a clarification of the intention of the Company regarding participation in the Plan for any Plan Year, including Plan Years prior to the amendment of this definition of
“Covered Employee.” 

  

 8 

	1.20	 “Effective Date” means January 1, 2010, the date this amended and restated Plan becomes effective. The Plan was originally
effective May 1, 1984. 

  

	1.21	 “Eligibility Computation Period” means, with respect to an Employee, the applicable of (a) or (b) as follows:

  

	 	(a)	 the 12-consecutive-month period commencing on the Employee’s Employment Commencement Date in which he is credited with at least 1,000 Hours of
Service; or 

  

	 	(b)	 in the case of an Employee who is not credited with at least 1,000 Hours of Service in the 12-month period described in Section 1.21(a) above,
a Plan Year, commencing with the Plan Year beginning immediately following the Employee’s Employment Commencement Date, in which he has been credited with at least 1,000 Hours of Service. 

An Employee’s Eligibility Computation Periods are subject to and may be ignored pursuant to the Rule of Parity.

 Notwithstanding the foregoing, individuals who (i) became Employees as a result of the acquisition of
Anaheim Property, Inc. (d.b.a.) as Pan Pacific Hotel Anaheim or the entity commonly know as the California Angeles, or (ii) were employees of Carlson Travel dedicated to the Disney account who became Employees as a result of an immediate
transfer from Carlson Travel shall be deemed to have completed one Eligibility Computation Period on their Employment Commencement Date, provided that they had completed a least one year of prior service with their relevant employers on such date.

  

	1.22	 “Eligible Employee” means a Covered Employee who has attained age eighteen (18) and has reached the ninetieth (90th) day
following his Employment Commencement Date; provided, however, that the requirement that the Covered Employee attain age eighteen (18) shall not apply to an ABC Employee. 

 

	1.23	 “Employee” means any person receiving Compensation for services rendered to an Employer or an Affiliated Employer, whose
Compensation is subject to withholding of 

  

 9 

	 	 
United States federal income tax and/or for whom Social Security contributions are made by an Employer or an Affiliated Employer, including any Leased Employee but excluding any person who serves
solely as a director or independent contractor. In determining whether an individual is an Employee for purposes of the Plan, the individual shall only be classified as an Employee with respect to a period of time only if the Employer or Affiliated
Employer treated the individual as a common law employee for payroll tax purposes for such period of time, regardless of any later determination that such individual was or may have been a common law employee during such period. Notwithstanding the
foregoing, a Leased Employee, although not treated as a common law employee for payroll tax purposes by an Employer or an Affiliated Employer, shall be considered an Employee under the Plan. 

Employee excludes the following: 
  

	 	(a)	 an individual who serves solely as a director or independent contractor or an individual whom the Employer or Affiliated Employer regards to be an
independent contractor; 

  

	 	(b)	 an individual who is not classified as an Employee by an Employer or Affiliated Employer, but who is treated as an Employee by reason of being
treated as a “common law” employee of the Employer or Affiliated Employer pursuant to the standards prescribed by Internal Revenue Service Ruling 87-41 or any successor thereto; 

 

	 	(c)	 an individual whose basic compensation for services on behalf of an Employer or Affiliated Employer is not paid directly by an Employer or
Affiliated Employer; and 

  

	 	(d)	 an individual working for a company providing goods or services (including temporary employee services) to an Employer or Affiliated Employer whom
the Employer or Affiliated Employer does not regard to be a common law employee of the Employer or Affiliated Employer. 

  

 10 

	1.24	 “Employer” means the Company and any subsidiary or affiliate of the Company that adopts this Plan in accordance with
Section 12.03. 

  

	1.25	 “Employment Commencement Date” means, subject to any applicable Appendix, the first date as of which an Employee is credited with
an Hour of Service for an Employer or an Affiliated Employer. For an Employee of an entity that first becomes an Affiliated Employer on or after December 3, 2007, the first date as of which the Employee is credited with an Hour of Service shall
be determined taking into account hours of service with such entity (determined under Section 1.29 as if the entity had been at all times an Affiliated Employer), but only if the Board of Directors or the Committee has not determined in advance
that service with such entity will not be credited for this purpose. 

  

	1.26	 “Enrollment Date” means the first day of the first payroll period after an Employee becomes an Eligible Employee, or the beginning
of any payroll period thereafter, as of which the Eligible Employee elects to commence participation in the Plan in accordance with Section 2.02. 

  

	1.27	 “ERISA” means the Employee Retirement Income Security Act of 1974, as amended. 

 

	1.28	 “Highly Compensated Employee” means for any Plan Year, any Employee of the Employer or an Affiliated Employer (whether or not
eligible for participation in the Plan) who: 

  

	 	(a)	 was a 5 percent owner (as defined in Section 414(q)(2) and Section 416(i) of the Code) for such Plan Year or the prior Plan Year, or

  

	 	(b)	 for the preceding Plan Year received Statutory Compensation in excess of $110,000 (which is the dollar amount in effect for the Plan Year beginning
on the Effective Date and the immediately preceding Plan Year), and was among the highest 20 percent of employees for the preceding Plan Year when ranked by Statutory Compensation paid for that year, excluding, for purposes of determining the
number of such employees, such Employees as the Committee may determine on a consistent basis pursuant to Section 414(q) of the Code. The $110,000 dollar amount in the preceding sentence shall be adjusted from time to time for the cost of
living in accordance with Section 414(q) of the Code. 

  

 11 

 Notwithstanding the foregoing, Employees who are nonresident aliens and who
receive no earned income from the Employer or an Affiliated Employer that constitutes income from sources within the United States shall be disregarded for all purposes of this Section. 

The Employer’s top-paid group election as described above shall be used consistently in determining Highly
Compensated Employees for determination years of all employee benefit plans of the Employer and Affiliated Employers to which Section 414(q) of the Code applies (other than a multiemployer plan) that begin with or within the same calendar year,
until such election is changed by Plan amendment in accordance with IRS requirements. The provisions of this Section shall be further subject to such additional requirements as shall be described in Section 414(q) of the Code and its applicable
regulations, which shall override any aspects of this Section inconsistent therewith. 
  

	1.29	 “Hour of Service” means, with respect to any applicable computation period: 

 

	 	(a)	 each hour for which an Employee is paid or is entitled to payment for the performance of duties for an Employer or an Affiliated Employer during the
applicable computation period; 

  

	 	(b)	 each hour for which an Employee is paid, or is entitled to payment, by an Employer or an Affiliated Employer on account of a period during which no
duties are performed (regardless of whether the employment relationship has terminated) because of vacation, holiday, illness, incapacity (including disability), layoff, jury duty, military duty, or leave of absence, but:

  

	 	(i)	 no more than 501 Hours of Service are to be credited under this subsection (b) to an Employee for any single continuous period during which he
performs no duties (whether or not the period occurs in a single computation period); 

  

 12 

	 	(ii)	 an hour is not credited where an individual directly or indirectly is paid or is entitled to payment because of a period during which no duties are
performed if that payment is made or is due under a plan maintained solely for the purpose of complying with applicable workers’ compensation or unemployment compensation or disability insurance laws; and 

 

	 	(iii)	 Hours of Service will not be credited for a payment that solely reimburses an Employee for medical or medically related expenses incurred. For
purposes of this subsection (b), a payment is deemed to be made by or be due from an Employer or an Affiliated Employer regardless of whether it is made by or due from that entity directly or indirectly through a trust fund or insurers (among
others) to which that entity contributes or pays premiums and regardless of whether contributions made or due to the trust fund or insurer or other funding vehicle are for the benefit of particular individuals or are on behalf of a group of
individuals in the aggregate. 

  

	 	(c)	 each hour for which back pay, irrespective of mitigation of damages, is either awarded or agreed to by an Employer or Affiliated Employer. The same
Hours of Service must not be credited both under subsection (a) or (b) and also under this subsection (c). Thus, for example, if an Employee receives a back-pay award following a determination that he was paid at an unlawful rate for Hours
of Service previously credited, he is not entitled to additional credit for the same Hours of Service. Crediting of Hours of Service for back pay awarded or agreed to with respect to periods described in subsection (b) is subject to the
limitations set forth in that subsection. For example, no more than 501 Hours of Service are required to be credited for payment of back pay, to the extent that the back pay is awarded or agreed to for a period of time during which an Employee did
not or would not have performed duties. 

  

	 	(d)	 For determining Hours of Service for reasons other than the performance of duties, the special rule provided in 29 C.F.R.
Section 2530.200b-2(b) is 

  

 13 

	 	 
incorporated by reference. That rule provides that Hours of Service are credited on the basis of the number of hours in the Employee’s regular work schedule or, in the case of a payment not
calculated in units or time, by dividing the payment in question by the Employee’s most recent hourly rate of pay. 

  

	 	(e)	 For purposes of crediting Hours of Service to computation periods, the special rule provided in 29 C.F.R. Section 2530.200b-2(c) is
incorporated by reference. That rule provides that Hours of Service are credited to an Employee in the computation periods covered by the Employee’s regular work schedule during the period of nonperformance. 

 

	 	(f)	 The determination of Hours of Service must be made from records of hours worked and hours for which payment is made or due.

  

	 	(g)	 For purpose of determining Hours of Service credited each Employee must be credited with at least forty-five (45) Hours of Service for each
week for which he would be required to be credited with at least one Hour of Service under subsection (a). 

  

	 	(h)	 Hours of Service credit for a period of “qualified military service” shall be determined in accordance with Section 2.04.

  

	1.30	 “Income” means the net gain or loss of the Trust Fund from investments, as reflected by interest payments, dividends, realized and
unrealized gains and losses on securities, other investment transactions and expenses paid from the Trust Fund. In determining the Income of the Trust Fund as of any date, assets shall be valued on the basis of their then fair market value.

  

	1.31	 “Investment Fund” means the one or more investment funds provided pursuant to Section 6.01(a) hereof.

  

	1.32	 “Leased Employee” means any person (other than a person treated as a common law employee of the Employer or Affiliated Employer)
who, pursuant to an agreement between the Employer or Affiliated Employer and any other person (“leasing 

 

 14 

	 	 
organization”), performed services for the Employer or Affiliated Employer or any related persons determined in accordance with Section 414(n)(6) of the Code on a substantially
full-time basis for a period of at least one year (i.e., has completed at least 1,500 Hours of Service in the initial 12 consecutive months services were performed or during any Plan Year that begins during or after such initial year) and such
services are performed under the primary direction of or control by the Employer or Affiliated Employer. In the case of any person who is a Leased Employee before or after a period of service as an Employee, the entire period during which he
performed services as a Leased Employee shall be counted as service as an Employee for all purposes of the Plan, except that he shall not, by reason of that status, become a Participant of the Plan. 

 

	1.33	 “Matching Account” means the account maintained for a Participant to record Matching Contributions made on his behalf pursuant to
Section 3.02 and adjustments relating thereto. 

  

	1.34	 “Matching Contribution” means the Employer Matching Contribution made to the Plan on behalf of a Participant pursuant to
Section 3.02. 

  

	1.35	 “Maximum Compensation Limitation” means $245,000 as of the Effective Date, adjusted thereafter for cost-of-living increases in
accordance with Code Section 401(a)(17)(B). Annual Compensation means compensation during the Plan Year or such other consecutive 12-month period over which compensation is otherwise determined under the Plan (the determination period). The
cost-of-living adjustment in effect for a calendar year applies to annual compensation for the determination period that begins with or within such calendar year. 

 

	1.36	 “Participant” means any individual on whose behalf any Accounts are maintained under the Plan, the balance of which has not been
distributed in full to him or his Beneficiary. 

  

	1.37	 “Plan” means the Disney Savings and Investment Plan (the “Disney Salaried Savings and Investment Plan” before
February 1, 2007) as set forth in this document, and as it may be amended from time to time. 

  

 15 

	1.38	 “Plan Year” means the calendar year, except for the short year from May 1, 1984 through December 31, 1984, which was the
first year of the Plan. 

  

	1.39	 “Qualified Domestic Relations Order” means a domestic relations order that creates or recognizes the existence of an Alternate
Payee’s right to, or assigns to an Alternate Payee the right to, receive all or portion of the benefits payable with respect to a Participant. The order must (a) be a judgment, decree or order (including the approval of a property
settlement agreement) that is made pursuant to a state domestic relations law, (b) relate to the provision of child support, alimony payments or marital property rights for the benefit of a Spouse, former Spouse, child, or other dependent of
the Participant, and (c) otherwise meets the requirements of Section 206(d)(3) of ERISA and Section 414(p) of the Code, as determined by the Committee. 

 

	1.40	 “Reemployment Commencement Date” means the date an Employee first is credited with an Hour of Service following a prior Break in
Service. 

  

	1.41	 “Rollover Account” means the account maintained for a Participant to record his Rollover Contributions to the Trust Fund pursuant
to Section 3.05 and adjustments relating thereto. 

  

	1.42	 “Rollover Contribution” means a Rollover Contribution made to the Plan by a Participant pursuant to Section 3.05.

  

	1.43	 “Roth Account” means the account maintained for a Participant to record contributions made on his behalf by an Employer pursuant to
a Roth Contribution agreement described in Section 3.08, any rollover Roth amounts accepted by the Plan pursuant to Section 3.05(b), and adjustments relating to Roth Contributions or rollover Roth amounts. 

 

	1.44	 “Roth Contributions” means an Employer’s contribution made to the Plan on behalf of a Participant pursuant to a Roth
Contribution agreement described in Section 3.08. 

  

	1.45	 “Rule of Parity” means a rule pursuant to which an Employee who incurs a Break in Service shall have his Eligibility Computation
Periods that occur prior to such Break in Service ignored or restored. If an Employee incurs a Break in Service prior to becoming 

 

 16 

	 	 
eligible to participate hereunder, his Eligibility Computation Periods prior to such Break in Service shall not be taken into account if the number of consecutive one-year Breaks in Service
equals or exceeds the greater of the Employee’s Eligibility Computation Periods completed prior to the first such Break in Service or five. Eligibility Computation Periods previously eliminated by a prior application of this Section 1.45
shall not be counted for purposes of this Section 1.45. 

  

	1.46	 “Section 402(g) Limit” means for any calendar year, the dollar limitation contained in Code Section 402(g) in effect for such
calendar year. 

  

	1.47	 “Special Account” means the account maintained for a Participant to record Special Contributions made on his behalf pursuant to
Section 3.03, and adjustments relating thereto. 

  

	1.48	 “Special Contribution” means the Employer Special Contribution made to the Plan on behalf of a Participant pursuant to
Section 3.03. 

  

	1.49	 “Spousal Consent” means written consent given by a Participant’s Spouse to an election made by the Participant of a specified
form of benefit or a designation by the Participant of a specified Beneficiary other than the Spouse. The specified form or specified beneficiary shall not be changed unless further Spousal Consent is given, unless the Spouse expressly waives the
right to consent to any future changes. Spousal Consent shall be duly witnessed by a Plan representative or notary public and shall acknowledge the effect on the Spouse of the Participant’s election. The requirement for Spousal Consent may be
waived by the Committee if it is established to its satisfaction that there is no Spouse, or that the Spouse cannot be located, or because of such other circumstances as may be established by applicable law. Spousal Consent shall be applicable only
to the particular Spouse who provides such consent. 

  

	1.50	 “Spouse” means a “spouse” as defined by the Defense of Marriage Act (Pub. Law No. 104-199). The term
“Spouse” also shall include a former Spouse of a Participant to the extent required by a Qualified Domestic Relations Order. 

  

 17 

	1.51	 “Statutory Compensation” means “compensation” actually paid or made available to the Participant (or includable in the
gross income of the Participant) by the Employer or an Affiliated Employer, where “compensation” includes the items described in Treas. Reg. § 1.415(c)-2(b)(1) and (2), but excludes the items described in Treas. Reg. §
1.415(c)-2(c). Statutory Compensation includes amounts that would otherwise be included in compensation as described in the immediately preceding sentence but for an election under Code Sections 125(a), 132(f)(4), 402(e)(3), 402(h)(1)(B), 402(k), or
457(b); provided, however, that amounts not included in income under Section 125 of the Code include any amount not available to a Participant in cash in lieu of group health coverage because the Participant is unable to certify that he has
other health coverage, but only if the Employer or Affiliated Employer does not otherwise request or collect information regarding the Participant’s other health coverage as part of the enrollment process for the health plan. Notwithstanding
the foregoing, Statutory Compensation shall not include compensation paid or made available to the Participant after the Participant’s termination of employment with the Employer or Affiliated Employer, except (I) regular pay (within the
meaning of Treas. Reg. § 1.415(c)-2(e)(3)(ii)) that is paid by the later of two and one-half months after the Participant terminates employment or the end of the Plan Year or limitation year (as applicable) in which the Participant terminates
employment and (II) differential pay amounts required to be included pursuant to Code Section 414(u)(12). 

  

	1.52	 “Tax-Deferred Account” means the account maintained for a Participant to record contributions made on his behalf by an Employer
pursuant to a Tax-Deferred Contribution agreement described in Section 3.01 and adjustments relating thereto. 

  

	1.53	 “Tax-Deferred Contributions” means an Employer’s contribution made to the Plan on behalf of a Participant pursuant to a
Tax-Deferred Contribution agreement described in Section 3.01. 

  

	1.54	 “Trust Agreement” means the trust agreement or agreements that may be established from time to time hereunder and as the same may
from time to time be amended and/or restated. 

  

 18 

	1.55	 “Trust Fund” means all money or other property that is held by the Trustee, pursuant to the terms of the Trust Agreement.

  

	1.56	 “Trustee” means the entity or its successor acting as the trustee under the Trust Agreement, or any other trustee or trustees
designated in any trust agreement or agreements that may be established to carry out the purposes of this Plan. 

  

	1.57	 “Valuation Date” means the date as of which the Trustee shall determine the value of the assets in the Trust Fund for purposes of
enabling the Committee or its delegate to determine the value of the Aggregate Accounts. 

  

 19 

 ARTICLE 2 

Eligibility and Participation 
  

	2.01	 Eligibility 

Only Eligible Employees may participate in this Plan. 

 

	2.02	 Participation 

Any individual who was a Participant in the Plan immediately preceding the Effective Date shall be considered a
Participant on the Effective Date. Thereafter, an Eligible Employee shall become a Participant as of the first Enrollment Date after he: 
  

	 	(a)	 authorizes his Tax-Deferred Contributions in accordance with Section 3.01 or Roth Contributions in accordance with Section 3.08;

  

	 	(b)	 names a Beneficiary; and 

  

	 	(c)	 selects investment fund(s) pursuant to Article 6. 

The Company may, in its sole and absolute discretion, waive any or all of the participation requirements set forth above
for the Employees of any Employer. 
  

	2.03	 Reemployment of Former Employees and Former Participants 

Any person employed by an Employer as an Eligible Employee who was previously a Participant or was previously eligible to
become a Participant shall be immediately eligible to become a Participant in the Plan. Any other person reemployed by an Employer may participate in the Plan on meeting the requirements of Section 2.02. 

 

	2.04	 Special Rules Relating to Veteran’s Reemployment Rights Under USERRA 

 

	 	(a)	 Notwithstanding any contrary provision of the Plan, the rules of Sections 2.04(d) and 2.04(e) shall apply to any Participant who is reemployed upon
return from qualified military service as set forth in Sections 2.04(b) and 2.04(c). It is intended that contributions, benefits and service credit with respect to qualified military service will be provided in accordance with Code
Section 414(u). 

  

 20 

	 	(b)	 “Qualified military service” means any service in the uniformed services, as defined in chapter 43 of title 38, United States Code, by an
individual if the individual is entitled to reemployment rights under chapter 43 with respect to such service. 

  

	 	(c)	 A Participant shall be treated as reemployed upon returning to work with an Employer or Affiliated Employer following qualified military service if:

  

	 	(i)	 The Participant did not separate from military service with a disqualifying discharge or under other than honorable conditions;

  

	 	(ii)	 The Participant, or an appropriate officer of the uniformed service, gave the Employer or Affiliated Employer advance notice of his intent to serve
(unless prevented by military necessity or impossible or unreasonable under all circumstances); 

  

	 	(iii)	 The Participant has five years or less of cumulative qualified military service in his employment relationship with the Employer or Affiliated
Employer (excluding any periods that are disregarded when applying the five-year limit under chapter 43 of title 38, United States Code); and 

  

	 	(iv)	 The Participant reports for work or submits an application for reemployment with the Employer or Affiliated Employer in a timely manner. Subject to
special rules set forth in chapter 43, title 38 of the United States Code for individuals who are hospitalized or convalescing from illness or injury, a reemployment request is timely if the Participant reports for work or submits an application for
reemployment to the Employer or Affiliated Employer after his period of qualified military service ends as follows: 

  

 21 

			
	 Period of Qualified Military Service
	 	 Deadline for Report/Submission

		
	 Fewer than 31 days or any length if the service was for purposes of fitness examination
	 	 The beginning of the first full regularly-scheduled work period on the first full calendar day following completion of the service, and the expiration of 8 hours
after a period allowing for safe transportation from the place of that service to the Participant’s residence (unless impossible or unreasonable)

		
	 31 to 180 days
	 	 Within 14 days (unless impossible or unreasonable)

		
	 181 days or more
	 	 Within 90 days

  

	 	(d)	 In the event this Section 2.04 applies to a Participant: 

 

	 	(i)	 The Participant shall not incur a Break in Service by reason of his period of qualified military service. 

 

	 	(ii)	 The Participant’s period of absence due to qualified military service shall be included in the determination of his Hours of Service, his
status as an Eligible Employee under Section 1.22, and his eligibility for Matching Contributions under Section 3.02(b), as if the Participant had remained employed in the position he held with the Employer or Affiliated Employer before
such absence began. 

  

	 	(iii)	 The Participant shall be deemed to have received Compensation during the period of absence due to qualified military service at the rate he would
have received Compensation had he remained employed as an Employee for that period or, if such rate is not reasonably certain, on the basis of the Participant’s average rate of Compensation during the 12-month period immediately preceding such
period of qualified military service (or, if shorter, the period of the Participant’s employment as an Employee immediately preceding such period). 

  

 22 

	 	(e)	 In the event this Section 2.04 applies to a Participant, he shall be permitted to make additional Tax-Deferred Contributions or Roth
Contributions as provided in this Section 2.04(e): 

  

	 	(i)	 Tax-Deferred Contributions or Roth Contributions made under this Section 2.04(e) must be made within five years (or, if less, three times the
length of his most recent period of qualified military service) after his reemployment and while the Participant is an Employee. 

  

	 	(ii)	 The maximum amount of Tax-Deferred Contributions or Roth Contributions that the Participant may make under this Section 2.04(e) is the maximum
amount of Tax-Deferred Contributions or Roth Contributions that he would have been permitted to make during the period of absence due to qualified military service if he had continued to be employed by the Employer during such period in the position
he held with the Employer immediately before such absence and received Compensation as set forth in Section 2.04(d)(iii). The maximum amount of Tax-Deferred Contributions or Roth Contributions so determined shall be reduced by the amount of any
Tax-Deferred Contributions or Roth Contributions actually made by the Participant during his period of absence due to qualified military service. 

  

	 	(iii)	 The Employer shall contribute Matching Contributions that would have been attributable to Tax-Deferred Contributions or Roth Contributions made
pursuant to this Section 2.04(e) as soon as practicable after such Tax-Deferred Contributions or Roth Contributions are made. 

  

	 	(iv)	 Contributions made pursuant to this Section 2.04(e): 

(A) shall not be taken into account for purposes of the Section 402(g) Limit and the otherwise
applicable limitations under Section 14.05 for the taxable year or limitation year in which the contributions are made; rather such contributions shall be taken into account for purposes of such limitations for the year to which the
contributions relate; and 
  

 23 

 (B) shall not be taken into account for purposes of the
limitations described in Sections 14.02 or 14.03 for any year. 
  

	 	(v)	 Although Tax-Deferred Contributions, Roth Contributions or Matching Contributions made under to this Section 2.04(e) may relate to a prior
period, no investment earnings or losses shall be credited to such contributions prior to the date they are actually made. 

  

	 	(f)	 In the event a Participant has an outstanding loan under the Plan at the time a period of qualified military service begins, the rules set forth in
Section 7.02(f) shall apply. 

  

	 	(g)	 In accordance with Code Section 401(a)(37) and guidance issued thereunder, the survivors of a Participant who dies while performing qualified
military service shall be eligible for any additional benefits (other than additional contributions related to the period of qualified military service) that would have been provided under the Plan if the Participant had resumed employment as
described in Section 2.04(c) and immediately thereafter terminated employment due to death. 

  

	 	(h)	 To the extent required by Code Section 414(u)(12) and guidance issued thereunder, an individual receiving differential wage payments (within
the meaning of Code Section 3401(h)(2)) from the Employer or an Affiliated Employer shall be treated as an employee and the differential wage payments shall be treated as compensation. 

 

	 	(i)	 The following distribution options are available to Participants (including Participants who have terminated employment) who are absent from work
due to military service: 

  

	 	(i)	 A Participant who, by reason of being a member of a reserve component (as defined in section 101 of title 37, United States Code), is ordered or

  

 24 

	 	 
called to active duty after September 11, 2001 for a period in excess of 179 days or for an indefinite period may elect a distribution of all or part of his Tax-Deferred Account and Roth
Account in the form of a lump sum. Such election may be made, in the form and manner prescribed by the Committee, at any time during the period beginning on the date of such order or call (or January 1, 2009 if later) and ending at the close of
the active duty period. 

  

	 	(ii)	 A Participant who is performing service in the uniformed services (as defined in chapter 43 of title 38, United States Code) while on active duty
for a period of more than 30 days may elect a distribution of all or part of his Tax-Deferred Account and Roth Account in the form of a lump sum. Such election may be made, in the form and manner prescribed by the Committee, at any time during such
active duty period. If a Participant who has not terminated employment receives a distribution under this clause (ii) that is not otherwise permitted under clause (i) above or Section 8.07 of the Plan, the Participant shall be
prohibited from making Tax-Deferred Contributions or Roth Contributions under this Plan during the six-month period beginning on the date of the distribution. This clause (ii) is intended to satisfy the requirements of Code
Section 414(u)(12)(B) and shall be construed in a manner that will effectuate this intent. 

  

	2.05	 Transferred Participants 

  

	 	(a)	 If a Participant remains in the employ of an Employer or an Affiliated Employer but ceases to be an Eligible Employee, his participation under the
Plan shall be suspended, provided, however, that during the period of his employment in such ineligible position: 

  

	 	(i)	 he shall cease to have any right to elect Tax-Deferred or Roth Contributions or to make Rollover Contributions; 

 

 25 

	 	(ii)	 he shall not receive allocations of Matching Contributions or Special Contributions; 

 

	 	(iii)	 he shall continue to participate in income allocations pursuant to Section 4.02(a); and 

 

	 	(iv)	 the provisions of Articles 6 and 8 shall continue to apply. 

 

	 	(b)	 If an Employee again becomes an Eligible Employee, his rights and privileges as an Eligible Employee under this Plan shall be restored. In addition,
to the extent applicable, the Employee’s Matching Contribution for the Plan Year in which he again becomes an Eligible Employee shall be determined under Section 3.02 after taking into account any tax-deferred, Roth and matching
contributions allocated to the Employee for such Plan Year under any qualified defined contribution plan maintained by an Affiliated Employer in which the Employee was participating immediately before he resumed Eligible Employee status.

  

	2.06	 Termination of Employment and Termination of Participation 

Under this Plan, termination of employment occurs on the date an Employee is no longer employed with an Employer or an
Affiliated Employer. An Eligible Employee’s participation in the Plan shall terminate on the date he terminates employment, unless the Participant is entitled to benefits under the Plan, in which event his participation shall terminate when
those benefits are distributed to him. 
  

 26 

 ARTICLE 3 

Contributions 
  

	3.01	 Tax-Deferred Contributions 

  

	 	(a)	 A Tax-Deferred Contribution represents an agreement by an Eligible Employee with his Employer to accept a reduction in Compensation in consideration
of a contribution to the Plan by the Employer on the Participant’s behalf in the same amount. 

  

	 	(b)	 In accordance with rules that the Committee shall prescribe from time to time, an Eligible Employee may elect to enter into an agreement with his
Employer as described in Section 3.01(a) by indicating the amount of Tax-Deferred Contributions he wishes to be contributed by his Employer. Tax-Deferred Contributions shall be subject to the following: 

 

	 	(i)	 Tax-Deferred Contributions may be any whole percentage of a Participant’s Compensation (determined without regard to the Maximum Compensation
Limitation) between one (1) percent and fifty (50) percent. 

  

	 	(ii)	 Except as provided in Section 2.04 or 3.07, a Participant’s Tax-Deferred Contributions for any Plan Year may not exceed the
Section 402(g) Limit for the applicable Plan Year or fifty (50) percent of the Participant’s Compensation for the Plan Year limited by the Maximum Compensation Limitation, if less. 

 

	 	(iii)	 Tax-Deferred Contributions shall be made by regular payroll reduction. 

 

	 	(c)	 Tax-Deferred Contribution elections are effective following the Participant’s Enrollment Date or as soon as administratively feasible
thereafter. An election of Tax-Deferred Contributions shall remain in force until changed in the form and manner specified by the Committee. A Participant may elect to cease contributions at any time. Elections to increase, decrease or cease
Tax-Deferred Contributions are effective as soon as administratively possible following receipt 

  

 27 

	 	 
by the Committee. A Participant may not change his election with respect to Tax-Deferred Contributions already made by payroll deduction. Notwithstanding the foregoing, if a Participant is
reclassified or transferred to an employment category not included among Eligible Employees, deferrals shall cease as of the first payroll period in which the reclassification or transfer is effective. 

Notwithstanding any contrary provision of this Section 3.01, if the amount being deducted from a Participant’s
Compensation is changed due to an error by the Company, the Participant shall be deemed to have elected to make such change, as of the effective date of the change, if the Participant does not advise the Committee in writing (or by any other means
that is acceptable to the Committee) of his objection to such change within 90 days after his receipt of the first paycheck (or payroll advice) reflecting such change. 
  

	 	(d)	 Tax-Deferred Contributions shall be transmitted to the Trustee as of the earliest date on which such contributions can reasonably be segregated from
the Employer’s general assets, but no later than the fifteenth business day of the month following the payroll month in which the Tax-Deferred Contribution was deducted from the Participant’s Compensation. 

 

	 	(e)	 All Tax-Deferred Contributions are subject to the limitations of Article 14 and the further limitations of this Article.

  

	3.02	 Matching Contributions 

  

	 	(a)	 Each Employer will contribute, with respect to Participants employed by it who have met the eligibility requirements set forth in
Section 3.02(b), a Matching Contribution equal to 50% of so much of the aggregate Tax-Deferred Contributions and Roth Contributions made on behalf of the Participant for the Plan Year as do not exceed 4% of the Participant’s Compensation
for the Plan Year, determined without regard to the Maximum Compensation Limitation, disregarding, for the Plan Year in which the Participant first satisfies the eligibility requirements, contributions made and Compensation earned before the
Participant satisfies the eligibility requirements or enrolls in the Plan, if later; 

  

 28 

	 	 
provided, however, that Matching Contributions made on behalf of a Participant for any Plan Year shall not exceed 2% of the Participant’s Compensation for the Plan Year, limited by the
Maximum Compensation Limitation. 

  

	 	(b)	 A Participant shall be eligible for Matching Contributions if he is a Covered Employee who has attained age eighteen (18) and has reached the
one-year anniversary of his Employment Commencement Date; provided, however, that the requirement that the Covered Employee attain age eighteen (18) shall not apply to an ABC Employee. 

 

	 	(c)	 Notwithstanding the foregoing, Matching Contributions of the Employers are discretionary and are not required. 

 

	 	(d)	 All Matching Contributions shall be paid to the Trustee no later than the time prescribed by law for filing the federal income tax returns of the
Employers, including any extensions granted for the filing of such tax returns. 

  

	 	(e)	 All Matching Contributions are subject to the limitations of Article 14 and the further limitations of this Article. 

 

	3.03	 Special Contributions 

  

	 	(a)	 Special Contributions are not required and are made at each Employer’s discretion. 

 

	 	(b)	 Special Contributions may be made to correct an Actual Deferral Percentage test failure under Section 14.02, or to correct a Contribution
Percentage test failure under Section 14.03, provided that the requirements for taking such contributions into account in such tests as set forth in applicable Treasury regulations (including the requirement that such contributions not be
disproportionate) are met. 

  

	 	(c)	 Special Contributions are made on behalf of Participants who are not Highly Compensated Employees and who are actively employed by the Employer on
the last day of the pay period for which a Special Contribution is made. 

  

 29 

	 	(d)	 All Special Contributions shall be paid to the Trustee no later than the time prescribed by law for filing the federal income tax returns of the
Employers, including any extensions granted for the filing of such tax returns. 

  

	 	(e)	 All Special Contributions are subject to the limitations of Article 14 and the further limitations of this Article. 

 

	3.04	 Deductibility Limitations and Form of Contribution 

 

	 	(a)	 In no event shall the aggregate Tax-Deferred, Roth, Matching and Special Contributions of the Employers exceed the amount deductible by the
Employers for such Plan Year for income tax purposes as a contribution to the Trust under the applicable provisions of the Code. All Participant Tax-Deferred or Roth Contribution elections, Matching Contributions and Special Contributions are
specifically conditioned on such deductibility. 

  

	 	(b)	 All contributions of the Employers shall be in cash, except that Matching Contributions and Special Contributions may be made in the form of Company
Stock. 

  

	3.05	 Rollover Contributions 

  

	 	(a)	 Subject to Committee procedures and without regard to any limitations on contributions set forth in this Plan, the Plan may receive from a Covered
Employee, regardless of whether he is an Eligible Employee, in cash, any portion of: 

  

	 	(i)	 An Eligible Rollover Distribution (as defined in Section 8.05(d)(i)) paid to the Covered Employee from a qualified trust described in Code
Section 401(a), an annuity plan described in Code Section 403(a), an annuity contract described in Section 403(b) of the Code or an eligible plan under Section 457(b) of the Code which is maintained by a state, political
subdivision of a state, or any agency or instrumentality of a state or political subdivision of a state, provided that the Covered Employee pays over such amount to the Trustee on or before the 60th day after the day it was received by the Covered
Employee; 

  

 30 

	 	(ii)	 An Eligible Rollover Distribution (as defined in Section 8.05(d)(i)) paid as a direct rollover to the Trustee on behalf of the Covered Employee
by a qualified trust described in Code Section 401(a), an annuity plan described in Code Section 403(a), an annuity contract described in Section 403(b) of the Code or an eligible plan under Section 457(b) of the Code which is
maintained by a state, political subdivision of a state, or any agency or instrumentality of a state or political subdivision of a state; and 

  

	 	(iii)	 A distribution described in Code Section 408(d)(3)(A)(ii) (as modified by Code Section 408(d)(3)(D)) from a conduit individual retirement
account or annuity paid to the Covered Employee provided that the Covered Employee pays over such amount to the Trustee on or before the 60th day after the day it was received by the Covered Employee. 

 

	 	(b)	 Notwithstanding the foregoing: 

  

	 	(i)	 the Plan shall not accept any after-tax amounts under this Section 3.05; that is, amounts (other than Roth amounts described below in paragraph
(iii)) that would not be taxable to the Covered Employee upon distribution from this Plan; 

  

	 	(ii)	 the Plan shall not accept any amounts from a Covered Employee or on behalf of a Covered Employee from a contributory individual retirement account
or annuity of the Covered Employee; and 

  

	 	(iii)	 the Plan may accept a “rollover” contribution to a Participant’s Roth Account only if it is a direct rollover from another Roth
contribution account under an applicable retirement plan described in Code Section 402A(e)(1) and only to the extent the rollover is permitted under the rules of Code Section 402(c). 

 

 31 

	 	(c)	 Upon approval by the Committee the amount transferred to the Plan by the Covered Employee shall be deposited by the Trustee. Any rollover Roth
amounts accepted pursuant to Section 3.05(b)(iii) shall be credited to the Covered Employee’s Roth Account, and any other rollover amounts shall be credited to the Covered Employee’s Rollover Account. A Covered Employee shall be 100%
vested in his Rollover Account and such Rollover Account shall share in allocations of income, gains and losses from investment options. 

  

	 	(d)	 Upon a transfer described in this Section 3.05 by a Covered Employee who is not a Participant, the Covered Employee’s Rollover Account
shall represent his sole interest in the Plan until he becomes a Participant. 

  

	 	(e)	 The Committee shall develop such other procedures and may require such information from a Covered Employee desiring to make a rollover as it deems
necessary or desirable to determine that the proposed rollover will meet the requirements of this Section 3.05 and that the amount rolled over qualifies for rollover treatment pursuant to applicable provisions of the Code.

  

	3.06	 After Tax-Contributions 

Voluntary after-tax contributions made by a Participant prior to January 1, 1987 are maintained in his After-Tax
Account, which is 100% vested and nonforfeitable at all times. 
  

	3.07	 Catch-up Contributions 

All Employees who are eligible to make Tax-Deferred Contributions under this Plan and who have attained age 50 before the
end of the Plan Year shall be eligible to make catch-up contributions in accordance with and subject to the limitations of Code Section 414(v). Such catch-up contributions shall not be taken into account for purposes of the provisions of the
Plan implementing the required limitations of Code Sections 402(g) and 415. The Plan shall not be treated as failing to satisfy the provisions of the Plan implementing the requirements of Code Sections 401(a)(4), 401(k)(3), 401(k)(11), 401(k)(12),
410(b) or 416, as applicable, by reason of the making of such catch-up contributions. 
  

 32 

	3.08	 Roth Contributions 

  

	 	(a)	 Eligible Employees will be permitted to make Roth Contributions. A Roth Contribution represents an agreement by an Eligible Employee with his
Employer to (i) accept a reduction in Compensation in consideration of a contribution to the Plan by the Employer on the Participant’s behalf in the same amount, (ii) designate the contribution irrevocably, at the time of the election
as a Roth Contribution that is being made in lieu of all or a portion of the Tax-Deferred Contribution the Participant is otherwise eligible to make under Section 3.01 of the Plan; and (iii) provide that the contribution will be treated by
the Employer as includable in the Participant’s income pursuant to Section 402A of the Code. 

  

	 	(b)	 An Eligible Employee may enter into an agreement with his Employer as described in Section 3.08(a) in accordance with the same rules that apply
to Tax-Deferred Contributions under Section 3.01(b). 

  

	 	(c)	 An Eligible Employee’s aggregate Tax-Deferred and Roth Contributions shall not exceed the limits set forth in Section 3.01(b), the
limitations of Article 14, or the further limitations of this Article. 

  

	 	(d)	 Roth Contribution elections and Roth Contributions shall be subject to Sections 3.01(c) and 3.01(d), respectively. 

 

 33 

 ARTICLE 4 

Allocations to Participants’ Accounts 
  

	4.01	 Individual Accounts 

The Committee shall create and maintain adequate records to disclose the interest in the Trust Fund of each Participant
and Beneficiary. Such records shall be in the form of individual accounts and credits and charges shall be made to such accounts in the manner herein described. When appropriate, a Participant shall have any or all of the following separate
accounts: a Tax-Deferred Account, a Roth Account, a Matching Account, a Special Account, a Rollover Account and an After-Tax Account. The maintenance of individual accounts is only for accounting purposes, and a segregation of the assets of the
Trust Fund to each account shall not be required. Distributions and withdrawals made from an account shall be charged to the account as of the date paid. 
  

	4.02	 Account Allocations 

The Accounts of Participants and Beneficiaries shall be adjusted in accordance with the following: 

 

	 	(a)	 Income: As of each Valuation Date, each Investment Fund shall be revalued separately. Based on such revaluation of the Investment Funds, each
Account shall be revalued as of the applicable Valuation Date to reflect its proportionate share of investment experience since the immediately preceding Valuation Date. 

 

	 	(b)	 Tax-Deferred Contributions: As of each Valuation Date, the Tax-Deferred Contributions received by the Trust Fund since the immediately
preceding Valuation Date shall be allocated to the Tax-Deferred Accounts of the Participants on whose behalf such contributions were made. 

  

	 	(c)	 Matching Contributions: As of each Valuation Date, the Matching Contributions received by the Trust Fund since the immediately preceding
Valuation Date shall be allocated to the Matching Account of the Participants on whose behalf such contributions were made. 

  

 34 

	 	(d)	 Special Contributions: As of each Valuation Date, Special Contributions received by the Trust Fund since the immediately preceding Valuation
Date shall be allocated to the Special Accounts of Participants who are not Highly Compensated Employees and who were actively employed on the last day of the pay period for which the Special Contribution was made. The allocation for each
Participant eligible to receive a share of the allocation shall be equal to the total amount of the Special Contribution divided by the total number of Participants eligible to receive an allocation of Special Contributions. Therefore, each eligible
Participant shall receive the same dollar amount of allocation of Special Contributions as each other eligible Participant. 

  

	 	(e)	 Rollover Contributions: As of each Valuation Date, the Rollover Contributions received by the Trust Fund since the immediately preceding
Valuation Date on behalf of a Participant shall be allocated to such Participant’s Rollover Account. 

  

	 	(f)	 Roth Contributions: As of each Valuation Date, the Roth Contributions and any rollover Roth amounts received by the Trust Fund since the
immediately preceding Valuation Date shall be allocated to the Roth Accounts of the Participants on whose behalf such Roth Contributions and Roth rollovers were made. 

 

	4.03	 Limitation on Allocations 

Notwithstanding any of the foregoing, the amount of contributions that may be allocated to a Participant’s Aggregate
Account for a Plan Year shall be subject to the limitations under Sections 401(k), 401(m) and 415 of the Code as set forth in Article 14. 
  

 35 

	4.04	 No Guarantee 

The Employers, the Committee, and the Trustee do not guarantee the Participants or their Beneficiaries against loss or
depreciation or fluctuation of the value of the assets of the Trust Fund. 
  

	4.05	 Statement of Accounts 

The Committee will furnish each Participant, each Alternate Payee, and each Beneficiary of a deceased Participant, at
least quarterly, a statement showing the value of his Aggregate Account, the allocations to and distributions from his Accounts, and such other information as may be required by applicable law. No statement will be provided to a Participant or
Beneficiary after the Participant’s entire vested and nonforfeitable interest in his Accounts is distributed. 
  

 36 

 ARTICLE 5 

Vesting 
  

	5.01	 Nonforfeitability 

Except as provided in Section 11.07 and Article 14, the interest of each Participant in his Aggregate Account shall
be 100% vested and nonforfeitable at all times. 
  

 37 

 ARTICLE 6 

Investment Elections and Voting of Company Stock 
  

	6.01	 Investment Options 

  

	 	(a)	 The assets of the Trust Fund shall be maintained in multiple Investment Funds so as to provide alternative investment vehicles for the assets of the
Plan. Such separate funds shall include: 

  

	 	(i)	 Funds Investing in Company Stock. Each of the Company Stock funds described in Section 6.01(a)(i)(A) shall be an Investment Fund under
the Plan when indicated, subject to Sections 6.01(a)(i)(B) through 6.01(a)(i)(F): 

(A) The Company Stock funds offered under the Plan on and after the Effective Date shall be as follows:

 (I) The Company Stock Fund (a fund unitized as described in
Section 6.01(a)(i)(C)(I)) shall be an investment fund under the Plan through October 4, 2010, after which it shall be replaced by the Company Stock ESOP Fund described in Section 6.01(a)(i)(A)(II) and shall no longer be available
under the Plan. Before October 5, 2010, the Company Stock Fund shall consist of two components, the ESOP component and the Non-ESOP component: 

(a) The ESOP component shall constitute an “employee stock ownership plan” within the meaning
of Section 4975(e)(7) of the Code (herein referred to as the “ESOP” with respect to periods before October 5, 2010). No contribution made to the Plan for years beginning on or after the Effective Date may be contributed to the
ESOP component. 
 (b) The Non-ESOP component shall not constitute an “employee
stock ownership plan” within the meaning of Section 4975(e)(7) of the Code. The Non-ESOP component shall be 

 

 38 

 
available for investment of contributions made for years beginning on or after the Effective Date, but will not be available after October 4, 2010. If a Participant has directed that all or
any portion of the contributions to his Account shall be invested in Company Stock, the Participant’s direction shall be deemed to refer exclusively to the Non-ESOP component of the Company Stock Fund in the case of contributions made for years
beginning on or after the Effective Date that are contributed before October 5, 2010. 
 Participant
elections pursuant to Section 6.01(d)(ii) to transfer funds from another Investment Fund into the Company Stock Fund that are effective before October 5, 2010 shall be deemed to occur between the ESOP component of the Company Stock Fund
and the other Investment Fund. Participant elections pursuant to Section 6.01(d)(ii) to transfer funds from the Company Stock Fund to another Investment Fund that are effective before October 5, 2010 will be deducted first from the
Participant’s interest in the Non-ESOP component of the Company Stock Fund; once all funds in the Non-ESOP component have been transferred, any remaining funds necessary to complete the transfer will be deducted from the Participant’s
interest in the ESOP component. 
 (II) The Company Stock ESOP Fund (a share-accounted
fund as described in Section 6.01(a)(i)(C)(II)) shall be an Investment Fund under the Plan on and after October 5, 2010. The Company Stock ESOP Fund shall constitute an “employee stock ownership plan” within the meaning of
Section 4975(e)(7) of the Code (herein referred to as the “ESOP” with respect to periods on and after October 5, 2010). No contribution made to the Plan on or after October 5, 2010 may be invested in the Company Stock ESOP
Fund. However, all Participant Account balances invested in the unitized Company Stock Fund described in Section 6.01(a)(i)(A)(I) (including both the ESOP and Non-ESOP components) as of the close of business on October 4, 2010 shall be

  

 39 

 
transferred to and invested in the share-accounted Company Stock ESOP Fund as of October 5, 2010. In addition, on and after October 5, 2010, Participants may elect to transfer funds
from another Investment Fund (other than the Company Stock Non-ESOP Fund described in Section 6.01(a)(i)(A)(III)) into the Company Stock ESOP Fund and to transfer funds from the Company Stock ESOP Fund to another Investment Fund (other than the
Company Stock Non-ESOP Fund) pursuant to Section 6.01(d)(ii). 
 (III) The Company Stock
Non-ESOP Fund (a share-accounted fund as described in Section 6.01(a)(i)(C)(II)) shall be an Investment Fund under the Plan on and after October 5, 2010. The Company Stock Non-ESOP Fund shall not constitute an “employee
stock ownership plan” within the meaning of Section 4975(e)(7) of the Code. Contributions made to the Plan on or after October 5, 2010 that are subject to a Participant’s direction to invest in Company Stock shall be invested in
the Company Stock Non-ESOP Fund. Participants may not elect to transfer funds from another Investment Fund into the Company Stock Non-ESOP Fund, although Participants may elect to transfer funds from the Company Stock Non-ESOP Fund to another
Investment Fund (other than the Company Stock ESOP Fund described in Section 6.01(a)(i)(A)(II)) pursuant to Section 6.01(d)(ii). In each Plan Year beginning on or after January 1, 2011, all assets of the Company Stock Non-ESOP Fund
shall be transferred to the Company Stock ESOP Fund as of the earliest business day after the record date for the Company Stock dividend and before the close of such year as is administratively practicable. 

(B) The Company Stock funds described in Section 6.01(a)(i)(A) shall not be managed investment funds
and shall be invested, to the maximum extent practicable, entirely in Company Stock at all times. Before October 5, 2010, to satisfy daily Participant requests for 

 

 40 

 
transfers and payments, the Company Stock Fund described in Section 6.01(a)(i)(A)(I) also shall include cash or short-term liquid investments in accordance with this paragraph. The Committee
shall, after consultation with the Trustee, establish and communicate to the Trustee in writing a target liquidity percentage and drift allowance for such short-term liquid investments. The Trustee is responsible for ensuring that the actual cash
held in the Company Stock Fund before October 5, 2010 falls within the agreed on range over time. 

(C) (I) For periods before October 5, 2010, each Participant’s proportional interest in
the Company Stock Fund shall be measured in units of participation rather than in shares of Company Stock. Such units shall represent a proportionate interest in all of the assets of the Company Stock Fund, which include shares of Company Stock,
short-term investments and, at times, receivables for dividends and/or Company Stock sold and payables for Company Stock purchased. A Net Asset Value (“NAV”) per unit will be determined as of each Valuation Date for each unit outstanding
of the Company Stock Fund. The NAV shall be adjusted by gains or losses realized on sales of Company Stock, appreciation or depreciation in the market price of those shares owned, interest on the short-term investments held by the Company Stock
Fund, expenses that pursuant to the Committee’s direction the Trustee accrues or pays from the Company Stock Fund, commissions on purchases and sales of Company Stock, and as otherwise provided in the Trust Agreement. 

(II) For periods on or after October 5, 2010, each Participant’s proportional interest in the
Company Stock ESOP Fund or the Company Stock Non-ESOP Fund shall be measured in full and fractional shares of Company Stock held by the Company Stock ESOP Fund or the Company Stock Non-ESOP Fund, respectively. 

 

 41 

 Any and all rights to sell Company Stock shall be administered in
accordance with the Company’s insider trading policy. 
 (D) The Company, the settlor of
the Plan, intends the Company Stock funds described in Section 6.01(a)(i)(A) to offer eligible employees opportunities to invest indirectly in Company Stock and to participate in the performance of Company Stock on terms similar to those that
apply to Company shareholders. The Company intends the Company Stock funds described in Section 6.01(a)(i)(A) to offer such opportunities over an indefinite period of time during which the performance of Company Stock could vary widely. The
Company intends such Company Stock funds to continue to offer such opportunities under all market conditions and regardless of the current, recent, or historical performance of the Company or Company Stock (for example, regardless of whether, over
any period of time (of whatever duration), the Company pays dividends to its shareholders and regardless of whether, over any period of time (of whatever duration), the market price of Company Stock (I) rises or falls, (II) is volatile or
stable, or (III) is high or low in relation to any reference point). The Company recognizes that an investment in an undiversified fund, such as the Company Stock Fund, the Company Stock ESOP Fund, or the Company Stock Non-ESOP Fund, is subject to
greater risk than is an investment in a diversified fund, and the Company expects eligible employees to take that greater risk into account when deciding whether to participate (or to continue participating) in any such fund. 

(E) Because the purpose of the Company Stock funds described in Section 6.01(a)(i)(A) is to offer
eligible employees opportunities to invest indirectly in Company Stock and to participate in the performance of such stock on terms similar to those that apply to Company shareholders, the Plan’s fiduciaries and administrators shall not
(I) disclose material non-public information regarding the Company or 
  

 42 

 
Company Stock to the Plan, to the Trustee or other Plan fiduciaries, or to Participants or their Beneficiaries or Alternate Payees before such information is publicly disclosed or (II) based on
such non-public information (and before such information is publicly disclosed), cause the Plan, the Trustee or other Plan fiduciaries, or Participants or their Beneficiaries or Alternate Payees to take any action with respect to Company Stock (such
as buying or selling Company Stock or directing funds into or out of a Company Stock fund described in Section 6.01(a)(i)(A)). 

(F) Each Participant shall be entitled to elect, at such time and such manner as the Committee shall
prescribe, to receive a distribution from the Plan of an amount in cash equal to the Participant’s proportional interest in any dividends paid with respect to Company Stock held on the record date for the dividend by the ESOP component of the
Company Stock Fund or the Company Stock ESOP Fund, as applicable. A Participant may make such an election with respect to the dividends paid on any given date only if the value of the Participant’s proportional interest in the dividends paid on
such date exceeds $10. Participants shall not be entitled to elect under this subparagraph to receive a distribution from the Plan of dividends paid with respect to Company Stock held on the record date for the dividend by the Non-ESOP component of
the Company Stock Fund or the Company Stock Non-ESOP Fund, as applicable. Dividends paid with respect to Company Stock held on the record date for the dividend by: 

(I) the ESOP component of the Company Stock Fund or the Company Stock ESOP Fund, as applicable, with
respect to which no election to receive a cash distribution has been made or is available, or 

(II) the Non-ESOP component of the Company Stock Fund or the Company Stock Non-ESOP Fund, as applicable,

  

 43 

 
shall be reinvested in additional shares of Company Stock (before October 5, 2010, to the extent it is unnecessary to retain such dividends as cash to maintain any target liquidity
percentage), and the Aggregate Accounts of eligible Participants will be credited with additional units of participation for reinvestments before October 5, 2010 and additional shares and/or fractional shares of Company Stock for reinvestments
on or after October 5, 2010. 
  

	 	(ii)	 Other Funds. Additional Investment Funds may be established by the Committee, which (except to the extent provided to the contrary in this
Section 6.01) shall have the sole discretion to determine the number and character of such additional Investment Funds. The Committee, in its sole discretion, shall have the authority to limit or eliminate the availability of any of the
Investment Funds established pursuant to this Section 6.01(a)(ii); provided, however, that the Committee, in its capacity as the Plan’s investment fiduciary, shall not have the authority to limit or eliminate the availability of any
Company Stock fund described in Section 6.01(a)(i)(A). 

  

	 	(b)	 Subject to the provisions of Section 6.01(f), the Committee shall adopt such rules and procedures as it deems advisable with respect to all
matters relating to the selection and use of the Investment Funds, provided that all Participants are treated uniformly. 

  

	 	(c)	 Except to the extent that a Participant’s loan is considered a separate investment pursuant to Section 7.01, each Participant shall
designate the Investment Fund(s) (to the extent such Investment Fund(s) are available for new contributions) under which his Tax-Deferred, Roth, After-Tax, Rollover, Matching, and Special Contributions and loan repayments under Article 7 are to be
invested. Such designation shall be in the form and manner prescribed by the Committee. If a Participant fails to designate the Investment Fund(s) under which any of his contributions are to be invested, such contributions shall be invested in the
default Investment Fund(s) specified in the Trust Agreement. 

  

 44 

	 	(d)	 A Participant may (i) change his election of Investment Funds with respect to his future contributions, or (ii) redesignate the
proportions and/or the Investment Funds in which amounts already allocated to his Tax-Deferred, Roth, After-Tax, Rollover, Matching, and Special Accounts shall be invested (to the extent such Investment Fund(s) are available to accept contributions
or transferred amounts). Elections made under this Section 6.01(d) shall be in the form and manner prescribed by the Committee, and shall be subject to any limitations described elsewhere in this Section 6.01. 

 

	 	(e)	 If a Participant dies, his Beneficiary has the same investment election rights as the Participant had prior to his death, until the
Participant’s Aggregate Account is distributed to the Beneficiary. 

  

	 	(f)	 The Plan, including its constituent ESOP, is intended to constitute a plan described in Section 404(c) of ERISA and Title 29 of the Code of
Federal Regulations, Section 2550.404c-1. As such, the Plan’s fiduciaries may be relieved of liability for any losses that are the direct and necessary result of investment instructions given by a Participant or a Beneficiary.

  

	 	(g)	 Each Participant is solely responsible for the selection of his investment options. The Trustee, the Committee, the Employers, and the officers,
supervisors and other employees of the Employers are not empowered to advise a Participant as to the manner in which his accounts shall be invested. The fact that an Investment Fund is available to Participants for investment under the Plan shall
not be construed as a recommendation for investment in that particular Investment Fund. 

  

 45 

	 	(h)	 Notwithstanding the foregoing provisions of Sections 6.01(a) through (g), the Plan shall comply with the diversification requirements of
Section 401(a)(35) of the Code and Treasury regulations and other applicable guidance issued thereunder. In this respect, a Participant, Beneficiary, or Alternate Payee shall be eligible to transfer all or part of the portion of his Aggregate
Account that is invested (I) before October 5, 2010, in the Company Stock Fund or (II) on or after October 5, 2010, in the Company Stock ESOP Fund or the Company Stock Non- ESOP Fund to any of the other available Investment Funds (to
the extent available for transfers in), as provided in Section 6.01(c) or (d). In addition: 

  

	 	(i)	 The Investment Funds described in Section 6.01(a) shall include not less than three Investment Funds, other than any Company Stock fund
described in Section 6.01(a)(i)(A), into which a Participant, Beneficiary, or Alternate Payee may elect to transfer amounts invested in such a Company Stock fund. Each such additional Investment Fund shall be diversified and have materially
different risk and return characteristics (or shall qualify to be treated as such pursuant to Treasury regulations or other applicable guidance). 

  

	 	(ii)	 The rules adopted by the Committee pursuant to Section 6.01(b): 

(A) shall provide Participants, Beneficiaries, and Alternate Payees with reasonable, periodic
opportunities to direct the transfer described in (i), occurring not less frequently than quarterly; and 

(B) shall not impose direct or indirect restrictions or conditions with respect to investment in any
Company Stock fund described in Section 6.01(a)(i)(A) that are not imposed on investments in other Investment Funds, other than restrictions or conditions required or designed to ensure compliance with securities laws (such as, the rules that
permit a three-day settlement period for securities transactions) or such other restrictions or conditions as may otherwise be permitted under Treasury regulations or other applicable guidance. 

 

	 	(iii)	 The Committee shall notify Participants, Beneficiaries, and Alternate Payees of their diversification rights at the time, in the manner, and to the
extent required pursuant to Section 101(m) of ERISA and regulations and other guidance issued thereunder. 

  

 46 

	6.02	 Voting of Company Stock 

  

	 	(a)	 Voting. Each Participant with an interest in any Company Stock fund described in Section 6.01(a)(i)(A) shall have the right to direct
the Trustee as to the manner in which the Trustee is to vote (including not to vote): 

  

	 	(i)	 before October 5, 2010, that number of shares of Company Stock attributable to the units of participation in the Company Stock Fund that are
credited to the Participant’s Aggregate Account, or 

  

	 	(ii)	 on or after October 5, 2010, the full and fractional shares of Company Stock held by the Company Stock ESOP Fund and the Company Stock Non-ESOP
Fund that are credited to the Participant’s Aggregate Account, 

 in either case,
hereinafter referred to as the “Participant’s interest in Company Stock.” Directions from a Participant to the Trustee concerning the voting of Company Stock shall be communicated in writing, or by such other means as is agreed upon
by the Trustee and the Committee. These directions shall be held in confidence by the Trustee and shall not be divulged to the Committee, the Company, or any officer or employee thereof, or any other person except to the extent that the consequences
of such directions are reflected in reports regularly communicated to any such persons in the ordinary course of the performance of the Trustee’s services hereunder. Upon its receipt of the directions, the Trustee shall vote the shares of
Company Stock reflecting the Participant’s interest in Company Stock as directed by the Participant. Except as otherwise required by law, the Trustee shall vote shares of Company Stock reflecting the Participant’s interest in Company Stock
for which it has received no direction from the Participant in the same proportion on each issue as it votes those shares reflecting Participants’ interests in Company Stock for which the Trustee has received voting directions from
Participants. 
  

	 	(b)	 Tender and Exchange Offers. Each Participant with an interest in any Company Stock fund described in Section 6.01(a)(i)(A) shall have
the right to direct the Trustee to tender or not to tender some or all of the shares of Company Stock 

 

 47 

	 	 
reflecting such Participant’s interest in Company Stock described in the first sentence of Section 6.02(a). Directions from a Participant to the Trustee concerning the tender of Company
Stock shall be communicated in writing, or by such other means as is agreed upon by the Trustee and the Committee. These directions shall be held in confidence by the Trustee and shall not be divulged to the Committee, the Company, or any officer or
employee thereof, or any other person except to the extent that the consequences of such directions are reflected in reports regularly communicated to any such persons in the ordinary course of the performance of the Trustee’s services
hereunder. The Trustee shall tender or not tender shares of Company Stock as directed by the Participant. Except as otherwise required by law, the Trustee shall not tender shares of Company Stock reflecting a Participant’s interest in Company
Stock for which it has received no direction from the Participant. 

  

	 	(i)	 Withdrawal of Tender. A Participant who has directed the Trustee to tender some or all of the shares of Company Stock reflecting the
Participant’s interest in Company Stock may, at any time prior to the tender offer withdrawal deadline, direct the Trustee to withdraw some or all of the tendered shares reflecting the Participant’s interest, and the Trustee shall withdraw
the directed number of shares from the tender offer prior to the tender offer withdrawal deadline. A Participant shall not be limited as to the number of directions to tender or withdraw that the Participant may give to the Trustee.

  

	 	(ii)	 Tender Proceeds. A direction by a Participant to the Trustee to tender shares of Company Stock reflecting the Participant’s interest in
Company Stock shall not be considered a written election under the Plan by the Participant to withdraw, or have distributed, any or all of his withdrawable interest in the Plan. The Trustee shall credit to each Account of the Participant from which
the tendered shares were taken the proceeds received by the Trustee in exchange for the shares of Company Stock tendered from the Account. Pending receipt of directions from the

  

 48 

	 	 
Participant or the Committee, as provided in the Plan, as to which of the remaining Investment Funds the proceeds should be invested in, the Trustee shall invest the proceeds in such Investment
Fund(s) as may be prescribed by the Trust Agreement. 

  

	 	(iii)	 Exchange Offers. All of the provisions of this Section 6.02(b) shall apply to exchange offers as well as to tender offers.

  

	 	(c)	 Other Shareholder Rights. With respect to all shareholder rights other than the right to vote, the right to tender or exchange, and the right
to withdraw shares previously tendered, in the case of Company Stock, the Trustee shall follow the procedures described in Section 6.02(a). 

  

	 	(d)	 Stock Conversions. All of the provisions of this Section 6.02 shall apply to securities received as a result of a conversion of Company
Stock. 

  

 49 

 ARTICLE 7 

Participant Loans 
  

	7.01	 Loans to Active Participants 

The Committee shall direct the Trustee to loan a Participant or Alternate Payee who is actively employed by an Employer an
amount from his Tax-Deferred, Roth, After-Tax, Matching, Special and Rollover Accounts in accordance with the rules of this Section and the Plan’s loan rules, which shall be considered to be a part of the Plan. 

 

	 	(a)	 A Participant or Alternate Payee may have only one outstanding loan at a time. 

 

	 	(b)	 A Participant’s or Alternate Payee’s loan shall not be less than $1,000 and shall not exceed the lesser of (i) $50,000, reduced to
the extent of the Participant’s or Alternate Payee’s highest outstanding loan balance during the immediately prior 12-month period (ending the day before the new loan is granted) under the Plan and any other qualified plan maintained by
the Employer or an Affiliated Employer or (ii) 50% of the total dollar value of the Participant’s or Alternate Payee’s Tax-Deferred, Roth, After-Tax, Matching, Special and Rollover Accounts as of the date the loan is made.

  

	 	(c)	 Spousal Consent for a loan will not be required. 

  

	 	(d)	 All loans shall be subject to the approval of the Committee and to such rules or regulations as the Committee shall adopt.

  

	 	(e)	 An application for a loan by a Participant or Alternate Payee shall be made in accordance with the administrative procedures set forth by the
Committee. 

  

	 	(f)	 Each loan shall be made at a reasonable rate of interest determined in accordance with the Plan’s loan rules. The interest rate so determined
with respect to a particular loan shall be fixed for the duration of such loan. Each loan shall be secured by the balance remaining in the borrower’s Aggregate Account or by such other security as the Committee may deem to be adequate.

  

 50 

	 	(g)	 Each loan shall be treated as a separate investment of the funds credited to a Participant’s or Alternate Payee’s Tax-Deferred, Roth,
After-Tax, Matching, Special or Rollover Account. 

  

	 	(h)	 For loans funded on or after the Effective Date, loan proceeds shall be taken from the Participant’s or Alternate Payee’s Aggregate
Accounts in the following order: 

  

	 	(i)	 first, the Rollover Account; 

  

	 	(ii)	 second, that portion of the Tax-Deferred Account attributable to Tax-Deferred Contributions that are not catch-up contributions described in
Section 3.07 (with amounts attributable to Tax-Deferred Contributions made before 2003 taken first to the extent such amounts are accounted for separately); 

 

	 	(iii)	 third, the After-Tax Account; 

  

	 	(iv)	 fourth, that portion of the Tax-Deferred Account attributable to Tax-Deferred Contributions that are catch-up contributions described in
Section 3.07; 

  

	 	(v)	 fifth, the Matching Account; and 

  

	 	(vi)	 lastly, the Roth Account. 

  

	 	(i)	 In accordance with Code Section 72(p)(3), the Committee shall notify the borrower that no interest deduction can be claimed with respect to any
loan secured by the borrower’s Tax-Deferred Account or Roth Account. 

  

	 	(j)	 Loan documentation will be processed within the time periods established by the Committee in its administrative procedures.

  

	7.02	 Repayment of Loans 

  

	 	(a)	 The period of repayment for any loan shall be arrived at by agreement between the Committee and the borrower, but all loans shall become due and
payable on 

  

 51 

	 	 
termination of employment. The repayment period shall be in full year increments and shall not exceed five (5) years, except that a 30-year repayment period may apply to any loan used for
the purpose of purchasing a home that is the Participant’s or Alternate Payee’s principal residence. 

  

	 	(b)	 Loans may be repaid in full at any time. Partial prepayment is not allowed. 

 

	 	(c)	 On the Participant’s or Alternate Payee’s termination of employment, the full amount of the loan becomes due and payable, regardless of
whether a distribution is made pursuant to Section 8.03 at that time. 

  

	 	(d)	 Repayment of loans shall be by regular payroll deduction, and all loans shall be contingent on the borrower’s payroll deduction authorization,
provided that if a Participant is subsequently granted an unpaid leave of absence or is transferred to an Affiliated Employer or a position or location with the Employer that is not covered by the Plan (or ceases to have sufficient compensation from
which the loan payment can be made), the Participant must continue to make timely level installment payments of principal and interest, by certified check, bank check, or money order or by such other method as may be prescribed by the Committee.
Loan payments shall be transmitted to the Trustee in accordance with the Committee’s usual administrative practice, provided that, if a Participant’s loan is funded in part by an amount attributable to his Roth Account, a proportionate
share of each of the Participant’s loan payments shall be allocated to the Participant’s Roth Account. 

  

	 	(e)	 Loan defaults shall be treated as taxable distributions pursuant to Code requirements, but may not be applied to the borrower’s collateral in
his Tax-Deferred, Roth, Matching, or Special Account until such time as a distribution from such accounts could otherwise be made under the Plan. 

  

	 	(f)	 Notwithstanding the foregoing, in the event a Participant enters qualified military service as defined in Section 2.04(b), loan repayments
shall be suspended (and interest shall cease to accrue) during the period of service, and the period of 

  

 52 

	 	 
repayment shall be extended by the number of months of the period of qualified military service; provided, however, if the Participant incurs a termination of employment and requests a
distribution pursuant to Article 8, the loan shall be canceled, and the outstanding loan balance shall be distributed pursuant to Article 8. 

  

 53 

 ARTICLE 8 

Distributions to Participants and Beneficiaries 
  

	8.01	 Withdrawals from After-Tax Account and Rollover Account 

 

	 	(a)	 A Participant may elect to withdraw amounts credited to his After-Tax Account, provided that the minimum withdrawal amount shall be $250 or, if
less, the total value of the Participant’s After-Tax Account. 

  

	 	(b)	 A Participant may elect to withdraw amounts credited to his Rollover Account, provided that the minimum withdrawal amount shall be $250 or, if less,
the total value of the Participant’s Rollover Account. 

  

	 	(c)	 Elections under this Section 8.01 shall be on forms approved by the Committee for that purpose. 

 

	8.02	 Hardship Withdrawals 

  

	 	(a)	 A Participant who either: 

  

	 	(i)	 has not terminated employment, or 

  

	 	(ii)	 has terminated employment but is a former ABC Employee who first became a member under the ABC, Inc. Savings & Investment Plan before
January 1, 1995, 

 may request a distribution in the event the Participant has a
hardship as defined in subsections (b) and (c). Hardship withdrawals are limited to the excess of the total amount of the Participant’s Rollover Account, the total amount of the Participant’s Matching Account, the value of the
Participant’s Tax-Deferred Account as of December 31, 1988, plus the principal of the Participant’s Tax-Deferred Contributions made from and after January 1, 1989 and the principal of the Participant’s Roth Contributions
over any outstanding loan the Participant may have and the sum of any prior hardship withdrawals. A hardship withdrawal shall not be made for an amount less than $250. 
  

 54 

	 	(b)	 A distribution will be made on account of hardship only if the distribution is necessary to satisfy an immediate and heavy financial need of the
Participant. For purposes of this Plan, a distribution is made on account of an immediate and heavy financial need of the Participant only if the distribution is for: 

 

	 	(i)	 the payment of medical expenses described in Section 213(d) of the Code incurred or to be incurred by the Participant, the Participant’s
Spouse, any dependents of the Participant (as defined in Section 152 of the Code, but without regard to Sections 152(b)(1), (b)(2), and (d)(1)(B)), or the Participant’s Beneficiary; 

 

	 	(ii)	 costs directly related to the purchase of a principal residence for the Participant or a major rehabilitation of the living quarters of the
Participant’s principal residence, but excluding mortgage payments; 

  

	 	(iii)	 the payment of tuition, related educational fees, room and board for up to the next twelve (12) months of post-secondary education for the
Participant, his or her Spouse, children, dependents (as defined in Code Section 152, but without regard to Sections 152(b)(1), (b)(2), and (d)(1)(B)), or the Participant’s Beneficiary; 

 

	 	(iv)	 the prevention of the eviction of the Participant from his principal residence or foreclosure on the mortgage of the Participant’s principal
residence; 

  

	 	(v)	 the payment of burial or funeral expenses for the Participant’s Spouse, child, parent, mother-in-law, father-in-law, other dependents (as
defined in Code Section 152, but without regard to Section 152(d)(1)(B)), or Beneficiary; or 

  

	 	(vi)	 the payment of expenses for the repair of damage to the Participant’s principal residence that would qualify for the casualty deduction under
Section 165 of the Code (without regard to whether the loss exceeds 10% of adjusted gross income). 

  

 55 

	 	(c)	 A distribution will be considered necessary to satisfy an immediate and heavy financial need of the Participant only if all three (3) of the
following requirements are satisfied: 

  

	 	(i)	 the distribution is not in excess of the amount required to relieve the immediate and heavy financial need of the Participant (taking into account
the taxable nature of the distribution); 

  

	 	(ii)	 the Participant has obtained (or is currently obtaining) all distributions, withdrawals, and loans available under the Plan and all other plans
maintained by any Employer or any Affiliated Employer (including any available distribution of dividends described in Section 6.01(a)(i)(F)) other than hardship distributions and the Participant represents in writing, on forms provided by the
Committee and by providing any documentation required by the Committee, that the need cannot be relieved through reimbursement or compensation by insurance or otherwise, by reasonable liquidation of the Participant’s assets, to the extent such
liquidation would not itself cause an immediate and heavy financial need, by cessation of Tax-Deferred and Roth Contributions under the Plan, by withdrawals, distributions (other than hardship distributions) or nontaxable loans (at the time of the
loan) from any plan maintained by any other entity by which the Participant is employed, or by borrowing from commercial sources on reasonable commercial terms; and 

 

	 	(iii)	 the Committee determines that it can reasonably rely on the Participant’s written representation. 

 

	 	(d)	 Distributions pursuant to this Section will be made as soon as practicable following the Committee’s approval of the Participant’s written
request for withdrawal and will be made in the form of a single lump sum payment. The Committee may request any documentation it may require from a Participant to make a determination that the Participant is eligible for a hardship withdrawal
hereunder. 

  

 56 

	 	(e)	 A Participant who receives a hardship withdrawal under this Section 8.02 shall be prohibited from making Tax-Deferred or Roth Contributions
under this Plan and elective deferrals and employee contributions under all other plans of the Employer or an Affiliated Employer for six months after receipt of the distribution. 

 

	 	(f)	 All hardship withdrawal elections must be made on forms approved by the Committee for that purpose. 

 

	8.03	 Distributions on Account of Termination of Employment 

 

	 	(a)	 Except as set forth in Section 8.03(c) below, distribution of a Participant’s Aggregate Account shall commence as soon as practicable
after the Participant’s termination of employment. A Participant’s distributable Aggregate Account is based on the value of that Account as of the Valuation Date the Aggregate Account is to be distributed, except that there will be added
to the value of the Participant’s Aggregate Account the fair market value of any amounts allocated to his Aggregate Account under Article 4 after that Valuation Date. If a loan is outstanding from the Trust Fund to the Participant on the date
of distribution, the amount distributed will be reduced by the outstanding loan balance. The distribution will be paid to the Participant’s Beneficiary in the event the Participant’s termination of employment is caused by his death. In all
other cases, payment will be made to the Participant. 

  

	 	(b)	 Distributions will be in the form of a lump sum cash payment, except that the Participant may request that any portion of the Participant’s
Aggregate Account that is invested in a Company Stock fund described in Section 6.01(a)(i)(A) will be distributed in shares of Company Stock, plus cash for any fractional shares. 

 

	 	(c)	 If the Participant’s termination of employment is due to reasons other than death and if the amount of his Aggregate Account (determined
without regard to the value of his Rollover Account) exceeds the Cashout Limit, the Committee will not automatically distribute the Participant’s Aggregate Account. The Cashout Limit is $1,000 for distributions after March 27, 2005.

  

 57 

 The Participant may elect an immediate lump sum distribution at any time
after his termination of employment; however, a Participant may elect to delay his distribution until the earliest date that distribution of his Aggregate Account must commence pursuant to Section 8.08. All elections under this
Section 8.03(c) shall be made in the manner approved by the Committee. 
  

	 	(d)	 If a Participant dies prior to receiving the lump sum distribution of his Aggregate Account under this Section, the distribution shall be paid to
the Participant’s Beneficiary as soon as practical after the Participant’s death. Notwithstanding the foregoing, in the event of the death of a Participant who is an ABC Employee (including a former ABC Employee) before he has received
distribution of his Aggregate Account, distribution to such Participant’s Beneficiary shall be made as of the Valuation Date coincident with or next following the Participant’s normal retirement date (or the Participant’s date of
death if later) or as of such earlier Valuation Date as the Beneficiary may elect in such form and manner, and at such time, as the Committee shall prescribe, provided that the Beneficiary shall receive distribution no later than the date on which
distribution is required to be made pursuant to Section 8.08. For purposes of the immediately preceding sentence, “normal retirement date” shall mean the first day of the month coincident with or next following the date the
Participant attained or would have attained age 65. 

  

	 	(e)	 It is possible for a Participant or Beneficiary to receive a distribution under this Section before all Matching and Special Contributions on behalf
of the Participant are made to the Trust Fund. In such case, such additional amounts shall be paid to the Participant or Beneficiary as soon as practical after the Trust Fund’s receipt thereof. 

 

	 	(f)	 If a Participant who terminated employment again becomes an Employee before commencing a distribution of his Aggregate Account, no distribution from
the 

  

 58 

	 	 
Trust Fund will be made while he is an Employee, and amounts distributable to him on account of his prior termination will be held in the Trust Fund until he is again entitled to a distribution
under the Plan. If a Participant who terminated employment again becomes an Employee after commencing a distribution of his Aggregate Account (including in a form other than a lump sum that may be preserved in an Appendix to the Plan for account
balances transferred to the Plan from other plans), distributions that have begun shall continue while he is an Employee. However, amounts, if any, that are contributed to the Plan by or on behalf of the Employee during his reemployment will be held
in the Trust Fund until he is again entitled to a distribution under the Plan. 

  

	 	(g)	 Notwithstanding any provision of this Plan to the contrary, a lump sum payment shall be made in lieu of all vested benefits if the value of the
vested portion of the Participant’s Aggregate Accounts (determined without regard to the value of his Rollover Account) does not exceed the Cashout Limit. The Cashout Limit is $1,000 for distributions after March 27, 2005.

  

	8.04	 Restrictions and Requirements on Distributions 

 

	 	(a)	 Except for distributions permitted under Section 8.01 with respect to Participants who withdraw from their After-Tax Account or Rollover
Account, Section 8.02 with respect to Participants who suffer a hardship, Section 8.07 with respect to Participants who reach age
59- 1/2, or Section 2.04(i) for certain
Participants on active military duty, a Participant’s interest in the Plan will not be distributed before the Participant’s termination of employment or death; provided, however, that if: 

 

	 	(i)	 The Plan is terminated without the establishment or maintenance by the Employers of an alternative defined contribution plan (within the meaning of
Code Section 401(k)(10), Section 1.401(k)-1(d)(4) of the Treasury regulations, and other applicable guidance), or 

  

 59 

	 	(ii)	 A Participant incurs a “severance from employment” (within the meaning of Code Section 401(k)(2)(B), Section 1.401(k)-1(d)(2) of
the Treasury regulations, and other applicable guidance) on account of an Employer’s or Affiliated Employer’s sale of the assets in a trade or business or sale of a subsidiary, 

the Participant shall receive, or be entitled to receive payment of his Accounts following such event in accordance with
the provisions of this Article 8, including Section 8.04(b). 
  

	 	(b)	 An event described in Section 8.04(a)(i) that otherwise would permit distribution of a Participant’s interest in the Plan will not be
treated as described in Section 8.04(a)(i) unless the Participant receives a lump sum distribution by reason of the event. A lump sum distribution for this purpose will be a distribution described in Section 402(e)(4)(D) of the Code
(without regard to subclauses (I), (II), (III), and (IV) of clause (i) thereof). 

  

	 	(c)	 The provisions of this Section 8.04(c) will apply to restrict the Committee’s ability to delay the commencement of distributions. Except
as otherwise provided in this Article 8, distribution of the Participant’s interest in his Aggregate Account shall begin no later than the 60th day after the close of the Plan Year in which occurs the latest of: 

 

	 	(i)	 The Participant’s 65th birthday; 

  

	 	(ii)	 The tenth anniversary of the date on which he became a Participant; or 

 

	 	(iii)	 The date he terminates employment. 

  

	 	(d)	 The provisions of Section 8.08 will apply to restrict a Participant’s ability to delay distribution of benefits.

  

	 	(e)	 The Committee or its delegate shall provide recipients of a benefit hereunder with appropriate claim forms, election forms, withholding forms and an
officially approved notice supplied by the Secretary of the Treasury that specifies certain information regarding the federal income tax treatment of Plan benefits paid in the form of a lump sum. 

 

 60 

	8.05	 Method of Payment for Eligible Rollover Distributions 

 

	 	(a)	 Notwithstanding any provision of the Plan to the contrary, if a Distributee is entitled to receive an Eligible Rollover Distribution that exceeds
$200, the Distributee may elect, at the time and in the manner prescribed by Committee and in accordance with this Section 8.05, to have his Eligible Rollover Distribution paid in accordance with one of the following methods:

  

	 	(i)	 all of the Eligible Rollover Distribution shall be paid directly to the Distributee; 

 

	 	(ii)	 all of the Eligible Rollover Distribution shall be paid as a Direct Rollover to the Eligible Retirement Plan designated by the Distributee; or

  

	 	(iii)	 the portion of the Eligible Rollover Distribution as designated by the Participant, which portion shall be at least $500 or such lesser amount as
the Committee shall determine, shall be paid as a Direct Rollover to the Eligible Retirement Plan designated by the Distributee and the balance of the Eligible Rollover Distribution shall be paid directly to the Distributee.

  

	 	(b)	 No less than thirty (30) days and no more than one hundred eighty (180) days prior to the Distributee’s payment date, the Committee
shall provide the Distributee with an election form and a notice that satisfies the requirements of Section 1.411(a)-11(c) of the Treasury regulations and Section 402(f) of the Code. 

 

	 	(c)	 Notwithstanding the provisions of Section 8.05(b) above, distributions paid in accordance with Section 8.05(a) may commence less than 30
days after the material described in Section 8.05(b) is given to the Distributee provided that: 

  

	 	(i)	 If the Distributee is the Participant, the value of his Aggregate Accounts (determined without regard to the value of his Rollover Account) does not
exceed the Cashout Limit. The Cashout Limit is $1,000 for distributions after March 27, 2005; or 

  

 61 

	 	(ii)	 The Distributee is notified that he has the right to a period of at least thirty (30) days after receipt of the material to decide whether or
not to elect a distribution and, after receipt of such notification, the Distributee affirmatively elects to receive a distribution. 

  

	 	(d)	 The following definitions apply to the terms used in this Section 8.05: 

 

	 	(i)	 “Eligible Rollover Distribution” means any distribution of all or any portion of the balance to the credit of the Distributee, except that
an Eligible Rollover Distribution does not include: 

 (A) Any distribution
that is one of a series of substantially equal periodic payments (not less frequently than annually) made for the life (or life expectancy) of the Distributee or the joint lives (or joint life expectancies) of the Distributee and the
Distributee’s designated beneficiary, or for a specified period of ten (10) years or more; 

(B) Any distribution to the extent such distribution is required under Section 401(a)(9) of the
Code; 
 (C) Any amount that is distributed on account of hardship; and 

(D) Any other type of distribution that the Internal Revenue Service announces (pursuant to regulation,
notice or otherwise) is not an Eligible Rollover Distribution pursuant to Section 402(c) of the Code. 
 A
portion of a distribution shall not fail to be an Eligible Rollover Distribution merely because the portion consists of after-tax contributions that are not includible in an Employee’s gross income. However, such portion may be paid only to
(A) an individual retirement account or annuity described in Code Section 408(a) or (b), or (B) an annuity contract described in Code Section 403(b) or a qualified plan described in Code

  

 62 

 
Section 401(a) or 403(a) that separately accounts for amounts so transferred (and earnings thereon), including separately accounting for the portion that is includible in gross income and
the portion that is not so includible. Likewise, a portion of a distribution shall not fail to be an Eligible Rollover Distribution merely because the portion consists of Roth contributions, provided that such portion may be paid only to (A) a
Roth IRA described in Section 408A(b) of the Code or (B) an applicable retirement plan described in Section 402A(e)(1) of the Code that separately accounts for amounts so transferred (and earnings thereon), and in either case, only to
the extent the rollover is permitted under the rules of Section 402(c) of the Code. 
  

	 	(ii)	 “Eligible Retirement Plan” means any of the following that accepts the Distributee’s Eligible Rollover Distribution: (A) an
individual retirement account described in Section 408(a) of the Code, (B) an individual retirement annuity described in Section 408(b) of the Code (other than an endowment contract), (C) an annuity plan described in
Section 403(a) of the Code, (D) a qualified trust described in Section 401(a) of the Code, (E) an annuity contract described in Section 403(b) of the Code, (F) an eligible plan under Section 457(b) of the Code that
is maintained by a state, political subdivision of a state or any agency or instrumentality of a state or political subdivision of a state and that agrees to separately account for amounts transferred into such plan from this Plan, and (G) a
Roth IRA described in Section 408A(b) of the Code. This definition of Eligible Retirement Plan shall also apply in the case of a distribution to a surviving Spouse or to a Spouse or former Spouse who is the alternate payee under a qualified
domestic relations order (as defined in Code Section 414(p)). For a non-Spouse Beneficiary described in (iii)(C) below, an eligible retirement plan shall include only an individual retirement plan or annuity described in (A), (B), or (G),
above, that is treated as an inherited IRA of the Beneficiary. 

  

 63 

	 	(iii)	 “Distributee” includes (A) an Employee or former Employee, (B) the Employee’s or former Employee’s surviving Spouse
and the Employee’s or former Employee’s Spouse or former Spouse who is the Alternate Payee pursuant to a qualified domestic relations order (with respect to the interest of the Spouse or former Spouse), or (C) a non-Spouse Beneficiary
of an Employee or former Employee (with respect to the interest of the Beneficiary). 

  

	 	(iv)	 “Direct Rollover” means a payment by the Plan to the Eligible Retirement Plan specified by the Distributee. 

 

	8.06	 Recapture of Payments 

  

	 	(a)	 By error, it is possible that payments to a Participant or Beneficiary may exceed the amounts to which the recipient is entitled. When notified of
the error, the recipient must return the excess to the Trust Fund. This requirement is limited where explicit statutory provisions require limitation. 

  

	 	(b)	 To prevent hardship, repayment under Section 8.06(a) may be made in installments, determined at the sole discretion of the Committee. A
repayment arrangement, however, may not be contrary to law, and it may not be used as a disguised loan. 

  

	 	(c)	 If a Trustee is authorized by statute to recover some payments, no Plan provision may be construed to contravene the statute.

  

	8.07	 Age
59 1/2 Withdrawals

 A Participant who has attained age
59 1/2 and who has not terminated employment may
request a distribution from his Aggregate Account at any time, provided that a distribution shall not be made for an amount less than $250. Such distributions will be made as soon as practicable following the Committee’s receipt of the
Participant’s request for withdrawal (on forms approved by the Committee) and will be made in the form of a single lump sum payment. 
  

 64 

	8.08	 Required Minimum Distributions 

The following provisions will apply to limit a Participant’s ability to delay the distribution of benefits.

  

	 	(a)	 The provisions of this Section 8.08 will apply for purposes of determining required minimum distributions. 

 

	 	(i)	 The requirements of this Section 8.08 will take precedence over any inconsistent provisions of the Plan. 

 

	 	(ii)	 All distributions required under this Section 8.08 will be determined and made in accordance with Treasury regulations under Code
Section 401(a)(9). 

  

	 	(b)	 The Participant’s entire interest will be distributed or begin to be distributed to the Participant no later than the Participant’s
required beginning date. 

  

	 	(c)	 If the Participant dies before distributions begin, the Participant’s entire interest will be distributed, or begin to be distributed, no later
than as follows: 

  

	 	(i)	 If the Participant’s surviving Spouse is the Participant’s sole designated beneficiary, then distributions to the surviving Spouse will
begin by December 31 of the calendar year immediately following the calendar year in which the Participant died, or, if later, by December 31 of the calendar year in which the Participant would have attained age
70 1/2. 

 

	 	(ii)	 If the Participant’s surviving Spouse is not the Participant’s sole designated beneficiary, then distributions to the designated
beneficiary will begin by December 31 of the calendar year immediately following the calendar year in which the Participant died. 

  

	 	(iii)	 If there is no designated beneficiary as of September 30 of the year following the year of the Participant’s death, the Participant’s
entire interest will be distributed by December 31 of the calendar year containing the fifth anniversary of the Participant’s death. 

  

 65 

	 	(iv)	 If the Participant’s surviving Spouse is the Participant’s sole designated beneficiary and the surviving Spouse dies after the Participant
but before distributions to the surviving Spouse begin, this Section 8.08(c), other than Section 8.08(c)(i), will apply as if the surviving Spouse were the Participant. 

For purposes of this Section 8.08(c) and Sections 8.08(g) through (j), unless Section 8.08(c)(iv) applies,
distributions are considered to begin on the Participant’s required beginning date. If Section 8.08(c)(iv) applies, distributions are considered to begin on the date distributions are required to begin to the surviving Spouse under
Section 8.08(c)(i). 
  

	 	(d)	 Unless the Participant’s interest is distributed in a single sum on or before the required beginning date, as of the first distribution
calendar year distributions will be made in accordance with Sections 8.08(e) through (j). 

  

	 	(e)	 During the Participant’s lifetime, the minimum amount that will be distributed for each distribution calendar year is the lesser of:

  

	 	(i)	 The quotient obtained by dividing the Participant’s account balance by the distribution period in the Uniform Lifetime Table set forth in
Section 1.401(a)(9)-(9) of the Treasury regulations, using the Participant’s age as of the Participant’s birthday in the distribution calendar year; or 

 

	 	(ii)	 If the Participant’s sole designated beneficiary for the distribution calendar year is the Participant’s Spouse, the quotient obtained by
dividing the Participant’s account balance by the number in the Joint and Last Survivor Table set forth in Section 1.401(a)(9)-(9) of the Treasury regulations, using the Participant’s and Spouse’s ages as of the
Participant’s and Spouse’s birthdays in the distribution calendar year. 

  

 66 

	 	(f)	 Required minimum distributions will be determined under Section 8.08(e) beginning with the first distribution calendar year up to and including
the distribution calendar year that includes the Participant’s date of death. 

  

	 	(g)	 If the Participant dies on or after the date distributions begin and there is a designated beneficiary, the minimum amount that will be distributed
for each distribution calendar year after the year of the Participant’s death is the quotient obtained by dividing the Participant’s account balance by the longer of the remaining life expectancy of the Participant or the remaining life
expectancy of the beneficiary, determined as follows: 

  

	 	(i)	 The Participant’s remaining life expectancy is calculated using the age of the Participant on his or her birthday in the year of death, reduced
by one for each subsequent year. 

  

	 	(ii)	 If the Participant’s surviving Spouse is the Participant’s sole designated beneficiary, the remaining life expectancy of the surviving
Spouse is calculated for each distribution calendar year after the year of the Participant’s death using the surviving Spouse’s age as of the Spouse’s birthday in that year. For distribution calendar years after the year of the
surviving Spouse’s death, the remaining life expectancy of the surviving Spouse is calculated using the age of the surviving Spouse as of the Spouse’s birthday in the calendar year of the Spouse’s death, reduced by one for each
subsequent calendar year. 

  

	 	(iii)	 If the Participant’s surviving Spouse is not the Participant’s sole designated beneficiary, the beneficiary’s remaining life
expectancy is based on the age of the beneficiary on his birthday in the year following the year of the Participant’s death, reduced by one for each subsequent year. 

 

	 	(h)	 If the Participant dies on or after the date distributions begin and there is no designated beneficiary as of September 30 of the year after
the year of the 

  

 67 

	 	 
Participant’s death, the minimum amount that will be distributed for each distribution calendar year after the year of the Participant’s death is the quotient obtained by dividing the
Participant’s account balance by the Participant’s remaining life expectancy calculated using the age of the Participant on his birthday in the year of death, reduced by one for each subsequent year. 

 

	 	(i)	 If the Participant dies before the date distributions begin and there is a designated beneficiary, distribution to the designated beneficiary is not
required to begin by the date specified in Section 8.08(c), but the Participant’s entire interest will be distributed to the designated beneficiary by December 31 of the calendar year containing the fifth anniversary of the
Participant’s death. If the Participant’s surviving Spouse is the Participant’s sole designated beneficiary and the surviving Spouse dies after the Participant but before distributions to either the Participant or the surviving Spouse
begin, this Section 8.08(i) will apply as if the surviving Spouse were the Participant. 

  

	 	(j)	 If the Participant dies before the date distributions begin and there is no designated beneficiary as of September 30 of the year after the
year of the Participant’s death, distribution of the Participant’s entire interest will be completed by December 31 of the calendar year containing the fifth anniversary of the Participant’s death. 

 

	 	(k)	 The following definitions apply for purposes of this Section 8.08: 

 

	 	(i)	 “Designated beneficiary” or “beneficiary” means an individual who is designated as the beneficiary under Section 1.08 of
the Plan and is the designated beneficiary under Code Section 401(a)(9) and Section 1.401(a)(9)-1, Q&A-4 of the Treasury regulations. 

  

	 	(ii)	 “Distribution calendar year” means a calendar year for which a minimum distribution is required. For distributions beginning before the
Participant’s death, the first distribution calendar year is the calendar year immediately preceding the calendar year that contains the Participant’s 

 

 68 

	 	 
required beginning date. For distributions beginning after the Participant’s death, the first distribution calendar year is the calendar year in which distributions are required to begin
under Section 8.08(c). The required minimum distribution for the Participant’s first distribution calendar year will be made on or before the Participant’s required beginning date. The required minimum distribution for other
distribution calendar years, including the required minimum distribution for the distribution calendar year in which the Participant’s required beginning date occurs, will be made on or before December 31 of that distribution calendar
year. 

  

	 	(iii)	 “Life expectancy” means life expectancy based on the Single Life Table under Section 1.401(a)(9)-9 of the Treasury regulations.

  

	 	(iv)	 “Account balance” means the Aggregate Account as of the last Valuation Date in the calendar year immediately preceding the distribution
calendar year (valuation calendar year) increased by the amount of any contributions made and allocated to the Aggregate Account as of dates in the valuation calendar year after the Valuation Date and decreased by distributions made in the valuation
calendar year after the Valuation Date. The account balance for the valuation calendar year includes any amounts rolled over or transferred to the Plan either in the valuation calendar year or in the distribution calendar year if distributed or
transferred in the valuation calendar year. 

  

	 	(v)	 “Required beginning date” means, for a Participant who is a five percent owner (as defined in Code Section 416(i)), the April 1
following the calendar year in which the Participant attains age
70 1/2. For any other Participant, required
beginning date means the April 1 following the later of the calendar year in which he attains age 70 1/2
 or the calendar year in which he terminates employment. 

  

	 	(l)	 Notwithstanding anything to the contrary in this Section 8.08, effective for the 2009 distribution calendar year, a Participant who
(i) would have been required to 

  

 69 

	 	 
receive required minimum distributions for the 2009 distribution calendar year (“2009 RMDs”) but for the enactment of Code Section 401(a)(9)(H), (ii) would have satisfied the
requirement by receiving distributions from the Plan that are either equal to the 2009 RMDs or one or more payments in a series of substantially equal distributions (that include 2009 RMDs) made at least annually and expected to last for the life
(or life expectancy) of the Participant, the joint lives (or joint life expectancies) of the Participant and his designated beneficiary, or for a period of at least 10 years (“Extended 2009 RMDs”), and (iii) has not set up scheduled
payments but is receiving required minimum distributions from the Plan automatically will not receive those distributions for the 2009 distribution calendar year unless the Participant elects to receive such distributions. Affected Participants will
be given the opportunity to make the elections described in the preceding sentence. A direct rollover will be offered only for distributions that would be eligible rollover distributions without regard to Code Section 401(a)(9)(H).

  

 70 

 ARTICLE 9 

Administration of Plan 
  

	9.01	 Plan Administrative Committee 

The general administration of the Plan and the responsibility for carrying out the provisions of the Plan shall be
assigned to the Investment and Administrative Committee of The Walt Disney Company Sponsored Qualified Benefits Plans and Key Employees Deferred Compensation and Retirement Plan (the “Committee”), consisting of: 

 

	 	(a)	 The individuals holding, from time to time, the following positions within the Company, who shall be voting members of the Committee:

 Senior Executive Vice President and Chief Financial Officer 

Senior Executive Vice President and General Counsel 

Executive Vice President — Planning and Control 

Senior Vice President and Treasurer 

Senior Vice President — Human Resources 

Senior Vice President — Compensation and Benefits; and 

 

	 	(b)	 The individuals holding, from time to time, the following positions within the Company or Disney Worldwide Services, Inc., who shall be non-voting
members of the Committee: 

 Vice President — Financial Risk Management 

Vice President — Counsel, Benefits 

Vice President — Employee Benefits 

If any of the Committee members ceases to hold a position specified above, then he or she shall immediately cease to be a
member of the Committee and his or her successor in such position shall automatically become a Committee member. If any of the positions listed in Section 9.01(a) or (b) is eliminated, the individual holding the position that is most
comparable to the eliminated position shall become a member of the Committee. 
  

 71 

	9.02	 Duties of Committee 

The members of the Committee shall elect a chairman from their number and a secretary who may be but need not be one of
the members of the Committee; may appoint from their number such subcommittees with such powers as they shall determine; and may authorize one or more of their number or any agent to execute or deliver any instrument or make any payment on their
behalf. In addition, the Committee may retain counsel, employ agents, and provide for such clerical, accounting, actuarial and consulting services as they may require in carrying out the provisions of the Plan; and may allocate among themselves or
delegate all or such portion of the duties under the Plan, other than those granted to the Trustee under the trust agreement adopted for use in implementing the Plan, as they, in their sole discretion, shall decide. 

 

	9.03	 Meetings 

The Committee shall hold meetings on such notice, at such place or places, and at such time or times as it may from time
to time determine. 
  

	9.04	 Actions By the Committee 

Any act that the Plan authorizes or requires the Committee to do may be done, if done at a meeting, by a majority of a
quorum of members. A quorum is 50% of all members of the Committee then in office. The action of that majority expressed from time to time by a vote at a meeting shall constitute the action of the Committee and shall have the same effect for all
purposes as if assented to by all members of the Committee at the time in office. Alternatively, any action required or permitted to be taken by the Committee may be done by unanimous written consent in lieu of a meeting. 

 

	9.05	 Compensation and Bonding 

No member of the Committee shall receive any compensation from the Plan for his services as such. Except as may otherwise
be required by law, no bond or other security need be required of any member in that capacity in any jurisdiction. 
  

 72 

	9.06	 Establishment of Rules and Interpretation of Plan 

The Committee shall have full discretionary power and authority as may be necessary to carry out the provisions of the
Plan and to control and manage the operation and administration of the Plan, including, without limiting the generality of the foregoing, the discretionary power to: 
  

	 	(a)	 promulgate and enforce rules and regulations as it deems necessary or appropriate for the administration of the Plan; 

 

	 	(b)	 construe and interpret the Plan and decide all matters arising thereunder, including the right to remedy possible ambiguities, inconsistencies, and
omissions and correct defects; 

  

	 	(c)	 make factual determinations and decide all questions relating to individuals’ eligibility for participation in the Plan, vesting, forfeitures,
the amount, manner and timing of payment, and the status of persons as Participants, Employees, Covered Employees, Eligible Employees, Highly Compensated Employees, Spouses, Beneficiaries, and Alternate Payees; 

 

	 	(d)	 require any person to furnish such documentation, information, or other matter as the Committee may require for the proper administration of the
Plan and as a prerequisite to any payment or distribution by the Plan; 

  

	 	(e)	 direct that the Trust Fund be used to pay the reasonable administration expenses of the Plan; and 

 

	 	(f)	 impose reasonable restrictions (including temporary prohibitions) on Participants’ contribution elections, changes in contribution elections,
investment elections, changes in investment elections, loans, withdrawals, and distributions to accommodate the administrative requirements of the Plan. 

All decisions of the Committee relating to matters within its jurisdiction shall be final, conclusive, and binding.

  

 73 

	9.07	 Service in More Than One Fiduciary Capacity 

Any individual, entity, or group of persons may serve in more than one fiduciary capacity with respect to the Plan and/or
the funds of the Plan. 
  

	9.08	 Limitation of Liability 

Except as and to the extent otherwise provided by applicable law, no liability whatever shall attach to or be incurred by
the members of the Committee or by the shareholders, directors, officers, or employees of an Employer or an Affiliated Employer under or by reason of any of the terms and conditions contained in the Plan or in any of the contracts procured pursuant
thereto or implied therefrom. 
  

	9.09	 Indemnification 

To the maximum extent permitted by the Company’s by-laws, as amended from time to time, the Company shall indemnify
each member of the Committee, and each director, officer, and employee or agent of the Company or an Affiliated Employer against any expenses and liabilities that such person may incur as a result of any act or failure to act, made in good faith, by
such person in relation to the Plan or the funds of the Plan. 
  

	9.10	 Expenses of Administration 

All expenses incurred prior to the termination of the Plan that shall arise in connection with the administration of the
Plan, including but not limited to the compensation of the Trustee, administrative expenses and proper charges and disbursements of the Trustee, and compensation and other expenses and charges of any Enrolled Actuary, counsel, accountant,
specialist, or other person who shall be employed by the Committee in connection with the administration thereof, shall be paid from the Trust Fund to the extent not paid by the Employers. 

 

 74 

	9.11	 Claims Procedures 

  

	 	(a)	 Every claim for benefits under the Plan by a person (hereinafter referred to as “Claimant”) or by a Claimant’s authorized
representative shall be filed by submitting to the person (the “claim administrator”) designated by the Committee, a written application on a form designated by the Committee. The claim administrator shall process such application and
approve or disapprove it. Claims for benefits under the Plan other than disability benefits shall be governed by Sections 9.11(b) through 9.11(f). Claims for disability benefits under the Plan shall be governed by Section 9.11(g). Sections
9.11(h), 9.12, and 9.13 shall apply to all claims under the Plan, including, but not limited to claims for benefits (both based on the terms of the Plan and those based on an alleged violation of the law), claims for breach of fiduciary duty, and
other claims that some aspect of the Plan’s operation, administration or design or some aspect of the Plan’s investments, is unlawful or violates the terms of the Plan. 

 

	 	(b)	 If a Claimant is denied any benefits under the Plan (other than disability benefits) either in total or in an amount less than the full benefit to
which he claims to be entitled, the claim administrator shall advise the Claimant of the denial within 90 days after receipt of the claim by the claim administrator. The claim administrator shall furnish the Claimant with a written notice setting
forth: 

  

	 	(i)	 The computation of the Claimant’s benefit, if any; 

 

	 	(ii)	 The specific reason or reasons for the denial; 

  

	 	(iii)	 The specific Plan sections on which the denial is based; 

 

	 	(iv)	 A description of any additional material or information necessary for the Claimant to perfect his claim, if possible, and an explanation of why such
material or information is needed; and 

  

	 	(v)	 A description of the Plan’s claim review procedures, the time limits under such procedures and a statement of the Claimant’s right to
bring a civil action under Section 502(a) of ERISA following a denial of benefits on appeal. 

  

 75 

 If unforeseeable or special administrative problems or circumstances
require an extension of time for processing the claim, the claim administrator shall furnish a written notice to the Claimant prior to close of the 90-day period explaining why an extension of time is needed and the approximate date by which the
claim administrator expects to have processed the claim. In no event shall the claim administrator render a final decision on the validity of a claim later than 180 days after the claim administrator initially receives the claim. 

 

	 	(c)	 Within 60 days of receipt of the information described in Section 9.11(b), the Claimant or his duly authorized representative may file written
appeal of the determination with the Committee. As part of his appeal, the Claimant may submit written comments, documents, records and other information relating to the claim. 

 

	 	(d)	 As long as the Claimant’s appeal is pending (including the 60-day period described in Section 9.11(c)) the Claimant or his duly authorized
representative shall be provided, upon request and free of charge, access to and copies of all documents, records and other information relevant to the claim and may review pertinent Plan documents and may submit issues and comments in writing to
the Committee. 

  

	 	(e)	 The Committee shall notify the Claimant in writing of the appeals decision (whether or not adverse) in written or electronic form within a
reasonable period of time, but not later than 60 days after the Committee’s receipt of the appeal. Notwithstanding, if the Committee determines that special circumstances (for example, the need to hold a hearing) require an extension of time,
the Committee shall notify the Claimant of the reason or reasons for the extension and of the date by which it expects to make its decision. This extended period shall not exceed 60 days from the end of the initial 60-day period. The
Committee’s decision on 

  

 76 

	 	 
appeal shall take into account all comments, documents, records and other information submitted by the Claimant and relevant to the claim, without regard to whether such information was submitted
or considered in the initial benefit determination. 

  

	 	(f)	 If the Committee decides to deny benefits on appeal, the Committee shall provide the Claimant in writing with: 

 

	 	(i)	 The specific reason or reasons for the denial; 

  

	 	(ii)	 The specific Plan provisions on which the denial is made; 

 

	 	(iii)	 A statement that the Claimant is entitled to receive, upon request and free of charge, access to and copies of all documents, records and other
information relevant to the claim; and 

  

	 	(iv)	 A statement regarding the Claimant’s right to bring a civil action under Section 502(a) of ERISA following a denial of benefits on appeal.

  

	 	(g)	 If the Claimant seeks a disability benefit under the Plan, this Section 9.11(g) shall govern the claim. 

If the claim is wholly or partially denied the claim administrator shall advise the Claimant of the denial within 45 days
after receipt of the claim by the claim administrator. If the claim administrator determines that an extension of time for processing the claim is needed due to circumstances beyond the control of the Plan, the claim administrator shall notify the
Claimant prior to the close of the 45-day period of the reasons for the extension and the approximate date the claim administrator expects to have processed the claim. The extended period shall not exceed 75 days after the initial receipt of the
claim by the claim administrator. 
 If the claim administrator determines that a second extension of time is
needed to process the claim due to circumstances beyond the control of the Plan, the claim administrator shall notify the Claimant prior to the close of the 75-day period of the reasons for the extension and the approximate date the claim
administrator 
  

 77 

 
expects to have processed the claim. The extended period shall not exceed 105 days after the initial receipt of the claim by the claim administrator. The notice shall explain the standards on
which an entitlement to a disability benefit under the Plan is based and the unresolved issues that prevent a decision on the claim and shall describe any additional information that is needed to resolve the issues. The Claimant shall have at least
45 days from the date of receipt of such notice to submit the additional information. If additional information is requested, the time period for making a benefit decision shall be tolled from the date on which the notice is sent to the Claimant
until the Claimant responds to the request. 
 The claim administrator shall furnish the Claimant with a written
notice setting forth: 
  

	 	(i)	 The specific reason or reasons for the denial; 

  

	 	(ii)	 The specific Plan sections on which the denial is based; 

 

	 	(iii)	 A description of any additional information necessary for the Claimant to perfect his claim, if possible, and an explanation of why such material or
information is needed; 

  

	 	(iv)	 A description of the Plan’s claim review procedures, the time limits under such procedures and a statement of the Claimant’s right to
bring a civil action under Section 502(a) of ERISA following a denial of benefits on appeal; and 

  

	 	(v)	 If applicable, a copy of the internal rule, guideline or protocol that was relied on to make the denial or a statement that such a rule was relied
on and that a copy of such rule will be provided free of charge to the Claimant upon request. 

Within 180 days following the receipt of the denial the Claimant or his duly authorized representative may file written
appeal of the denial with the Committee. As part of his appeal, the Claimant may submit written comments, documents, records and other information relating to the claim. 
  

 78 

 As long as the Claimant’s appeal is pending (including the 180-day
period described in the preceding paragraph) the Claimant or his duly authorized representative shall be provided, upon request and free of charge, access to and copies of all documents, records and other information relevant to the claim and may
review pertinent Plan documents and may submit issues and comments in writing to the Committee. 
 The
Committee’s decision on appeal shall take into account all comments, documents, records and other information submitted by the Claimant and relevant to the claim, without regard to whether such information was submitted or considered in the
initial benefit determination. Moreover, such decision shall not defer to the initial determination and may not be conducted by the same individual who made the initial determination nor by any subordinate of such individual. 

In deciding an appeal of any benefit determination that is based in whole or in part on medical judgment, the Committee
shall consult with a health care professional who has appropriate training and experience in the field of medicine involved in the medical judgment; such health care professional may not be an individual who was consulted in connection with the
initial determination nor by any subordinate of such individual. If the Claimant or his representative so requests, the Committee shall notify the Claimant of the medical experts whose advice was obtained by the Committee on behalf of the Plan in
connection with the benefit determination. 
 The Committee shall notify the Claimant in writing of the appeals
decision (whether or not adverse) in written or electronic form within a reasonable period of time, but not later than 45 days after the Committee’s receipt of the appeal. Notwithstanding, if the Committee determines that special circumstances
(for example, the need to hold a hearing) require an extension of time, the Committee shall notify the Claimant of the reason or reasons for the extension and of the date by which it expects to make its decision. This extended period shall not
exceed 45 days from the end of the initial 45-day period. 
  

 79 

 If the Committee decides to deny benefits on appeal, the Committee shall
provide the Claimant in writing with: 
  

	 	(i)	 The specific reason or reasons for the denial; 

  

	 	(ii)	 The specific Plan sections on which the denial is based; 

 

	 	(iii)	 A statement that the Claimant is entitled to receive, upon request and free of charge, access to and copies of all documents, records and other
information relevant to the claim; 

  

	 	(iv)	 A statement of the Claimant’s right to bring a civil action under Section 502(a) of ERISA following a denial of benefits on appeal;

  

	 	(v)	 If applicable, a copy of the internal rule, guideline or protocol that was relied on to make the denial or a statement that such a rule was relied
on and that a copy of such rule will be provided free of charge to the Claimant; and 

  

	 	(vi)	 If the denial is based on a medical judgment an explanation of the scientific or clinical judgment for the determination or a statement that such
explanation will be provided free of charge to the Claimant on request. 

  

	 	(h)	 Any person eligible to receive benefits under the Plan shall furnish to the claim administrator or the Committee any information or evidence
requested by the claim administrator or the Committee and reasonably required for the proper administration of the Plan. Failure on the part of any person to comply with any such request within a reasonable period of time shall be sufficient grounds
for delay in the payment of any benefits that may be due under the Plan until such information or evidence is received by the claim administrator or the Committee. If any person claiming benefits under the Plan makes a false statement that is

  

 80 

	 	 
material to the claim for benefits, the claim administrator or the Committee may offset against future payments any amount paid to such person to which he was not entitled under the provisions of
the Plan. 

  

	9.12	 Limitation on Actions 

Neither: 
  

	 	(a)	 A claim or action to recover benefits allegedly due under the provisions of the Plan or by reason of any law, nor 

 

	 	(b)	 A claim or action to enforce rights under the Plan, nor 

 

	 	(c)	 A claim or action to clarify rights to future benefits under the Plan, nor 

 

	 	(d)	 Any other claim or action that (I) relates to the Plan and (II) seeks a remedy, ruling, or judgment of any kind against the Plan, the
Committee, a Plan fiduciary (within the meaning of Section 3(21) of ERISA), or a party in interest (within the meaning of Section 3(14) of ERISA) with respect to the Plan 

may be filed in any court— 
  

	 	(i)	 Until the claimant has exhausted the administrative review procedure set forth in Section 9.11; and 

 

	 	(ii)	 Unless such claim or action is filed in a court with jurisdiction over such claim or action no later than thirty-six (36) months after:

 (A) In the case of a claim or action to recover benefits, the date the
first benefit payment was actually made or was allegedly due whichever is earlier; 
 (B) In the
case of a claim or action to enforce a right, the date the Committee or its delegate first denied the claimant’s request to exercise such right, regardless of whether such denial occurred during administrative review pursuant to
Section 9.11; 
  

 81 

 (C) In the case of a claim or action to clarify rights to
future benefits, the date the Committee first repudiated its alleged obligation to provide such future benefits, regardless of whether such repudiation occurred during administrative review pursuant to Section 9.11; or 

(D) In the case of any other claim or action described in clause (d), above, the earliest date on which
the claimant knew or should have known of the material facts on which such claim or action is based; 
 provided
that if a request for administrative review pursuant to Section 9.11 is pending before the claims administrator designated by the Committee to review such claims when the 36-month period described in this paragraph (ii) expires, the
deadline for filing such claim or action in a court with proper jurisdiction shall be extended to the date that is 60 calendar days after the final denial of the claim on administrative review. 

The period described by paragraph (ii), above, is hereafter referred to as the “Applicable Limitations Period.”
The Applicable Limitations Period replaces and supersedes any limitations period that might otherwise be deemed applicable under state or federal law in the absence of this Section 9.12. Except as provided in the following two sentences, a
claim or action filed after the expiration of the Applicable Limitations Period shall be deemed time-barred. The Committee shall have the discretion to extend the Applicable Limitations Period upon a showing of exceptional circumstances that, in the
opinion of the Committee, provide good cause for extension. The exercise of this discretion is committed solely to the Committee, and is not subject to review. Notwithstanding the foregoing, neither paragraph (ii), above, nor the Applicable
Limitations Period shall apply to an action governed by Section 413 of ERISA. 
  

	9.13	 Class Action Forum 

  

	 	(a)	 To the fullest extent permitted by law, any putative class action lawsuit brought in whole or in part under Section 502 of ERISA (or any
successor provision) and relating to the Plan, the lawfulness of any Plan provision, the administration of the 

 

 82 

	 	 
Plan, the management, investment, or handling of Plan assets, or the performance or non-performance of Plan fiduciaries or administrators shall be filed in one of the following jurisdictions:
(i) the jurisdiction in which the Plan is principally administered, or (ii) the jurisdiction in which the largest number of putative class members resides (or if that jurisdiction cannot be determined, the jurisdiction in which the largest
number of class members is reasonably believed to reside). 

  

	 	(b)	 If any putative class action within the scope of Section 9.13(a) is filed in a jurisdiction other than one of those described in
Section 9.13(a), or if any non-class action filed in such a jurisdiction is subsequently amended or altered to include class action allegations, then the Plan, all parties to such action that are related to the Plan (such as a Plan fiduciary,
administrator, or party in interest), all alleged Plan participants and beneficiaries shall take all necessary steps to have the action removed to, transferred to, or re-filed in a jurisdiction described in Section 9.13(a). Such steps may
include, but are not limited to, (i) a joint motion to transfer the action, or (ii) a joint motion to dismiss the action without prejudice to its re-filing in a jurisdiction described in Section 9.13(a), with any applicable time
limits or statutes of limitations applied as if the suit or class action allegation had originally been filed or asserted in a jurisdiction described in Section 9.13(a) at the same time that it was filed or asserted in a jurisdiction not
described therein. 

  

	 	(c)	 The provisions of this Section 9.13 shall be waived if no party invokes them within 120 days of the filing of a putative class action or the
assertion of class action allegations. 

  

	 	(d)	 This Section 9.13 does not relieve any putative class member of any obligation existing under the Plan or by law to exhaust administrative
remedies before initiating litigation. 

  

 83 

 ARTICLE 10 

Management of Funds 
  

	10.01	 Trust Agreement 

All the funds of the Plan shall be held by a Trustee appointed from time to time by the Committee under a Trust Agreement
adopted, or as amended, by the Committee for use in providing benefits under the Plan and paying its expenses not paid directly by the Employers. The Employers shall have no liability for the payment of benefits under the Plan or for the
administration of the funds paid over to the Trustee. 
 The Committee shall have the power to amend the Trust
Agreement, and any other funding vehicle document, to: 
  

	 	(a)	 comply with laws and regulations, or as otherwise may be desirable when prompted by a change in law or regulation; and 

 

	 	(b)	 make any other change that may be necessary or desirable, provided that any amendment adopted pursuant to this subsection shall not increase the
Company’s annual expense by more than five (5) million dollars. 

  

	10.02	 Exclusive Benefit Rule 

Except as otherwise provided in the Plan, no part of the corpus or income of the funds of the Plan shall be used for, or
diverted to, purposes other than for the exclusive benefit of Participants and other persons entitled to benefits under the Plan before satisfaction of all liabilities with respect to them. No person shall have any interest in or right to any part
of the earnings of the funds of the Plan, or any right in, or to, any part of the assets held under the Plan, except as and to the extent expressly provided in the Plan. 

 

	10.03	 Committee Power and Duties 

  

	 	(a)	 The Committee may, in its discretion, appoint one or more investment managers (within the meaning of Section 3(38) of ERISA) to manage
(including the power to acquire and dispose of) all or part of the assets of the Plan, as the Committee 

  

 84 

	 	 
shall designate. In that event, authority over and responsibility for the management of the assets so designated shall be the sole responsibility of that investment manager.

  

	 	(b)	 The Committee shall have the duty to advise any investment adviser or person (including any investment manager) with discretionary investment
authority over all or a portion of the Plan’s Trust Fund of the investment objectives which such person should observe. Such advice should, looking at the assets of the Plan as a whole, take into account the short-term cash needed for benefit
payment as well as the long-term growth needed to discharge the Plan’s liabilities. The Committee may make such changes in the appointment of the Trustee or any investment advisers or investment managers, and may remove or replace the Trustee
or any investment adviser or investment manager, as it deems advisable. The Committee also shall have the power and authority specified in any agreements with the Trustee or any investment adviser or investment manager. 

 

	 	(c)	 With the approval of the Committee, a portion of the Plan’s Trust Fund may be invested in the Trustee’s certificates of deposit, or in the
Trustee’s pooled or commingled qualified trust funds. 

  

	 	(d)	 Notwithstanding the foregoing, the Trust Fund shall consist of separate Investment Funds as provided in Article 6, and to the extent required by
Participant elections, may be fully invested in Company Stock. 

  

	 	(e)	 The Committee shall prepare periodically a report of its actions that constitute settlor activities with respect to the Plan and shall deliver a
copy of such report to the Board. 

  

 85 

 ARTICLE 11 

Assignments and Liens 
  

	11.01	 Nonalienation 

  

	 	(a)	 Except as required by any applicable law or by subsection (c), no benefit under the Plan shall in any manner be anticipated, assigned, or alienated,
and any attempt to do so shall be void. However, payment shall be made in accordance with the provisions of any judgment, decree, or order that: 

  

	 	(i)	 creates for, or assigns to, a Spouse, former Spouse, child, or other dependent of a Participant the right to receive all or a portion of the
Participant’s benefits under the Plan for the purpose of providing child support, alimony payments, or marital property rights to that Spouse, child, or dependent; 

 

	 	(ii)	 is made pursuant to a state domestic relations law; 

 

	 	(iii)	 does not require the Plan to provide any type of benefit, or any option, not otherwise provided under the Plan; and 

 

	 	(iv)	 otherwise meets the requirements of Section 206(d) of ERISA, as amended, as a qualified domestic relations order. 

 

	 	(b)	 Notwithstanding anything herein to the contrary, if the amount payable to the Alternate Payee under the Qualified Domestic Relations Order does not
exceed the Cashout Limit, such amount shall be paid in one lump sum as soon as practicable following the qualification of the order. If the amount exceeds the Cashout Limit, it may be paid as soon as practicable following the qualification of the
order if the Qualified Domestic Relations Order so provides and the Alternate Payee consents thereto; otherwise, it may not be payable before the earliest of (i) the Participant’s termination of employment, (ii) the time such amount
could be withdrawn while still employed, or (iii) the Participant’s attainment of age 50. The Cashout Limit is $1,000 for distributions after March 27, 2005. 

 

 86 

	 	(c)	 A Participant’s benefit under the Plan shall be offset or reduced by the amount the Participant is required to pay to the Plan under the
circumstances set forth in Section 401(a)(13)(C) of the Code. 

  

	11.02	 Qualified Domestic Relations Orders 

Notwithstanding any provisions in this Plan to the contrary, the Committee shall comply with any judgment, decree, or
order that the Committee determines to be a Qualified Domestic Relations Order. 
  

	 	(a)	 Establishment of Procedures. The Committee shall establish reasonable written procedures to determine the qualified status of domestic
relations orders and to administer distributions under orders determined to be Qualified Domestic Relations Orders, which procedures may include, without limitation, the adoption of one or more model Qualified Domestic Relations Orders. Such
procedures shall be consistent with the requirements of Section 206(d) of ERISA and Sections 401(a)(13) and 414(p) of the Code. The Committee shall promptly notify the affected Participant and any other Alternate Payee of the receipt of a
domestic relations order and the procedures for determining the qualified status of domestic relations orders. Within a reasonable period after the receipt of such order, the Committee shall determine whether such order is a Qualified Domestic
Relations Order and shall notify the Participant and each Alternate Payee of such determination. 

  

	 	(b)	 Disposition of Benefits Pending Determination. During any period in which the qualified status of a domestic relations order is being
determined (by the Committee, by a court, or otherwise), the Committee shall make arrangements to account separately for the amounts that would have been payable to each Alternate Payee if the order had been determined to be a Qualified Domestic
Relations Order. If within 18 months of the receipt of the order, the order (or modification thereof) is determined to be a Qualified Domestic Relations Order, the Plan shall pay the amounts that have been separately accounted for to the person or
persons entitled thereto. If within 18 months of the receipt of the order 

  

 87 

	 	 
it is determined that the order is not qualified, or the issue as to whether the order is qualified is not resolved by the end of the 18-month period, then the Plan shall pay the amounts that
have been separately accounted for to the person or persons, if any, who would have been entitled to payment of such amounts if there had been no order. Any determination that an order is qualified that is made after the close of the 18-month period
shall apply prospectively only. 

  

	 	(c)	 Allocation of Expenses to Participant’s Account. Expenses incurred by the Plan with respect to a putative Qualified Domestic Relations
Order shall be charged against the affected Participant’s Aggregate Account. 

  

	11.03	 Facility of Payment 

If the Committee shall find that a Participant or other person entitled to a benefit is unable to care for his affairs
because of illness or accident or is a minor, the Committee may direct that any benefit due him, unless claim shall have been made for the benefit by a duly appointed legal representative, be paid to his Spouse, a child, a parent or other blood
relative, or to a person with whom he resides. Any payment so made shall be a complete discharge of the liabilities of the Plan for that benefit. 
  

	11.04	 Information 

Each Participant, Beneficiary, or other person entitled to a benefit, before any benefit shall be payable to him or on his
account under the Plan, shall file with the Committee the information that it shall require to establish his rights and benefits under the Plan. 
  

	11.05	 Construction 

  

	 	(a)	 Governing Laws. Except as otherwise provided by ERISA, this Plan and all provisions thereof shall be construed and administered according to
the laws of the State of California. 

  

	 	(b)	 Title and Headings Not to Control. The titles to the Articles and the headings of Sections in the Plan are placed herein for convenience of
reference only and, in the case of any conflict, the text of this instrument rather than such titles or headings shall control. 

  

 88 

	 	(c)	 Gender and Person. The masculine pronoun shall include the feminine, the feminine pronoun shall include the masculine, and the singular shall
include the plural wherever the context so requires. 

  

	11.06	 Proof of Death and Right of Beneficiary or Other Person 

The Committee may require and rely on such proof of death and such evidence of the right of any Beneficiary or other
person to receive the value of the Plan benefits of a deceased Participant as the Committee may deem proper, and its determination of death and of the right of that Beneficiary or other person to receive payment shall be conclusive. 

 

	11.07	 Failure to Locate Recipient 

In the event that the Committee is unable to locate a Participant or Beneficiary who is entitled to payment under the Plan
within five (5) years from the date such payment was to have been made, the amount to which such Participant or Beneficiary was entitled shall be declared a forfeiture and shall be used to reduce future Matching Contributions to the Plan. If
the Participant or Beneficiary later is located, the benefit that was previously forfeited hereunder shall be restored by means of additional Employer contributions to the Plan. 

 

	11.08	 Electronic Transmission of Notices to Participants 

Notwithstanding any provision of the Plan to the contrary, any notice required to be distributed to Participants,
Beneficiaries and Alternate Payees pursuant to the terms of the Plan may, at the direction of the Committee, be transmitted electronically to the extent permitted by, and in accordance with any procedures set forth in, applicable law and
regulations. 
  

 89 

 ARTICLE 12 

Amendment, Merger and Termination 
  

	12.01	 Amendment of Plan 

  

	 	(a)	 The Company, acting through the Board, reserves the right at any time and from time to time, and retroactively if deemed necessary or appropriate,
to amend in whole or in part any or all of the provisions of the Plan. The Committee, or its delegate, shall have the power to amend the Plan to: 

  

	 	(i)	 comply with laws and regulations, or as otherwise may be desirable when prompted by a change in law or regulation; and 

 

	 	(ii)	 make any other change that may be necessary or desirable provided any amendment adopted pursuant to this Section 12.01 shall not increase the
Company’s annual expense by more than five (5) million dollars. 

  

	 	(b)	 Any action required or permitted to be taken by the Board or the Committee under the Plan shall be by resolution adopted by the Board or the
Committee at a meeting held either in person or by telephone or other electronic means, or by unanimous written consent in lieu of a meeting. 

  

	 	(c)	 No amendment shall make it possible for any part of the funds of the Plan to be used for, or diverted to, purposes other than for the exclusive
benefit of persons entitled to benefits under the Plan. No amendment shall be made that has the effect of decreasing the accrued benefits of any Participant or of reducing the nonforfeitable percentage of the accrued benefits of a Participant below
the nonforfeitable percentage computed under the Plan as in effect on the date on which the amendment is adopted or, if later, the date on which the amendment becomes effective. 

 

	12.02	 Merger or Consolidation 

The Plan may not be merged or consolidated with, and its assets or liabilities may not be transferred to, any other plan
unless each person entitled to benefits under the Plan 
  

 90 

 
would, if the resulting plan were then terminated, receive a benefit immediately after the merger, consolidation, or transfer that is equal to or greater than the benefit he would have been
entitled to receive immediately before the merger, consolidation, or transfer if the Plan had then terminated. The purpose of this Section 12.02 is to comply with the provisions of Code Section 414(l) and shall be interpreted and construed
consistent with Code Section 414(l) and Treasury regulations thereunder. This Section 12.02 shall not be construed in a manner that would impose limitations that are more stringent than those required by Code Section 414(l).

  

	12.03	 Additional Participating Employers 

  

	 	(a)	 With the consent of the Company, any subsidiary or affiliated corporation or division of such corporation may adopt the Plan for its Eligible
Employees. An Employer adopting the Plan shall compile and submit all information required by the Committee with reference to its Eligible Employees. An entity will be considered to have adopted the Plan with the consent of the Company if it takes
significant action that is consistent with the adoption of the Plan, the Board or Committee is aware of the action, and neither objects to the action. 

  

	 	(b)	 If an entity adopts the Plan in accordance with Section 12.03(a), or if any persons become Employees of an Employer as the result of merger or
consolidation or as the result of acquisition of all or part of the assets or business of another company, the Company shall determine to what extent, if any, previous service with the subsidiary or associated company shall be recognized under the
Plan, but subject to the continued qualification of the trust for the Plan as tax-exempt under the Code. 

  

	 	(c)	 A participating Employer may withdraw its participation in the Plan upon appropriate action by it. In addition, an Employer will cease to
participate in the Plan from and after the date it ceases to be an Affiliated Employer. In either event, the assets of the Plan held on account of Participants in the employ of that Employer, and any unpaid Aggregate Accounts of all Participants who
have separated from the employ of that Employer, shall be determined by the 

  

 91 

	 	 
Committee. Subject to the provisions of Section 8.04, those assets shall be distributed as provided in Section 12.05 if the Plan is terminated or partially terminated as a result of the
withdrawal of such Employer. Otherwise, benefits payable to Employees employed by the withdrawing Employer shall be payable to such Employees when due under the Plan, but such Employees shall not be considered Eligible Employees from and after the
date of withdrawal by their Employer. 

  

	12.04	 Termination of Plan 

The Company may terminate the Plan for any reason at any time. 

 

	12.05	 Distribution of Assets on Plan Termination or a Complete Discontinuance of Contributions 

 

	 	(a)	 Subject to the provisions of Section 8.04, in case of termination of the Plan or a complete discontinuance of contributions under the Plan, the
rights of Participants to the benefits accrued under the Plan to date of termination or discontinuance of contributions shall remain fully vested and nonforfeitable. 

 

	 	(b)	 After providing for payment of any expenses properly chargeable against the Trust Fund, the Committee may direct the Trustee to distribute assets
remaining in the Trust Fund. Distributions to Participants or Beneficiaries may be in cash or in kind and are not subject to the regular distribution provisions of this Plan except that distributions must be in a form that the Committee deems
consistent with statutory requirements. Except as specifically provided otherwise by law, the Committee’s determination is conclusive on all persons. 

 

	 	(c)	 In the event of a partial termination of the Plan, the provisions of this Section shall be applicable to the Participants affected by the partial
termination. 

  

	12.06	 Notification of Termination 

On a termination of the Plan in accordance with this Article, the Committee shall notify the Employers, the Trustee, the
Participants, and all other necessary parties. The 
  

 92 

 
Committee shall thereafter continue the administration of the Plan for the purpose of winding up its affairs and may take all action reasonably required to accomplish such purpose. 

 

 93 

 ARTICLE 13 

Top-Heavy Provisions 
  

	13.01	 Priority Over Other Plan Provisions 

If the Plan is or becomes a Top-Heavy Plan in any Plan Year, the provisions of this Article shall supersede any
conflicting provisions of the Plan. However, the provisions of this Article shall not operate to increase the rights or benefits of Participants under the Plan except to the extent required by the Code Section 416 and other provisions of law
applicable to Top-Heavy Plans. 
  

	13.02	 Definitions Used in this Article 

The following words and phrases, when used with initial capital letters, will have the meanings set forth below.

  

	 	(a)	 “Defined Benefit Plan” means a qualified plan other than a Defined Contribution Plan. 

 

	 	(b)	 “Defined Contribution Plan” means the tax-qualified plan described in Code Section 414(i). 

 

	 	(c)	 “Determination Date” means, for the first Plan Year of the Plan, the last day of the Plan Year and, for any subsequent Plan Year,
the last day of the preceding Plan Year. 

  

	 	(d)	 “Includable Compensation” means Statutory Compensation limited each year by the Maximum Compensation Limitation.

  

	 	(e)	 “Key Employee” means any Employee or former Employee (including any deceased Employee) who at any time during the Plan Year that
includes the Determination Date was an officer of the Employer or an Affiliated Employer having annual Includible Compensation greater than $130,000 (as adjusted under Code Section 416(i)(1) for Plan Years beginning after December 31,
2002), a 5-percent owner of the Employer or an Affiliated Employer, or a 1-percent owner of 

  

 94 

	 	 
the Employer or an Affiliated Employer having annual Includible Compensation of more than $150,000. The determination of who is a Key Employee will be made in accordance with Code
Section 416(i)(1) and the applicable regulations and other guidance of general applicability issued thereunder. 

  

	 	(f)	 “Minimum Allocation” means the allocation described in the first sentence of Section 13.03(a). 

 

	 	(g)	 “Permissive Aggregation Group” means the Required Aggregation Group of qualified plans plus any other qualified plan or qualified
plans of an Employer or an Affiliated Employer that when considered as a group with the Required Aggregation Group, would continue to satisfy the requirements of Code Sections 401(a)(4) and 410 (including simplified employee pension plans).

  

	 	(h)	 “Present Value” means present value based only on the interest and mortality rates specified in a Defined Benefit Plan.

  

	 	(i)	 “Required Aggregation Group” means each qualified plan of an Employer or an Affiliated Employer in which at least one key employee
participates (regardless of whether the plan has terminated), and any other qualified plan of the Employer or an Affiliated Employer that enables such plan to meet the requirements of Code Sections 401(a)(4) or 410(b). 

 

	 	(j)	 “Top-Heavy Plan” means the Plan for any Plan Year in which any of the following conditions exists: (i) the Top-Heavy Ratio for
the Plan exceeds 60% and the Plan is not a part of any Required Aggregation Group or Permissive Aggregation Group of qualified plans; (ii) the Plan is a part of a Required Aggregation Group but not part of a Permissive Aggregation Group of
qualified plans and the Top-Heavy Ratio for the Required Aggregation Group exceeds 60%; or (iii) the Plan is a part of a Required Aggregation Group and part of a Permissive Aggregation Group of qualified plans and the Top-Heavy Ratio for the
Permissive Aggregation Group exceeds 60%. 

  

 95 

	 	(k)	 “Top-Heavy Ratio” means a fraction, the numerator of which is the sum of the Present Value of accrued benefits and the account
balances (as required by Code Section 416)) of all Key Employees with respect to such qualified plans as of the Determination Date and the denominator of which is the sum of the Present Value of the accrued benefits and the Account balances of
all Employees with respect to such qualified plans as of the Determination Date. The value of account balances and the Present Value of accrued benefits will be determined as of the most recent Top-Heavy Valuation Date that falls within or ends with
the 12-month period ending on the Determination Date, except as provided in Code Section 416 for the first and second Plan Years of a Defined Benefit Plan. The account balances and accrued benefits of a Participant who is not a Key Employee but
who was a Key Employee in a prior year will be disregarded. The calculation of the Top-Heavy Ratio, and the extent to which distributions, rollovers, transfers, and contributions unpaid as of the Determination Date are taken into account, will be
made in accordance with Code Section 416. Employee contributions described in Code Section 219(e)(2) will not be taken into account for purposes of computing the Top-Heavy Ratio. When aggregating plans, the value of account balances and
accrued benefits will be calculated with reference to the Determination Dates that fall within the same calendar year. The accrued benefit of any Employee other than a Key Employee will be determined under the method, if any, that uniformly applies
for accrual purposes under all qualified plans maintained by an Employer or an Affiliated Employer and included in a Required Aggregation Group or a Permissive Aggregation Group or, if there is no such method, as if the benefit accrued not more
rapidly than the slowest accrual rate permitted under the fractional accrual rate of Code Section 411(b)(1)(C). In addition: 

  

	 	(i)	 The Present Values of accrued benefits and the amounts of account balances of an Employee as of the Determination Date shall be increased by the
distributions made with respect to the Employee under the Plan and any plan aggregated with the Plan under Code Section 416(g)(2) during the one-year period ending on the Determination Date. The preceding sentence shall also apply to
distributions under a terminated plan which, 

  

 96 

	 	 
had it not been terminated, would have been aggregated with the Plan under Code Section 416(g)(2)(A)(i). In the case of a distribution made for a reason other than severance from employment,
death or disability, this provision shall be applied by substituting “five-year period” for “one-year period.” 

  

	 	(ii)	 The accrued benefits and accounts of any individual who has not performed services for the Employer or an Affiliated Employer during the one-year
period ending on the Determination Date shall not be taken into account. 

  

	 	(l)	 “Top-Heavy Valuation Date” means the last day of each Plan Year. 

 

	13.03	 Minimum Allocation 

  

	 	(a)	 For any Plan Year in which the Plan is a Top-Heavy Plan, each Participant who is not a Key Employee will receive an allocation of Employer
contributions of not less than the lesser of 3% of his Includable Compensation for such Plan Year or the percentage of Includable Compensation that equals the largest percentage of participating Employer contributions (including Tax-Deferred
Contributions) and forfeitures allocated to a Key Employee. The Minimum Allocation is determined without regard to any Social Security contribution. Tax-Deferred or Roth Contributions made on behalf of Participants who are not Key Employees will not
be treated as Employer contributions for purposes of the Minimum Allocation. Matching Contributions shall be taken into account for purposes of satisfying the Minimum Allocation under the Plan or under such other plan that satisfies the minimum
contribution requirement of Code Section 416(c)(2) with respect to such Participant. Matching Contributions that are used to satisfy the Minimum Allocation shall continue to be treated as Matching Contributions for purposes of the contribution
percentage test under Section 14.03 and other requirements of Code Section 401(m). The Minimum Allocation applies even though under other Plan provisions the Participant would not otherwise be entitled to receive an allocation, or would
have received a lesser allocation for the Plan Year because (i)

  

 97 

	 	 
the non-Key Employee fails to make mandatory contributions to the Plan, (ii) the non-Key Employee’s Includable Compensation is less than a stated amount, or (iii) the non-Key
Employee fails to complete 1,000 Hours of Service in the Plan Year. 

  

	 	(b)	 No Minimum Allocation will be provided pursuant to subsection (a) to a Participant who is not employed by an Employer or an Affiliated Employer
on the last day of the Plan Year. 

  

	 	(c)	 If an Employer or an Affiliated Employer maintains one or more other Defined Contribution Plans covering Employees who are Participants in this
Plan, the Minimum Allocation will be provided under this Plan, unless such other Defined Contribution Plans make explicit reference to this Plan and provide that the Minimum Allocation will not be provided under this Plan, in which case the
provisions of subsection (a) will not apply to any Participant covered under such other Defined Contribution Plans. If an Employer or an Affiliated Employer maintains one or more Defined Benefit Plans covering Employees who are Participants in
this Plan and such Defined Benefit Plans provide that Employees who are Participants therein will accrue the minimum benefit applicable to top-heavy Defined Benefit Plans notwithstanding their participation in this Plan, then the provisions of
subsection (a) will not apply to any Participant covered under such Defined Benefit Plans. If an Employer or an Affiliated Employer maintains one or more Defined Benefit Plans covering Employees who are Participants in this Plan, and the
provisions of the preceding sentence do not apply, then each Participant who is not a Key Employee and who is covered by such Defined Benefit Plans will receive a Minimum Allocation determined by applying the provisions of subsection (a) with
the substitution of “5%” in each place that “3%” occurs therein. 

  

	 	(d)	 The Participant’s Minimum Allocation shall be fully vested and nonforfeitable. 

 

 98 

 ARTICLE 14 

Limitations on Contributions and Allocations to Participants’ Accounts 

 

	14.01	 Definitions Used in This Article 

The following defined terms have the meanings set forth below: 

 

	 	(a)	 “Actual Deferral Percentage” means, with respect to a specified group of Employees, the average of the ratios, calculated
separately for each Employee in that group, of (a) the amount of aggregate Tax-Deferred Contributions made pursuant to Section 3.01 and Roth Contributions made pursuant to Section 3.08 for a Plan Year to (b) the Employee’s
Statutory Compensation for that entire Plan Year capped by the Maximum Compensation Limitation, provided that, on the direction of the Committee, Statutory Compensation for a Plan Year shall be counted only if received during the period an Employee
is, or is eligible to become, a Participant. The Actual Deferral Percentage for each group and the ratio determined for each Employee in the group shall be calculated to the nearest one one-hundredth of one (1) percent. For purposes of
determining the Actual Deferral Percentage for a Plan Year, Tax-Deferred or Roth Contributions may be taken into account for a Plan Year only if they: 

  

	 	(i)	 relate to Compensation that either (A) would have been received by the Employee in the Plan Year but for the deferral election or (B) are
attributable to services performed by the Employee in the Plan Year and would have been received by the Employee within
2- 1/2 months after the close of the Plan Year but
for the deferral election (but only if such contributions are allocated to such Plan Year instead of the Plan Year in which the Compensation would have been paid); 

 

	 	(ii)	 are allocated to the Employee as of a date within that Plan Year and the allocation is not contingent on Plan participation or performance of
service after such date; 

  

 99 

	 	(iii)	 are actually paid to the Trustee no later than twelve (12) months after the end of the Plan Year; 

 

	 	(iv)	 are not catch-up contributions described in Section 3.07 for the Plan Year; 

 

	 	(v)	 are not returned to a Nonhighly Compensated Employee for the Plan Year pursuant to Section 14.07(a); 

 

	 	(vi)	 are not taken into account for purposes of determining the Contribution Percentage described in Section 14.01(b) for the Plan Year; and

  

	 	(vii)	 are not additional elective contributions made pursuant to Section 2.04(e). 

 

	 	(b)	 “Contribution Percentage” means, with respect to a specified group of Employees, the average of the ratios, calculated separately
for each Employee in that group, of (a) the sum of the Employee’s Matching Contribution for that Plan Year to (b) his Statutory Compensation for that entire Plan Year capped by the Maximum Compensation Limitation, provided that, on
the direction of the Committee, Statutory Compensation for a Plan Year shall be counted only if received during the period an Employee is, or is eligible to become, a Participant. The Contribution Percentage for each group and the ratio determined
for each Employee in the group shall be calculated to the nearest one one-hundredth of one (1) percent. For purposes of determining the Contribution Percentage for a Plan Year, Matching Contributions may be taken into account for a Plan
Year only if they: 

  

	 	(i)	 are allocated to the Employee as of a date within the Plan Year and on the basis of the Employee’s Tax-Deferred or Roth Contributions for the
Plan Year; 

  

	 	(ii)	 are actually paid to the Trustee no later than twelve (12) months after the end of the Plan Year; 

 

	 	(iii)	 are not taken into account for purposes of determining the Actual Deferral Percentage described in Section 14.01(a) for the Plan Year;

  

 100 

	 	(iv)	 are not forfeited under the provisions of Section 14.02 or 14.07 for the Plan Year; 

 

	 	(v)	 are not made pursuant to Section 2.04(e); and 

 

	 	(vi)	 are not disproportionate matching contributions with respect to Nonhighly Compensated Employees for the Plan Year, as described in Treas. Reg.
§ 1.401(m)-2(a)(5)(ii). 

  

	 	(c)	 “Earnings” means the amount of income to be returned with any excess deferrals, excess contributions, or excess aggregate
contributions under Section 14.02, 14.03, or 14.07. Earnings on excess deferrals and excess contributions shall be determined by multiplying the income earned on the Tax-Deferred and Roth Accounts for the Plan Year by a fraction, the numerator
of which is the excess deferrals or excess contributions, as the case may be, for the Plan Year and the denominator of which is the sum of the Tax-Deferred Account and Roth Account balances at the end of the Plan Year, disregarding any income or
loss occurring during the Plan Year. Earnings on excess aggregate contributions shall be determined in a similar manner by substituting the Matching Account for the Tax-Deferred and Roth Accounts, and the excess aggregate contributions for the
excess deferrals and excess contributions in the preceding sentence. 

  

	 	(d)	 “Nonhighly Compensated Employee” means for any Plan Year an Employee of the Employer or an Affiliated Employer who is not a Highly
Compensated Employee for that Plan Year. 

  

	14.02	 Actual Deferral Percentage Test 

With respect to each Plan Year, the Actual Deferral Percentage for the Plan Year for Highly Compensated Employees who are
Participants or eligible to become Participants for the Plan Year shall not exceed the Actual Deferral Percentage for the Plan Year for all Nonhighly Compensated Employees who are Participants or eligible to become Participants for the Plan Year
multiplied by 1.25. If the Actual Deferral Percentage for 
  

 101 

 
such Highly Compensated Employees does not meet the foregoing test, the Actual Deferral Percentage for such Highly Compensated Employees for the Plan Year may not exceed the Actual Deferral
Percentage for the Plan Year for all Nonhighly Compensated Employees who are Participants or eligible to become Participants for the Plan Year by more than two (2) percentage points, and such Actual Deferral Percentage for such Highly
Compensated Employees for the Plan Year may not be more than two (2) times the Actual Deferral Percentage for the Plan Year for all Nonhighly Compensated Employees who are Participants or eligible to become Participants for the Plan Year.

 The actual deferral percentage test for a Plan Year shall be applied to the Plan as a whole, including the
ESOP. 
 The Committee may implement rules limiting the Tax-Deferred or Roth Contributions that may be made on
behalf of some or all Highly Compensated Employees so that this limitation is satisfied. If the Committee determines that the limitation under this Section has been exceeded in any Plan Year, the following provisions shall apply: 

 

	 	(a)	 The actual deferral ratio of the Highly Compensated Employee with the highest actual deferral ratio shall be reduced to the extent necessary to meet
the actual deferral percentage test or to cause such ratio to equal the actual deferral ratio of the Highly Compensated Employee with the next-highest ratio. This process will be repeated until the actual deferral percentage test is passed. Each
ratio shall be rounded to the nearest one one-hundredth of one (1) percent of the Participant’s Statutory Compensation capped by the Maximum Compensation Limitation. The amount of Tax-Deferred and Roth Contributions made by each
Highly Compensated Employee in excess of the amount permitted under his revised deferral ratio shall be added together. This total dollar amount of excess contributions (“excess contributions”) shall then be allocated to some or all Highly
Compensated Employees in accordance with the provisions of subsection (b) below. 

  

	 	(b)	 The aggregate Tax-Deferred and Roth Contributions of the Highly Compensated Employee with the highest dollar amount of aggregate Tax-Deferred and
Roth 

  

 102 

	 	 
Contributions shall be reduced by the lesser of (i) the amount required to cause that Employee’s aggregate Tax-Deferred and Roth Contributions to equal the dollar amount of the
aggregate Tax-Deferred and Roth Contributions of the Highly Compensated Employee with the next-highest dollar amount of aggregate Tax-Deferred and Roth Contributions or (ii) an amount equal to the total excess contributions. Reductions will be
made first from a Highly Compensated Employee’s Tax-Deferred Account and, to the extent that the required reduction is more than the Employee’s Tax-Deferred Account, from his Roth Account. This procedure is repeated until all excess
contributions are allocated. The amount of excess contributions allocated to a Highly Compensated Employee, together with earnings thereon, shall be distributed to him in accordance with the provisions of subsection (c).

  

	 	(c)	 The excess contributions, together with earnings thereon, allocated to a Participant shall be paid to the Participant before the close of the Plan
Year following the Plan Year in which the excess contributions were made, and to the extent practicable, within
2 1/2 months of the close of the Plan Year in which
the excess contributions were made. However, any excess contributions for any Plan Year shall be reduced by any Tax-Deferred or Roth Contributions previously returned to the Participant under Section 14.07 for that Plan Year. In the event any
Tax-Deferred or Roth Contributions returned under this Section were matched by Matching Contributions, such corresponding Matching Contributions, with earnings thereon, shall be forfeited and used to reduce Employer contributions.

  

	 	(d)	 In the event any Matching Contributions subject to forfeiture under this Section have been distributed to the Participant, the Employer shall make
reasonable efforts to recover the contributions from the Participant. 

  

	 	(e)	 The provisions of this Section 14.02 shall be interpreted and applied in accordance with Section 401(k)(3) of the Code and the Treasury
Regulations and other guidance issued thereunder. 

  

 103 

	14.03	 Contribution Percentage Test 

With respect to each Plan Year, the Contribution Percentage for the Plan Year for Highly Compensated Employees who are
Participants or eligible to become Participants for the Plan Year shall not exceed the Contribution Percentage for the Plan Year for all Nonhighly Compensated Employees who are Participants or eligible to become Participants for the Plan Year
multiplied by 1.25. If the Contribution Percentage for such Plan Year for such Highly Compensated Employees does not meet the foregoing test, the Contribution Percentage for such Highly Compensated Employees for the Plan Year may not exceed the
Contribution Percentage for the Plan Year for all Nonhighly Compensated Employees who are Participants or eligible to become Participants for the Plan Year by more than two (2) percentage points, and the Contribution Percentage for such Highly
Compensated Employees for the Plan Year may not be more than two (2) times the Contribution Percentage for the Plan Year for all Nonhighly Compensated Employees who are Participants or eligible to become Participants for the Plan Year.

 The actual contribution percentage test for a Plan Year shall be applied to the Plan as a whole, including the
ESOP. 
 If the Committee determines that the limit under this Section 14.03 has been exceeded in any Plan
Year, the following provisions shall apply: 
  

	 	(a)	 The actual contribution ratio of the Highly Compensated Employee with the highest actual contribution ratio shall be reduced to the extent necessary
to meet the test or to cause such ratio to equal the actual contribution ratio of the Highly Compensated Employee with the next-highest actual contribution ratio. This process will be repeated until the actual contribution percentage test is passed.
Each ratio shall be rounded to the nearest one one-hundredth of one (1) percent of a Participant’s Statutory Compensation capped by the Maximum Compensation Limitation. The amount of Matching Contributions made by or on behalf of each
Highly Compensated Employee in excess of the amount permitted under his revised actual contribution ratio shall be added together. This total dollar amount of excess contributions (“excess aggregate contributions”) shall then be allocated
to some or all Highly Compensated Employees in accordance with the provisions of subsection (b) below. 

  

 104 

	 	(b)	 The Matching Contributions of the Highly Compensated Employee with the highest dollar amount of such contributions shall be reduced by the lesser of
(i) the amount required to cause that Employee’s Matching Contributions to equal the dollar amount of such contributions of the Highly Compensated Employee with the next-highest dollar amount of such contributions, or (ii) an amount
equal to the total excess aggregate contributions. This procedure is repeated until all excess aggregate contributions are allocated. The amount of excess aggregate contributions allocated to each Highly Compensated Employee, together with earnings
thereon, shall be distributed or forfeited in accordance with the provisions of subsection (c) below. 

  

	 	(c)	 If excess aggregate contributions are allocated to a Highly Compensated Employee under subsection (b) above, so much of the Matching
Contributions, together with earnings, as shall be necessary to equal the balance of the excess aggregate contributions shall be forfeited and applied to reduce Employer contributions. 

 

	 	(d)	 Any repayment or forfeiture of excess aggregate contributions shall be made before the close of the Plan Year following the Plan Year for which the
excess aggregate contributions were made and, to the extent practicable, any repayment or forfeiture shall be made within
2 1/2 months of the close of the Plan Year in which
the excess aggregate contributions were made. In the event any Matching Contributions subject to forfeiture have been distributed to the Participant, the Employer shall make reasonable efforts to recover the contributions from the Participant.

  

	 	(e)	 The provisions of this Section 14.03 shall be interpreted and applied in accordance with Section 401(m)(2) of the Code and the Treasury
Regulations and other guidance issued thereunder. 

  

 105 

	14.04	 Additional Discrimination Testing Provisions 

 

	 	(a)	 If any Highly Compensated Employee is a participant of another qualified plan of the Employer or an Affiliated Employer, other than any qualified
plan that is not permitted to be aggregated with the Plan under Sections 401(k) and 401(m) of the Code and Treasury Regulations issued thereunder (determined without regard to the prohibition on aggregation of plans with different plan years or
with different testing methods), under which tax-deferred or Roth contributions or matching contributions are made on behalf of the Highly Compensated Employee or under which the Highly Compensated Employee makes after-tax contributions, the
Committee shall implement rules, which shall be uniformly applicable to all employees similarly situated, to take into account all such contributions for the Highly Compensated Employee under all such plans in applying the limitations of
Sections 14.02 and 14.03. If any other such qualified plan has a plan year other than the Plan Year defined in Section 1.38, the contributions to be taken into account shall be the contributions that would be taken into account for the
Plan Year if the plan under which the contributions were made had the same Plan Year as the Plan. 

  

	 	(b)	 In the event that this Plan is aggregated with one or more other plans to satisfy the requirements of Sections 401(a)(4) and 410(b) of the Code
(other than for purposes of the average benefit percentage test) or if one or more other plans is aggregated with this Plan to satisfy the requirements of such sections of the Code, then the provisions of Sections 14.02 and 14.03 shall be
applied by determining the Actual Deferral Percentage and Contribution Percentage of employees as if all such plans were a single plan. If this Plan is permissively aggregated with any other plan or plans for purposes of satisfying the provisions of
Section 401(k)(3) of the Code, the aggregated plans also must satisfy the provisions of Sections 401(a)(4) and 410(b) of the Code as though they were a single plan. Plans may be aggregated under this subsection (b) only if they have
the same plan year and only if they apply consistent testing methods with respect to Code Sections 401(k) and 401(m). 

  

 106 

	 	(c)	 The Employer may elect to use Tax-Deferred or Roth Contributions to pass the tests described in Section 14.03, provided that the test described
in Section 14.02 is passed prior to such election and continues to be passed following the Employer’s election to shift the application of those Tax-Deferred or Roth Contributions from Section 14.02 to Section 14.03.

  

	 	(d)	 The Employer may elect to use Special Contributions to pass the tests described in Section 14.02 or 14.03 as set forth in Section 3.03(b).

  

	 	(e)	 Notwithstanding any provision of the Plan to the contrary, if Employees included in a unit of Employees covered by a collective bargaining agreement
are participating in the Plan and not more than two (2) percent of such Employees are Highly Compensated Employees and professionals, then such Employees shall be disregarded in applying the provisions of Sections 14.02 and 14.03. However,
a separate actual deferral percentage test must be performed for the group of collective bargaining Employees on the basis that those Employees are included in a separate cash-or-deferred arrangement. 

 

	 	(f)	 If the Employer elects to apply the provisions of Section 410(b)(4)(B) to satisfy the requirements of Section 401(k)(3)(A)(i) of the Code,
the Employer may apply the provisions of Sections 14.02 and 14.03: 

  

	 	(i)	 by excluding from consideration all eligible Employees (other than Highly Compensated Employees) for the applicable year who have not met the
minimum age and service requirements of Section 410(a)(1)(A) of the Code; or 

  

	 	(ii)	 by performing separate tests for the applicable year for all eligible Employees who have met such minimum age and service requirements and for all
eligible Employees who have not met such minimum age and service requirements. 

  

 107 

	14.05	 Maximum Annual Additions 

  

	 	(a)	 Except as permitted under Section 2.04 or 3.07, the annual addition to a Participant’s Accounts for any Plan Year, which shall be
considered the “limitation year” for purposes of Section 415 of the Code, when added to the Participant’s annual addition for that Plan Year under any other qualified defined contribution plan of the Employer or an Affiliated
Employer, shall not exceed an amount that is equal to the lesser of (i) one hundred (100) percent of his aggregate remuneration (as defined below) for that Plan Year or (ii) $49,000 as of the Effective Date, adjusted thereafter
pursuant to Section 415(d) of the Code. 

 The compensation limit referred to in
(i) in the previous sentence shall not apply to any contribution for medical benefits after separation from service (within the meaning of Code Sections 401(h) or 419A(f)(2)) that is otherwise treated as an annual addition. 

 

	 	(b)	 For purposes of this Section, the “annual addition” to a Participant’s Accounts under this Plan or any other qualified defined
contribution plan (including a deemed qualified defined contribution plan under a qualified defined benefit plan) maintained by the Employer or an Affiliated Employer shall be the sum of: 

 

	 	(i)	 the total contributions, including Tax-Deferred Contributions and Roth Contributions, made on the Participant’s behalf by the Employer and all
Affiliated Employers; 

  

	 	(ii)	 all Participant contributions, exclusive of any Rollover Contributions; 

 

	 	(iii)	 forfeitures, if applicable, that have been allocated to the Participant’s Accounts under this Plan or his accounts under any other such
qualified defined contribution plan; and 

  

	 	(iv)	 solely for purposes of clause (ii) of subsection (a), above, amounts described in Sections 415(1)(1) and 419A(d)(2) allocated to the
Participant. 

  

 108 

 For purposes of this subsection (b), any Tax-Deferred Contributions or
Roth Contributions distributed under Section 14.02 and any Matching Contributions distributed or forfeited under the provisions of Section 14.02, 14.03, and 14.07 shall be included in the annual addition for the year allocated. However,
any loan repayments made under Article 7, any excess deferrals timely distributed from the Plan under Section 14.07, and any restorative payments described in Treas. Reg. § 1.415(c)-1(b)(2)(ii)(C) shall be excluded from the definition of
annual addition. 
  

	 	(c)	 For purposes of this Section, the term “remuneration” with respect to any Participant means his Statutory Compensation not exceeding the
Maximum Compensation Limitation. 

  

	 	(d)	 If a Participant’s annual addition under the Plan for a limitation year or, if the Participant is participating in another qualified defined
contribution plan of the Employer or an Affiliated Employer during a particular limitation year, the Participant’s combined annual addition under the Plan and such other plan for such limitation year, prior to the application of the limitation
set forth in subsection (a) above, would exceed that limitation, the Committee shall adjust the Participant’s annual additions under the Plan and such other plan (as applicable) by reducing contributions before they are allocated, in the
following order of priority: 

  

	 	(i)	 First, the Participant’s unmatched Tax-Deferred Contributions under Section 3.01 or similar contributions under the other plan shall be
reduced to the extent necessary. 

  

	 	(ii)	 Second, the Participant’s unmatched Roth Contributions under Section 3.08 or similar contributions under the other plan shall be reduced
to the extent necessary. 

  

	 	(iii)	 Third, the Participant’s matched Tax-Deferred Contributions and corresponding Matching Contributions under the Plan or similar contributions
under the other plan shall be reduced to the extent necessary. 

  

 109 

	 	(iv)	 Fourth, the Participant’s matched Roth Contributions and corresponding Matching Contributions under the Plan or similar contributions under the
other plan shall be reduced to the extent necessary. 

  

	14.06	 Return of Contributions 

  

	 	(a)	 If all or part of the Employer’s deductions for contributions to the Plan are disallowed by the Internal Revenue Service, the portion of the
contributions to which that disallowance applies shall be returned to the Employer without interest but reduced by any investment loss attributable to those contributions, provided that the portion is returned within one year after the disallowance
of the deduction. For this purpose, all contributions made by the Employer are expressly declared to be conditioned on their deductibility under Section 404 of the Code. 

 

	 	(b)	 The Employer may recover, without interest, the amount of its contributions to the Plan made on account of a mistake of fact, reduced by any
investment loss attributable to those contributions, if recovery is made within one (1) year after the date of those contributions. 

  

	 	(c)	 In the event that Tax-Deferred or Roth Contributions are returned to the Employer in accordance with the provisions of this Section, the elections
to reduce Compensation that were made by Participants on whose behalf those contributions were made shall be void retroactive to the beginning of the period for which those contributions were made. The Tax-Deferred or Roth Contributions so returned
shall be distributed in cash to those Participants for whom those contributions were made, provided, however, that if the contributions are returned under the provisions of subsection (a) above, the amount of Tax-Deferred or Roth Contributions
to be distributed to Participants shall be adjusted to reflect any investment gains or losses attributable to those contributions. 

  

 110 

	14.07	 Contributions in Excess of Section 402(g) Limit 

 

	 	(a)	 Except as permitted under Section 2.04 or 3.07, in no event shall the Participant’s aggregate Tax-Deferred Contributions, Roth
Contributions and similar contributions made on his behalf by the Employer or an Affiliated Employer to all plans, contracts, or arrangements subject to the provisions of Code Section 401(a)(30) in any calendar year exceed the
Section 402(g) Limit in effect for such calendar year. If a Participant’s aggregate Tax-Deferred Contributions and Roth Contributions in a calendar year reach that dollar limit, his election of Tax-Deferred Contributions or Roth
Contributions for the remainder of the calendar year will be canceled. As of the first pay period of the calendar year following such cancellation, the Participant’s election of Tax-Deferred Contributions or Roth Contributions shall again
become effective in accordance with his previous election, unless the Participant elects otherwise. 

In the event that the sum of the Tax-Deferred Contributions, Roth Contributions, and similar contributions to any other
qualified defined contribution plan maintained by the Employer or an Affiliated Employer exceeds the dollar limit set forth above for any calendar year, the Participant shall be deemed to have elected a return of Tax-Deferred Contributions and Roth
Contributions in excess of such limit (“excess deferrals”) from this Plan. Tax-Deferred Contributions will be returned first and, to the extent that the excess deferrals are more than the Participant’s Tax-Deferred Contributions for
the year, then Roth Contributions equal to the remainder of the excess deferrals will be returned. The excess deferrals, together with earnings, shall be returned to the Participant no later than the April 15 following the end of the calendar
year in which the excess deferrals were made. The amount of excess deferrals to be returned for any calendar year shall be reduced by any Tax-Deferred or Roth Contributions previously returned to the Participant under Section 14.02 for that
calendar year. In the event any Tax-Deferred or Roth Contributions returned under this paragraph were matched by Matching Contributions under Section 3.02, those Matching Contributions, together with earnings, shall be forfeited and used
to reduce Employer 
  

 111 

 
contributions. In the event those Matching Contributions subject to forfeiture have been distributed to the Participant, the Employer shall make reasonable efforts to recover the contributions
from the Participant. 
  

	 	(b)	 If a Participant makes tax-deferred or Roth contributions under another qualified defined contribution plan maintained by an employer other than the
Employer or an Affiliated Employer for any calendar year and those contributions when added to his Tax-Deferred Contributions or Roth Contributions exceed the dollar limit under this Section 14.07 for that calendar year, the Participant may
allocate all or a portion of such excess deferrals to this Plan. In that event, Tax-Deferred Contributions will be returned first and, to the extent that the excess deferrals are more than the Participant’s Tax-Deferred Contributions for the
year, then Roth Contributions equal to the remainder of the excess deferrals will be returned. Such excess deferrals, together with earnings, shall be returned to the Participant no later than the April 15 following the end of the calendar year
in which such excess deferrals were made. However, the Plan shall not be required to return excess deferrals unless the Participant notifies the Committee, in writing, by March 1 of that following calendar year of the amount of the excess
deferrals allocated to this Plan. The amount of any such excess deferrals to be returned for any calendar year shall be reduced by any Tax-Deferred or Roth Contributions previously returned to the Participant under Section 14.02 for that
calendar year. In the event any Tax-Deferred or Roth Contributions returned under this Section 14.07 were matched by Matching Contributions under Section 3.02, those Matching Contributions, together with earnings, shall be forfeited and
used to reduce Employer contributions. In the event those Matching Contributions subject to forfeiture have been distributed to the Participant, the Employer shall make reasonable efforts to recover the contributions from the Participant.

  

 112 

 ARTICLE 15 

General Provisions 
  

	15.01	 No Contract of Employment 

The Plan shall not be deemed to constitute a contract between any Employer and any person or to be considered an
inducement for the employment of any person by any Employer. Nothing contained in the Plan shall be deemed: 
  

	 	(a)	 to give any person the right to be retained in the service of an Employer; or 

 

	 	(b)	 to interfere with the right of any Employer to discharge any person at any time without regard to the effect that such discharge shall have on his
rights or potential rights, if any, under the Plan. 

  

	 	(c)	 preclude any person from being or continuing to be an “at will” employee. 

 

	15.02	 Severability 

If any provision or any portion of any provision of this Plan shall be held invalid or unenforceable, the remaining
portions of such provision and the remaining provisions of this Plan shall remain valid and enforceable, and the invalid or unenforceable portions or provisions shall remain valid and enforceable as to persons or circumstances unrelated to those as
to which there was a holding of invalidity or unenforceability. 
  

	15.03	 Scrivener’s Errors 

If, due to errors in drafting, any Plan provision does not accurately reflect its intended meaning, as demonstrated by
consistent interpretations or other evidence of intent, as determined by the Committee, in it sole and exclusive judgment, the provision may be considered ambiguous and shall be interpreted by all Plan fiduciaries in a fashion consistent with its
intent, as determined by the Committee in its sole discretion. The Committee shall amend the Plan retroactively to cure any such ambiguity. This provision may not be invoked by any person to require the Plan to be interpreted in a manner that is
inconsistent with its interpretation by the Committee. 
  

 113 

 IN WITNESS WHEREOF, the Committee has caused this instrument
to be executed by its duly authorized representative effective as of January 1, 2010. 
 Dated: August 3, 2010

  

			
	 By:
	 	 /s/Barbara A. Kellams

		 	 Barbara A. Kellams

  

 114 

 APPENDIX A 

TRANSFER OF ASSETS FROM THE JUMBO PICTURES, INC. 

Certain assets of the Jumbo Pictures 401(k) Plan (the “Jumbo Plan”) representing the accounts of employees of
Jumbo Pictures, Inc. (“Jumbo”) who became employees of the Employer subsequent to the acquisition of Jumbo Pictures, Inc. by the Company were transferred to the Plan, effective on or about transfer date (the “Jumbo Transfer
Date”). The transfer of assets from the Jumbo Plan into the Plan was effected in accordance with the following provisions: 

A.l Transfer of Account Balances. The outstanding account balances of the Jumbo employees under the Jumbo
Plan were transferred to the Plan through a direct transfer from the trust fund for the Jumbo Plan to the Trust Fund for the Plan effected on the Jumbo Transfer Date. 

A.2 Amount of Account Balance. The account balance credited to each Jumbo employee under the Jumbo Plan
immediately prior to the Jumbo Transfer Date was credited to the Account (the “Jumbo Plan Account”) maintained for such individual under the Plan immediately after the Jumbo Transfer Date. Accordingly, the Jumbo Plan Account balance
maintained under the Plan for each individual who was a participant in the Jumbo Plan on the Jumbo Transfer Date was, immediately after such date, credited with a dollar amount equal to that individual’s account balance under the Jumbo Plan
immediately prior to the Jumbo Transfer Date. 
 A.3 Investment of Account Balance. The account
balances transferred from the Jumbo Plan to the Plan were invested in accordance with each Participant’s new investment directive. In the absence of such directives, the transferred account balances were invested in such Fund or Funds as the
Committee deemed appropriate, in its sole and absolute discretion. 
 A.4 Service Credit. Each
Participant in the Plan shall, for eligibility and vesting purposes under the Plan, be credited with all Service credited to such Participant for vesting and contribution purposes under the Jumbo Plan immediately prior to the Jumbo Transfer Date.

 A.5 Protected Benefits. The terms and provisions of the Plan shall govern the rights, benefits
and entitlements of all Participants and any other individuals who have an interest in any outstanding Account balance under the Plan. The terms and provisions of the Jumbo Plan shall, as of the Jumbo Transfer Date, be extinguished and cease to have
any force or effect. However, any benefits accrued under the Jumbo Plan prior to the Jumbo Transfer Date shall, to the extent these benefits are protected benefits under Code Section 411(d)(6) (the “Protected Benefits”), be preserved
under the Plan and shall not in any way be affected, reduced or eliminated as a result of the merger of the Jumbo Plan with and into the Plan. Other than as set forth in the Plan, there are no Protected Benefits for Participants who had account
balances in the Jumbo Plan as of the Jumbo Transfer Date. 
  

 A-1 

 APPENDIX B 

TRANSFERS OF CERTAIN ASSETS TO OR FROM THE 

GO. COM PLAN 

A. Transfer of Assets to the Go. Com Plan 

Certain assets of the Disney Salaried Savings and Investment Plan (the “Disney Plan”) representing the accounts of eligible
salaried employees of the Walt Disney Company (“Disney”) who became employees of Go. Com. on or after March 31, 2000 were transferred from the Disney Plan, effective on or about April 1, 2000 to the Go. Com 401(k) Savings and
Investment Plan (the “Go. Com Plan”). The transfer of assets from the Disney Plan into the Go. Com Plan was effected in accordance with the following provisions: 

1. Transfer of Account Balances. The outstanding account balances of the salaried Disney employees under the Disney
Plan were transferred to the Go. Com Plan through a direct transfer from the trust fund for the Disney Plan to the Trust Fund for the Go. Com Plan effected on or about April 2000 (the Disney Transfer Date). 

2. Amount of Account Balance. The account balance credited to each eligible Disney salaried employee under the
Disney Plan immediately prior to the Transfer Date was credited to the Account (the “Go. Com Plan Account”) maintained for such individual under the Go. Com Plan immediately after the Transfer Date. 

3. Protected Benefits. Other than as set forth in the Disney Plan, there are no Protected Benefits for Participants who had
account balances in the Disney Plan as of the Transfer Date. 
 B. Transfer of Assets from the Go. ComPlan 

Effective on July 27, 2005, the portion of the Go. Com Savings and Investment Plan (the “Go. Com Plan”) attributable to the
accounts of individuals who were Participants of the Plan on such date was merged with and into the Plan. 
 l. Transfer
of Account Balances. The Plan shall separately account for the portion of the Accounts of each Participant that is attributable to allocations made under the Go. Com Plan before the merger, which shall equal the Participant’s interest
in the Go. Com Plan immediately before the merger, as adjusted to reflect subsequent investment experience, distributions, withdrawals, and other adjustments provided under the Plan. The portion of a Participant’s Accounts attributable to the
Go. Com Plan shall be nonforfeitable. 
 2. Investment of Account Balance. The funds transferred from the Go. Com
Plan were initially invested in such Investment Fund(s) as were set forth in the fund mapping rules communicated to affected Participants before the transfer and may be transferred to other Investment Funds in accordance with Section 6.01 of
the Plan. 
  

 B-1 

 3. Service Credit. Each Participant with an account balance under the Go. Com
Plan immediately before the merger shall, for eligibility purposes under the Plan, be credited with all service credited to such Participant for eligibility purposes under the Go. Com Plan as of July 27, 2005, to the extent not otherwise
credited pursuant to any other Plan provision. 
 4. Protected Benefits. A Participant or a Beneficiary of a
Participant with an account balance under the Go. Com Plan immediately before the merger shall be entitled to elect any withdrawal or distribution option offered under the generally applicable provisions of the Plan with respect to the portion of
his Accounts that is attributable to the Go. Com Plan, but only if the Participant or Beneficiary complies with the provisions of the Plan that govern the election of such withdrawal and distribution options and subject to any restrictions on
distributions or withdrawals that may be required by applicable law due to the nature of the underlying contributions. Benefit rights and optional forms of benefit of the Go. Com Plan as they existed as of July 27, 2005 that are not available
under the Plan shall be preserved under this Plan with respect to accounts transferred from the Go. Com Plan, but only to the extent required by Code Section 411(d)(6). Other than as set forth in the Plan, there are no benefit rights or
optional forms that are required to be preserved for Participants described in this Appendix. 
  

 2 

 APPENDIX C 

RECOGNITION OF SERVICE WITH ACQUISITIONS 

OR PREDECESSOR EMPLOYERS 
  

	1.	 On October 25, 2001, the Company acquired ABC Family, Inc. (formerly Fox Family, Inc.). ABC Family, Inc. became a participating Employer on
April 28, 2002. Notwithstanding any contrary provision of the Plan, the Employment Commencement Date for any Employee of ABC Family, Inc. assigned to a Disney business unit shall be the first date as of which he would have been credited with an
Hour of Service for ABC Family, Inc. if ABC Family, Inc. had been an Employer or Affiliated Employer on such date; provided, however, that no Employee of ABC Family, Inc. shall become a Participant before April 28, 2002.

  

	2.	 On October 24, 2001, the Company acquired Baby Einstein Company. Baby Einstein Company became a participating Employer on April 1, 2002.
Notwithstanding any contrary provision of the Plan, the Employment Commencement Date for any Employee of Baby Einstein Company shall be the first date as of which he would have been credited with an Hour of Service for Baby Einstein Company if Baby
Einstein Company had been an Employer or Affiliated Employer on such date; provided, however, that no Employee of Baby Einstein Company shall become a Participant before April 1, 2002. 

 

	3.	 On May 11, 2005, the Company acquired the assets of Avalanche Software, LC. Notwithstanding any contrary provision of the Plan, the Employment
Commencement Date for any Employee whose employment with an Employer immediately followed employment with Avalanche Software, LC shall be the first date as of which he would have been credited with an Hour of Service for Avalanche Software, LC if
Avalanche Software, LC had been an Employer or Affiliated Employer on such date; provided, however, that no prior employee of Avalanche Software, LC shall become a Participant before May 11, 2005. 

 

 C-1 

 APPENDIX D 

TRANSFER OF ASSETS FROM THE FOX PLAN 

Effective on May 16, 2005, the portion of the Fox Family Worldwide, Inc. & Subsidiaries 401(k) Profit Sharing Plan (the
“Fox Plan”) attributable to the accounts of individuals who were Participants of the Plan on such date was merged with and into the Plan. 

l. Transfer of Account Balances. The Plan shall separately account for the portion of the Accounts of each Participant that
is attributable to allocations made under the Fox Plan before the merger, which shall equal the Participant’s interest in the Fox Plan immediately before the merger, as adjusted to reflect subsequent investment experience, distributions,
withdrawals, and other adjustments provided under the Plan. The portion of a Participant’s Accounts attributable to the Fox Plan shall be nonforfeitable. 

2. Investment of Account Balance. The funds transferred from the Fox Plan were initially invested in such Investment
Fund(s) as were set forth in the fund mapping rules communicated to affected Participants before the transfer and may be transferred to other Investment Funds in accordance with Section 6.01 of the Plan. 

3. Service Credit. Each Participant with an account balance under the Fox Plan immediately before the merger shall, for
eligibility purposes under the Plan, be credited with all service credited to such Participant for eligibility purposes under the Fox Plan as of May 16, 2005, to the extent not otherwise credited pursuant to any other Plan provision.

 4. Protected Benefits. A Participant or a Beneficiary of a Participant with an account balance under the Fox
Plan immediately before the merger shall be entitled to elect any withdrawal or distribution option offered under the generally applicable provisions of the Plan with respect to the portion of his Accounts that is attributable to the Fox Plan, but
only if the Participant or Beneficiary complies with the provisions of the Plan that govern the election of such withdrawal and distribution options and subject to any restrictions on distributions or withdrawals that may be required by applicable
law due to the nature of the underlying contributions. Benefit rights and optional forms of benefit of the Fox Plan as they existed as of May 16, 2005, other than the installment option described in Section 4.03(a)(ii) of the Fox Plan and
the annuity option described in Section 4.03(a)(iii) of the Fox Plan, that are not available under the Plan shall be preserved under this Plan with respect to accounts transferred from the Fox Plan, but only to the extent required by Code
Section 411(d)(6). Other than as set forth in the Plan, there are no benefit rights or optional forms that are required to be preserved for Participants described in this Appendix. 

 

 D-1 

 APPENDIX E 

TRANSFER OF ASSETS FROM THE MIRAMAX PLAN 

Effective on December 1, 2006, the Miramax Films 401(k) Savings Plan (the “Miramax Plan”) was merged with and into the
Plan. 
 l. Transfer of Account Balances. The Plan shall separately account for the portion of the Accounts of
each Participant that is attributable to allocations made under the Miramax Plan before the merger, which shall equal the Participant’s interest in the Miramax Plan immediately before the merger, as adjusted to reflect subsequent investment
experience, distributions, withdrawals, and other adjustments provided under the Plan. The portion of a Participant’s Accounts attributable to the Miramax Plan shall be nonforfeitable. 

2. Investment of Account Balance. The funds transferred from the Miramax Plan were initially invested in such Investment
Fund(s) as were set forth in the fund mapping rules communicated to affected Participants before the transfer and may be transferred to other Investment Funds in accordance with Section 6.01 of the Plan. 

3. Service Credit. Each Participant with an account balance under the Miramax Plan immediately before the merger shall, for
eligibility purposes under the Plan, be credited with all service credited to such Participant for eligibility purposes under the Miramax Plan as of December 1, 2006, to the extent not otherwise credited pursuant to any other Plan provision.

 4. Protected Benefits. A Participant or a Beneficiary of a Participant with an account balance under the
Miramax Plan immediately before the merger shall be entitled to elect any withdrawal or distribution option offered under the generally applicable provisions of the Plan with respect to the portion of his Accounts that is attributable to the Miramax
Plan, but only if the Participant or Beneficiary complies with the provisions of the Plan that govern the election of such withdrawal and distribution options and subject to any restrictions on distributions or withdrawals that may be required by
applicable law due to the nature of the underlying contributions. Benefit rights and optional forms of benefit of the Miramax Plan as they existed as of December 1, 2006 that are not available under the Plan shall be preserved under this Plan
with respect to accounts transferred from the Miramax Plan, but only to the extent required by Code Section 411(d)(6). Other than as set forth in the Plan, there are no benefit rights or optional forms that are required to be preserved for
Participants described in this Appendix. 
  

 E-1 

 APPENDIX F 

TRANSFER OF ASSETS FROM THE DREAM QUEST PLAN 

Effective on December 1, 2006, the Dream Quest Images 401(k) Profit Sharing Plan (the “Dream Quest Plan”) was merged with
and into the Plan. 
 l. Transfer of Account Balances. The Plan shall separately account for the portion of the
Accounts of each Participant that is attributable to allocations made under the Dream Quest Plan before the merger, which shall equal the Participant’s interest in the Dream Quest Plan immediately before the merger, as adjusted to reflect
subsequent investment experience, distributions, withdrawals, and other adjustments provided under the Plan. The portion of a Participant’s Accounts attributable to the Dream Quest Plan shall be nonforfeitable. 

2. Investment of Account Balance. The funds transferred from the Dream Quest Plan were initially invested in such
Investment Fund(s) as were set forth in the fund mapping rules communicated to affected Participants before the transfer and may be transferred to other Investment Funds in accordance with Section 6.01 of the Plan. 

3. Service Credit. Each Participant with an account balance under the Dream Quest Plan immediately before the merger shall,
for eligibility purposes under the Plan, be credited with all service credited to such Participant for eligibility purposes under the Dream Quest Plan as of December 1, 2006, to the extent not otherwise credited pursuant to any other Plan
provision. 
 4. Protected Benefits. A Participant or a Beneficiary of a Participant with an account balance under
the Dream Quest Plan immediately before the merger shall be entitled to elect any withdrawal or distribution option offered under the generally applicable provisions of the Plan with respect to the portion of his Accounts that is attributable to the
Dream Quest Plan, but only if the Participant or Beneficiary complies with the provisions of the Plan that govern the election of such withdrawal and distribution options and subject to any restrictions on distributions or withdrawals that may be
required by applicable law due to the nature of the underlying contributions. Benefit rights and optional forms of benefit of the Dream Quest Plan as they existed as of December 1, 2006 that are not available under the Plan shall be preserved
under this Plan with respect to accounts transferred from the Dream Quest Plan, but only to the extent required by Code Section 411(d)(6). Other than as set forth in the Plan, there are no benefit rights or optional forms that are required to
be preserved for Participants described in this Appendix. 
  

 F-1 

 APPENDIX G 

TRANSFER OF ASSETS FROM THE MAMMOTH RECORDS PLAN 

Effective on December 1, 2006, the Mammoth Records 401(k) Plan (the “Mammoth Plan”) was merged with and into the Plan.

 l. Transfer of Account Balances. The Plan shall separately account for the portion of the Accounts of each
Participant that is attributable to allocations made under the Mammoth Plan before the merger, which shall equal the Participant’s interest in the Mammoth Plan immediately before the merger, as adjusted to reflect subsequent investment
experience, distributions, withdrawals, and other adjustments provided under the Plan. The portion of a Participant’s Accounts attributable to the Mammoth Plan shall be nonforfeitable. 

2. Investment of Account Balance. The funds transferred from the Mammoth Plan were initially invested in such Investment
Fund(s) as were set forth in the fund mapping rules communicated to affected Participants before the transfer and may be transferred to other Investment Funds in accordance with Section 6.01 of the Plan. 

3. Service Credit. Each Participant with an account balance under the Mammoth Plan immediately before the merger shall, for
eligibility purposes under the Plan, be credited with all service credited to such Participant for eligibility purposes under the Mammoth Plan as of December 1, 2006, to the extent not otherwise credited pursuant to any other Plan provision.

 4. Protected Benefits. A Participant or a Beneficiary of a Participant with an account balance under the
Mammoth Plan immediately before the merger shall be entitled to elect any withdrawal or distribution option offered under the generally applicable provisions of the Plan with respect to the portion of his Accounts that is attributable to the Mammoth
Plan, but only if the Participant or Beneficiary complies with the provisions of the Plan that govern the election of such withdrawal and distribution options and subject to any restrictions on distributions or withdrawals that may be required by
applicable law due to the nature of the underlying contributions. Benefit rights and optional forms of benefit of the Mammoth Plan as they existed as of December 1, 2006 that are not available under the Plan shall be preserved under this Plan
with respect to accounts transferred from the Mammoth Plan, but only to the extent required by Code Section 411(d)(6). Other than as set forth in the Plan, there are no benefit rights or optional forms that are required to be preserved for
Participants described in this Appendix. 
  

 G-1 

 APPENDIX H 

TRANSFER OF ASSETS FROM THE ABC, INC. SAVINGS & INVESTMENT PLAN 

Effective on February 1, 2007 (the “Merger Date”), the ABC, Inc. Savings & Investment Plan (the “ABC
Plan”) was merged with and into the Plan. 
 1. Transfer of Account Balances. The Plan shall separately
account for the portion of the Accounts of each Participant that is attributable to allocations made under the ABC Plan before the merger, which shall equal the Participant’s interest in the ABC Plan immediately before the merger, as adjusted
to reflect subsequent investment experience, distributions, withdrawals, and other adjustments provided under the Plan. The portion of a Participant’s Accounts attributable to the ABC Plan shall be nonforfeitable, except as provided otherwise
under the terms of the ABC Plan for a Participant who was not an Employee as of the Merger Date. For purposes of the Plan, amounts attributable to rollover contributions, pre-tax contributions, matching contributions, and after-tax contributions, if
any, that are transferred from the ABC Plan for a Participant shall be treated as subaccounts under the Rollover Account, Tax-Deferred Account, Matching Account, and After-Tax Account, respectively, maintained for the Participant under the Plan.

 2. Investment of Account Balance. The funds transferred from the ABC Plan were initially invested in such
Investment Fund(s) as were set forth in the fund mapping rules communicated to affected Participants before the transfer and may be transferred to other Investment Funds in accordance with Section 6.01 of the Plan. 

3. Service Credit. Each Participant with an account balance under the ABC Plan immediately before the merger shall, for
eligibility purposes under the Plan, be credited with all service credited to such Participant for eligibility purposes under the ABC Plan as of the Merger Date, to the extent not otherwise credited pursuant to any Plan provision. 

4. Loans. Loans made from the ABC Plan before the Merger Date shall continue to be governed by Article X of the ABC Plan,
which is incorporated herein by reference. Loans made after the Merger Date shall be governed by Article 7 of the Plan. 
 5.
Benefit Rights and Optional Forms. A Participant or Beneficiary of a Participant with an account balance under the ABC Plan immediately before the merger shall be entitled to elect 

 

 H-1 

 
any withdrawal or distribution option offered under the generally applicable provisions of the Plan with respect to the portion of his Accounts that is attributable to the ABC Plan, but only if
the Participant or Beneficiary complies with the provisions of the Plan that govern the election of such withdrawal and distribution options and subject to any restrictions on distributions or withdrawals that may be required by applicable law due
to the nature of the underlying contributions. Benefit rights, spousal consent provisions (on loans, withdrawals, and/or distributions) and other requirements, and optional forms of benefit with respect to any amounts previously transferred to the
ABC Plan from another plan that are described in Schedules of the ABC Plan, are provided under the ABC Plan immediately before the Merger Date, and are not provided for under the Plan shall be preserved under this Plan with respect to amounts
described in such Schedules that have been transferred to the Plan from the ABC Plan. The Schedules of the ABC Plan referenced in the preceding sentence include: 

A. Schedule IX, relating to amounts transferred to the ABC Plan from the Satellite Music Network, Inc. 401(k) Plan;

 B. Schedule X, relating to amounts transferred to the ABC Plan from the Institutional Investor, Inc. Employee
Savings Plan; 
 C. Schedule XII, relating to amounts transferred to the ABC Plan from the International Medical
News Group Profit Sharing Plan; 
 D. Schedule XXI, relating to amounts transferred to the ABC Plan from the
WTVG, Inc. Employees Savings & Retirement Plan or the WJRT 401(k) Plan & Trust; 
 E. Schedule
XXVI, relating to amounts transferred to the ABC Plan from the Fairchild Publications, Inc. Publishing Pension Plan; 

F. Schedule XXVII, relating to amounts transferred to the ABC Plan from the Employee Profit Sharing Plan of ABC, Inc.;

 G. Schedule XXIX, relating to amounts transferred to the ABC Plan from the Fox Family Worldwide,
Inc. & Subsidiaries 401(k) Profit Sharing Plan; and 
 H. Schedule XXX, relating to amounts transferred
to the ABC Plan from the GO.com Savings and Investment Plan. 
  

 H-2 

 SCHEDULE OF EFFECTIVE DATES 

Provisions of the Plan have been amended from time to time to comply with changes in applicable law effective since the
enactment of the Economic Growth and Tax Relief Reconciliation Act of 2001. This Schedule of Effective Dates contains the effective dates of such amendments. 
  

					
	 REQUIRED AMENDMENT
	  	 EFFECTIVE DATE OF AMENDMENT
	  	 AFFECTED PLAN
SECTION(S)

	 EGTRRA § 613 and JCWAA § 411(k) changes to top-heavy rules under Code Section 416
	  	 Plan Years beginning on or after January 1, 2002
	  	Article 13
			
	 EGTRRA § 611(c) increasing annual compensation limit under Code section 401(a)(17) to $200,000, as adjusted
	  	 Plan Years beginning on or after January 1, 2002
	  	Section 1.35
			
	 EGTRRA §§ 641, 642, 643, and 636(b) changing definitions of eligible retirement plan and eligible rollover distribution for purposes of direct
rollovers under Code Section 401(a)(31)
	  	 Distributions on or after January 1, 2002
	  	Section 8.05
			
	 EGTRRA § 657(a) and Notice 2005-5 amending Code Section 401(a)(31) to require automatic rollover of certain mandatory distributions over
$1,000
	  	 Distributions on or after March 28, 2005
	  	 Sections 8.03(c) and

(g), 8.05(c)(i), and

11.01(b)

			
	 EGTRRA § 611(d) increasing annual dollar limit on elective deferrals under Code Section 402(g)
	  	 Years beginning after December 31, 2001
	  	Sections 1.46 and 14.07
			
	 EGTRRA § 666 eliminating multiple use test under Code Section 401(m)(9)
	  	 Plan Years beginning after on or after January 1, 2002
	  	Article 14
			
	 EGTRRA §§ 611(b) and 632 increasing maximum annual additions under Code Section 415(c) to $40,000, as adjusted
	  	 Limitation Years beginning on or after January 1, 2002
	  	Section 14.05(a)

					
	 REQUIRED AMENDMENT
	  	 EFFECTIVE DATE OF AMENDMENT
	  	 AFFECTED PLAN
SECTION(S)

	 EGTRRA §636(a) directing the Secretary of the Treasury to revise regulations to reduce the period contributions are suspended following a hardship
withdrawal to 6 months
	  	 Distributions made after December 31, 2001
	  	Section 8.02(e)
			
	 PPA 2006 § 901(a)(1) adding Code Section 401(a)(35) requiring certain rights to divest publicly traded securities
	  	 Plan Years beginning on or after January 1, 2007
	  	Section 6.01(h)
			
	 PPA 2006 § 902(e)(3) eliminating the gap period income rule for excess contributions and excess aggregate contributions under Code Sections 401(k)(8)(A)(i)
and 401(m)(6)(A)
	  	 Plan Years beginning on or after January 1, 2008
	  	Section 14.01(c)
			
	 PPA 2006 § 822(a) amending Code Section 402(c)(2)(A) to permit nontaxable distributions to be rolled over directly to qualified defined benefit plans
or Code Section 403(b) plans if accounted for separately
	  	 Distributions on or after January 1, 2007
	  	Section 8.05
			
	 PPA 2006 § 824 adding Code Section 408A(e) permitting rollovers to Roth IRAs from qualified plans
	  	 Distributions on or after January 1, 2008
	  	Section 8.05
			
	 PPA § 508 requiring that participants in plans with participant-directed investments be provided with a benefit statement at least once per
quarter
	  	 Plan Years beginning on or after January 1, 2007
	  	Section 4.05
			
	 HEART Act § 104(a) adding Code Section 401(a)(37) relating to benefits payable upon a participant’s death while performing qualified military
service
	  	 Deaths occurring on or after January 1, 2007
	  	Section 2.04(g)

					
	 REQUIRED AMENDMENT
	  	 EFFECTIVE DATE OF AMENDMENT
	  	 AFFECTED PLAN
SECTION(S)

	 HEART Act § 105(b)(1) adding Code Section 414(u)(12) relating to the treatment of participants receiving differential wages while performing military
service
	  	 Plan Years beginning on or after January 1, 2009
	  	Sections 1.51 and 2.04(h)
			
	 WRERA § 108(f) requiring that plans provide for nonspouse beneficiary rollovers under Code Section 402(c)(11)
	  	 Distributions on or after January 1, 2010
	  	Section 8.05
			
	 WRERA § 109(b)(3) eliminating the distribution of gap period earnings with excess deferrals
	  	 Plan Years beginning on or after January 1, 2008 (Gap period earnings were distributed with excess deferrals for the 2007 Plan Year pursuant to final regulations
under Code Section 402(g))
	  	Section 14.01(c)
			
	 WRERA § 201(a) adding Code Section 401(a)(9)(H) providing for the suspension of the minimum distribution requirements for 2009
	  	 2009 distribution calendar year
	  	Section 8.08(l)
			
	 Final regulations under Code Section 401(a)(9)
	  	 Distributions for calendar years beginning on or after January 1, 2003
	  	Section 8.08
			
	 Final regulations under Code Sections 401(k) and 401(m)
	  	 Plan Years beginning on or after January 1, 2006
	  	 Sections 3.03(b),

8.02, and 14.01

through 14.04

			
	 Final regulations under Code Section 415
	  	 Limitation Years beginning on or after January 1, 2008
	  	Sections 1.51 and 14.05Second Amended and Restated Collaboration Agreement, dated April 20, 2010

 [ * ] = Certain confidential information contained in this document, marked by brackets, is filed with
the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

Exhibit 10.1 

SECOND AMENDED AND RESTATED 

COLLABORATION AND LICENSE AGREEMENT 

THIS SECOND AMENDED AND RESTATED
COLLABORATION AND LICENSE AGREEMENT (the “Agreement”) is entered into and made effective as of April 20, 2010 (the “Amendment Effective Date”), by
and between ARCA biopharma, Inc. a Delaware corporation having its principal place of business at 8001 Arista Place, Suite 200, Broomfield, CO 80021 (successor-in-interest to NUVELO, INC., a Delaware
corporation having its principal place of business at 201 Industrial Road, Suite 310, San Carlos, CA 94070) (“ARCA”), and ARCHEMIX CORP., a Delaware corporation having its principal place of
business at 300 Third Street, Cambridge, MA 02142 (“Archemix”). ARCA and Archemix are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” 

RECITALS 

WHEREAS, Nuvelo, Inc. and Archemix entered into an Amended and Restated Collaboration Agreement effective
July 31, 2006 (the “Effective Date”)(the “Restated Agreement”), under which Archemix is responsible for the discovery of short-acting aptamers which bind to specifically defined protein targets causing an
anti-coagulation effect, and ARCA has the exclusive right to develop and commercialize aptamers so identified by Archemix; and 

WHEREAS, the Parties now desire to amend the Restated Agreement in order to eliminate certain financial and other
provisions to facilitate the out-licensing of ARC 2172 by ARCA and to allow Archemix to more fully exploit the field of short-acting aptamers; and 

WHEREAS, the Parties have by mutual agreement, agreed to supersede the terms of the Restated Agreement, with those
set forth in this Agreement as of the Amendment Effective Date. 
 NOW,
THEREFORE, the Parties agree as follows: 
  

	1.	DEFINITIONS 

The following terms have the meanings set forth below as used in this Agreement: 

1.1         “Affiliate” means a person, corporation, partnership, or other
entity that controls, is controlled by or is under common control with a Party. For the purposes of this Section 1.1, the word “control” (including, with correlative meaning, the terms “controlled by” or
“under the common control with”) means the actual power, either directly or indirectly through one or more intermediaries, to direct the management and policies of such entity, whether by the ownership of at least fifty percent
(50%) of the voting stock of such entity, or by contract or otherwise. 

1.2         “Aptamer” means any oligonucleotide that binds to a target through
means other than Watson-Crick base-pairing. 

 1.3         “ARC 2172” means the
DNA Aptamer having the following nucleotide sequence: [ * ]. 
 1.4        
“Archemix Background Technology” means any Technology used by Archemix, or provided by Archemix for use hereunder and/or which is otherwise necessary or useful for the Development, Commercialization, manufacture, importation or use of
ARC 2172 or any Licensed Product and that is (a) Controlled by Archemix as of the Effective Date, (b) conceived or first reduced to practice by employees of, or consultants to, Archemix after the Effective Date other than in the conduct of
Research, Development or Commercialization, (c) conceived or first reduced to practice in the conduct of Research, Development or Commercialization and that constitutes SELEX Inventions or SELEX Technology, or (d) Archemix’s interest
in all Program Technology to the extent it is not Compound Technology. 
 1.5        
“Archemix Patent Rights” means Patent Rights Controlled by Archemix claiming or disclosing Archemix Technology. For clarity, Archemix Patent Rights include all Licensed Patent Rights. 

1.6         “Archemix Product” has the meaning assigned in
Section 9.2(a)(ii). 
 1.7         “Archemix Program Technology”
means any Program Technology that is conceived or first reduced to practice by or through employees of, or consultants to, Archemix, alone or with any Third Party, in the conduct of the Research, Development or Commercialization of ARC 2172 or any
Licensed Products. 
 1.8         “Archemix Technology” means,
collectively, Archemix Background Technology, Archemix’s interest in all Joint Technology, and Archemix Program Technology. “Archemix Technology” includes the Compound Technology. 

1.9         “Bankrupt Party” has the meaning assigned in Section 13.2(a).

 1.10         “Collaboration” means all activities performed by or on
behalf of ARCA or Archemix in the course of performing the activities described in, or fulfilling of their obligations pursuant to, this Agreement. 

1.11         “Commercialization” or “Commercialized” means all
activities that are undertaken prior to, during or after completion of an NDA filing for a particular Licensed Product and that relate to the commercial manufacture, marketing and sale of such Licensed Product including but not limited to
pre-commercialization, advertising, education, planning, marketing, promotion, distribution, market and product support studies, and Phase 4 Trials. 

1.12         “Compound Patent Rights” means Patent Rights to the extent claiming
(a) Compound Technology or (b) ARC 2172. 
  

 2. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 1.13         “Compound Technology”
means any Program Technology developed solely by Archemix or which is Joint Technology and in either case to the extent specifically disclosing the composition of matter, formulation or use of ARC 2172 in the Field. 

1.14         “Confidential Information” has the meaning assigned to it in
Section 7.1. 
 1.15         “Control” means, with respect to an
item of Technology, a molecule or an intellectual property right, that a Party owns or has a license to such item, to a Patent Right claiming such molecule, or to such right and has the ability to disclose and grant a license or sublicense as
provided for in this Agreement under such item, Patent Right, or right without the payment of additional consideration to, and without violating the terms of any agreement or other arrangement with, any Third Party. 

1.16         “Develop” or “Development” means all activities with
respect to ARC 2172 or a Licensed Product relating to: (a) the preparation for and conducting of Phase 1 Trials, Phase 2 Trials, and Phase 3 Trials; (b) the filing and obtaining of Regulatory Approval for a Licensed Product; and
(c) all activities relating to developing the ability to manufacture ARC 2172 or Licensed Products. This includes, but is not limited to: (i) preclinical testing, toxicology, formulation development, clinical studies, regulatory affairs
and outside counsel regulatory legal services; and (ii) manufacturing process development and scale up for bulk and final forms of ARC 2172 and Licensed Products, validation documentation, all documentation generated in connection with the
manufacturing or processing activities and manufacturing and quality assurance technical support activities for ARC 2172 or Licensed Products prior to first commercial sale. 

1.17         “Diligent Efforts” means the carrying out of obligations or tasks
in a reasonable, good faith, and diligent manner consistent with efforts and resources as commonly used in the research-based biotechnology industry for a company of a similar size and a similar market capitalization, for a therapeutic product at a
similar stage of research, development or commercialization, and having similar market potential, taking into account issues of safety, efficacy, product profile, the costs to develop, the competitiveness of alternative products that are or are
expected to be in the relevant marketplace, the proprietary position of the product, the regulatory structure and the likelihood of regulatory approval and product reimbursement, the profitability of the product, and all other relevant commercial
factors. 
 1.18         “Drug Approval Application” means an
application for Regulatory Approval required before commercial sale or use of a Licensed Product as a drug in a regulatory jurisdiction. 

1.19         “EMEA” means the European Medicines Agency, or any successor
thereof. 
  

 3. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 1.20         “EMEA and Pricing
Approval” means approval by the EMEA to sell a Licensed Product together with pricing approval in at least one of France, Germany, Italy, Spain or United Kingdom. 

1.21         “FDA” means the United States Food and Drug Administration, or any
successor federal agency thereto. 
 1.22         “Field” means the
prevention, treatment, cure and/or delay of the onset or progression of all human therapeutic indications. 

1.23         “Generic IP” has the meaning assigned in Section 3.6.

 1.24         “Gilead” means Gilead Sciences, Inc., a Delaware
corporation with its principal offices located at 333 Lakeside Drive, Foster City, California 94404. 

1.25         “Gilead-Archemix Agreement” means the License Agreement
entered into by and between Gilead and Archemix dated October 23, 2001, as amended September 4, 2003. 

1.26         “IND” means: (a) an Investigational New Drug Application as
defined in the Federal Food, Drug and Cosmetic Act (“FDCA”) and regulations promulgated thereunder or any successor application or procedure required to initiate clinical testing of ARC 2172 and/or a Licensed Product in humans in the
United States; (b) a counterpart of an Investigational New Drug Application that is required in any other country or region in the Territory before beginning clinical testing of ARC 2172 and/or a Licensed Product in humans in such country or
region; and (c) all supplements and amendments to any of the foregoing. 

1.27         “In Vitro Diagnostics” means the use of the SELEX Process or
Aptamers or PhotoAptamers identified through the use of the SELEX Process in the assay, testing or determination, outside of a living organism, of a substance in a test material. In Vitro Diagnostics [ * ] other [ * ], the [ * ] of the [
* ] or Aptamers or [ * ] through the [ * ] of the [ * ] in the [ * ] or [ * ]: (a) [ * ] of a [ * ], (i) of a [ * ] in a [ * ], often to [ * ] or [ * ] of a [ * ] or [ * ], or
to [ * ] for [ * ]; (ii) of a [ * ] or other [ * ] in a [ * ], often to [ * ] or [ * ] the [ * ] of a [ * ] or [ * ] in a [ * ] or [ * ] and (iii) of [
* ] (as in [ * ]); (b) of a [ * ] on a [ * ] such as [ * ] (as in [ * ] or other [ * ] of [ * ] within [ * ]); and (c) any [ * ] in vitro diagnostic [ *
] of the [ * ] or Aptamers or [ * ] through the [ * ] of the [ * ] in [ * ] for example, [ * ] and [ * ], and the [ * ] of [ * ] of Aptamer [ * ]: (i) to [ * ],
through [ * ] in [ * ] or [ * ] of [ * ], and to [ * ] are [ * ] for the [ * ] of [ * ]; (ii) to [ * ] of [ * ] in a [ * ] of [ * ] in [ * ];
(iii) to [ * ] or [ * ] in [ * ] to [ * ] during [ * ] (e.g., as [ * ] of [ * ] or [ * ]); and (iv) to [ * ] or [ * ] in [ * ] to [ * ] (e.g.,
as [ * ] of [ * ] or [ * ]). 
 1.28         “ARCA
Indemnitees” and “ARCHEMIX Indemnitees” have the meaning assigned in Section 11.1(a) and 11.1(b), respectively. 

1.29         “Joint Patent Rights” means Patent Rights claiming Joint
Technology. 
  

 4. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 1.30         “Joint Technology”
means any Program Technology jointly conceived or reduced to practice by employees of or consultants to ARCA and employees of or consultants to Archemix under this Agreement. For clarity, any jointly developed Technology that is SELEX Technology
or SELEX Inventions shall not be considered Joint Technology regardless of which Party conceived or reduced to practice such Technology or Inventions. 

1.31         “Licensed Patent Rights” means any Archemix Patent Rights
(a) to the extent claiming ARC 2172 or a Licensed Product or the manufacture thereof or the use thereof in the Field, or (b) that are necessary or useful for ARCA to exercise the relevant licenses granted to it pursuant to Article 5. For
clarity, the Licensed Patent Rights shall exclude any Patent Rights that relate to the SELEX Inventions or the SELEX Technology and shall include, without limitation, the following United States Patents and their counterparts throughout the world to
the extent not SELEX Inventions or SELEX Technology: United States Patent Nos. 6,334,318 B1; 5,476,766; 5,543,293; 5,582,981; 5,688,291; 5,817,785; 5,840,867; and 6,331,398 B1. 

1.32         “Licensed Product” means a product that comprises, consists of, or
which incorporates ARC 2172. 
 1.33         “Licensed Technology”
means any Archemix Technology that (a) specifically relates to ARC 2172 or a Licensed Product, or (b) is necessary or useful for ARCA to exercise the relevant licenses granted to it pursuant to Article 3. 

1.34         “MHLW” means the Ministry of Health, Labor and Welfare, otherwise
referred to as “Korosho” or any successor thereto, which governs the scientific review of human pharmaceutical products in Japan. 

1.35         “NDA” means a New Drug Application submitted and filed with the FDA
or the equivalent application or filing filed with any equivalent agency or government authority outside of the United States (including any supra-national agency such as in the European Union) necessary for approval of a drug in such jurisdiction.

 1.36         “Net Sales:” 

(a)         means the gross amount invoiced by ARCA or its Affiliate or a licensee or
sublicensee (at any level, including a sublicensee of a sublicensee) for sales of Licensed Products to a Third Party (other than a Third Party Partner or a licensee or sublicensee) less, to the extent included within the gross amount invoiced to and
paid by the customer, deductions for: (i) transportation, and customs clearance, duty charges and insurance relating to such transportation; (ii) sales and excise taxes, customs and any other governmental charges, all to the extent imposed
upon the sale of the Licensed Products and paid by the selling party; (iii) distributors fees, rebates or allowances actually granted or allowed, including government and managed care rebates; (iv) quantity discounts, cash discounts or
chargebacks actually granted, allowed or incurred in the ordinary course of business in connection with the sale of the Licensed Products; and (v) allowances or credits to customers, not in excess of the selling price of the Licensed

  

 5. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
Products, on account of governmental requirements, rejection, recalls or return of the Licensed Products. 

(b)         Solely for the purpose of calculating Net Sales of Licensed Products, if a
Party or its Affiliate, or a licensee or sublicensee, sells such Licensed Products in the form of a combination product containing any such Licensed Product and one or more active ingredients or a delivery device (whether combined in a single
formulation or package, as applicable, or formulated or packaged separately but sold together for a single price) (a “Combination Product”), Net Sales of such Combination Product for the purpose of determining the royalty due to the
other Party pursuant to Sections 4.1(b)(i) and/or 9.2(b) will be calculated by multiplying actual Net Sales of such Combination Product as determined in subsection (a) above by the fraction A/(A+B) where A is the invoice price of such Licensed
Product if sold separately, and B is the total invoice price of the other active ingredient(s) or the delivery device in the combination if sold separately. If, on a country-by-country basis, such other active ingredient or ingredients or delivery
device in the Combination Product are not sold separately in such country, but the Licensed Product component of the Combination Product is sold separately in such country, Net Sales for the purpose of determining royalties due to the other Party
pursuant to Sections 4.1(b)(i) and/or 9.2(b) for the Combination Product shall be calculated by multiplying actual Net Sales of such Combination Product as determined in subsection (a) above by the fraction A/C where A is the invoice price of
such Licensed Product component if sold separately, and C is the invoice price of the Combination Product. If, on a country-by-country basis, such Licensed Product component is not sold separately in such country, Net Sales for the purposes of
determining royalties due to the other Party pursuant to Sections 4.1(b)(i) and/or 9.2(b) for the Combination Product shall be D/(D+E) where D is the fair market value of the portion of the Combination Products that contains the Licensed Product and
E is the fair market value of the portion of the Combination Products containing the other active ingredient(s) or delivery device included in such Combination Product as such fair market values are determined by mutual agreement of the Parties.

 1.37         “ARCA Background Technology” means any Technology that
is (a) Controlled by ARCA as of the Effective Date or (b) conceived or first reduced to practice by ARCA after the Effective Date other than in the conduct of Research, Development or Commercialization, and in either case is necessary or
useful for the Development, Commercialization, manufacture, importation, use or sale of ARC 2172 or Licensed Products under this Agreement. ARCA Background Technology does not include ARCA Program Technology or ARCA’s interest in Joint
Technology. For clarity, any Program Technology that is SELEX Technology or SELEX Inventions shall not be considered ARCA Background Technology regardless of which Party conceived or reduced to practice such Technology or Inventions. 

1.38         “ARCA Patent Rights” means Patent Rights Controlled by ARCA
claiming or disclosing ARCA Technology. 
 1.39         “ARCA Product”
has the meaning assigned to it in Section 9.2(a)(i). 
  

 6. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 1.40         “ARCA Program
Technology” means any Program Technology that is conceived or first reduced to practice by or through employees of, or consultants to, ARCA, alone or with any Third Party, in the conduct of the Research, Development or Commercialization of
ARC 2172 or Licensed Products. For clarity, any Program Technology that is SELEX Technology or SELEX Inventions shall not be considered ARCA Program Technology regardless of which Party conceived or reduced to practice such Technology or Inventions.

 1.41         “ARCA Technology” means, collectively, ARCA Background
Technology, ARCA Program Technology, and ARCA’s interest in all Joint Technology. 

1.42         “Partnering Agreement” means an executed and in-force written
agreement between ARCA and a Third Party or between a Third Party Partner and another Third Party, wherein such Third Party is granted the right to Develop or Commercialize, alone or in collaboration with ARCA or another Third Party Partner, a
Licensed Product. 
 1.43         “Patent Rights” means the rights and
interests in and to (a) a pending application for a patent anywhere in the world, including without limitation any provisional, converted provisional, continued prosecution application, substitution, continuation, divisional or
continuation-in-part thereof; (b) any patent issuing on any of the foregoing, including any inventor’s certificate, that has not expired or been declared invalid by a court from which no appeal can be or has been taken; or (c) any
extension, renewal, reissue or reexamination of any of the foregoing. 
 1.44        
“Phase 1 Trial” means that portion of the clinical development program that generally provides for the first introduction into humans of a product with the primary purpose of determining safety, metabolism and pharmacokinetic
properties and clinical pharmacology of the product, and that is consistent with 21 CFR §312.21(a) or the applicable rules and regulations of the jurisdiction in which the clinical trial is conducted. 

1.45         “Phase 2 Trial” means that portion of the clinical development
program that provides for a clinical trial of a product on patients, which may include pharmacokinetic studies, the principal purpose of which is to make a preliminary determination that such product is safe for its intended use, to determine
potential doses and to obtain sufficient information about such product’s efficacy to permit the design of further clinical trials, and that is consistent with 21 CFR §312.21(b) or the applicable rules and regulations of the jurisdiction
in which the clinical trial is conducted. 
 1.46         “Phase 3
Trial” means that portion of the clinical development program that provides for a pivotal human clinical trial of a product, which trial is designed to: (a) establish that a product is safe and efficacious for its intended use;
(b) define warnings, precautions and adverse reactions that are associated with the product in the dosage range to be prescribed; and (c) support Regulatory Approval of such product; and which trial is consistent with 21 CFR

  

 7. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
§312.21(c) or the applicable rules and regulations of the jurisdiction in which the clinical trial is conducted. 

1.47         “Program Technology” means any Technology that is generated,
conceived or first reduced to practice (actively or constructively) by either Party or both Parties in the conduct of the Research, Development or Commercialization of ARC 2172 or Licensed Products. 

1.48         “Radio Therapeutic Aptamer” means any product for human therapeutic
use that contains one or more Aptamers that targets specifically any diseased tissue, cells or disease-specific molecules or any tissue or cells which are affected by a disease or located in the close neighborhood of a disease process and is linked
to or incorporates: (a) radionucleotides; or (b) any structure or elements which develop therapeutic effects similar to the effect of linking or incorporating radionucleotides after submission of any kind of radiation. 

1.49         “Regulatory Approval” means any and all approvals (including
supplements, amendments, pre- and post-approvals, pricing and reimbursement approvals), licenses, registrations or authorizations of any national, supra-national (e.g., the European Commission or the Council of the European Union), regional,
state or local regulatory agency, department, bureau, commission, council or other governmental entity, that are necessary for the manufacture, distribution, use or sale of a Licensed Product in a regulatory jurisdiction. 

1.50         “Regulatory Authority” means the FDA or any counterpart of the FDA
outside the United States, or other national, supra-national, regional, state or local regulatory agency, department, bureau, commission, council, or other governmental entity with authority over the distribution, importation, exportation,
manufacture, production, use, storage, transport or clinical testing or sale of a Licensed Product. 

1.51         “Regulatory Documentation” means, with respect to a Licensed
Product, all regulatory filings and supporting documents created, submitted to the FDA or any equivalent agency or government authority outside of the United States (including any supra-national agency such as in the European Union) relating to such
product, and all data contained therein, including, without limitation, any IND(s), NDA(s), Biologics License Application(s) (“BLA(s)”), Investigator’s Brochures, Drug Master File(s) , correspondence to and from the FDA or any
equivalent agency or governmental authority outside of the United States, minutes from teleconferences with Regulatory Authorities, registrations and licenses, regulatory drug lists, advertising and promotion documents shared with Regulatory
Authorities, adverse event files, complaint files and manufacturing records. 

1.52         “Regulatory Filing” means the NDA, BLA, IND, or any foreign
counterparts thereof and any other filings required by Regulatory Authorities relating to the study, manufacture or commercialization of any Licensed Product. 

1.53         “Research” means: (a) the discovery and identification of ARC
2172 and (b) the biological characterization (including, without limitation, preclinical activities such as in vivo analysis) of ARC 2172. 
  

 8. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 1.54         “Royalty Period” has
the meaning assigned to it in Section 4.1(b)(iii). 
 1.55         “SELEX
Inventions” means any and all inventions, including any improvements, made solely by employees or independent contractors of one Party, or jointly by employees or independent contractors of each Party, in the course of the Party’s or
Parties’ performance under this Agreement, specifically relating to the SELEX Technology. 

1.56         “SELEX Portfolio” means those Patent Rights licensed by Gilead to
Archemix pursuant to the Gilead-Archemix Agreement. 
 1.57         “SELEX
Technology” means any Technology or process for identifying, modifying, optimizing and/or stabilizing an Aptamer, whether (i) existing as of the Effective Date or invented thereafter. For clarity for the purposes of this
Section 1.57: (i) the process of “identifying” includes, without limitation, any process which is disclosed in or falls within the claimed scope of U.S. Patent Nos. 5,270,163 or 5,843,653; and (ii) the processes of
“modifying”, “optimizing” and “stabilizing” include, without limitation, minimization, truncation, conjugation, pegylation, complexation, substitution, and deletion and/or incorporation of modified nucleotides.
“SELEX Technology” and “SELEX Inventions” does not include any Compound Technology. 

1.58         “SomaLogic Agreements” means the [ * ] by and between [ *
] and [ * ], the [ * ] between [ * ] and [ * ], and the [ * ]. 

1.59         “Technology” means, collectively, inventions, discoveries,
improvements, trade secrets, proprietary materials and proprietary methods, whether or not patentable, including without limitation: (a) methods of production or use of, and structural and functional information pertaining to, chemical
compounds; (b) compositions of matter, data, formulations, processes, techniques, know-how and results (including any negative results); and (c) any proprietary data, instructions, processes, methods, formulae, materials, expert opinions
and information including, without limitation, biological, chemical, pharmacological, toxicological, pharmaceutical, physical and analytical, clinical, safety, manufacturing and quality control data and information in the Control of a Party either
prior to or during this Agreement that relates in any way to Development activities. 

1.60         “Term” has the meaning assigned to it in Section 8.

 1.61         “Third Party” means any entity other than:
(a) ARCA; (b) Archemix; or (c) an Affiliate of either of them. 

1.62         “Third Party Royalty” has the meaning assigned to it in
Section 4.1(b)(ii). 
 1.63         “Title 11” has the meaning
assigned to it in Section 13.2(a). 
 1.64         “ULEHI
Agreement” means the [ * ] and [ * ] by and between [ * ] and [ * ] to the [ * ]. 
  

 9. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 1.65         “URC License
Agreement” means the [ * ] and [ * ], by and between [ * ] and [ * ] 

1.66         “UTC” means [ * ], the [ * ] to the [ * ].

 1.67         “Valid Claim” means (a) any claim of a pending
patent application which has been pending for a period of less than five (5) years from the date of issuance of a first patent office communication during examination of the first application related thereto, and shall not have been earlier
cancelled, withdrawn or abandoned on a country-by-country basis, or (b) an issued unexpired patent that (i) has not been finally cancelled, withdrawn, abandoned or rejected by any administration agency or other body of competent
jurisdiction, (ii) has not been permanently revoked, held invalid, or declared unpatentable or unenforceable in a decision of a court or other body of competent jurisdiction that is unappealable or unappealed within the time allowed for appeal,
(iii) has not been rendered unenforceable through disclaimer or otherwise, and (iv) is not lost through an interference proceeding. 

1.68         “Coagulation Cascade Protein” means a protein that is included on
the list set forth in Exhibit B. 
 1.69         “Inhibit” or
“Inhibition” means inhibition at a therapeutically useful level by binding to a pre-selected Coagulation Cascade Protein. 

1.70         “Short Acting Coagulation Cascade Aptamer” any Aptamer that:
(a) binds to a pre-selected Coagulation Cascade Protein; (b) Inhibits the blood coagulant function of the pre-selected Coagulation Cascade Protein; and (c) demonstrates the short-acting characteristics and limitations that are set
forth in Exhibit C. For clarity, Short Acting Coagulation Cascade Aptamers do not include [ * ]. 
  

	2.	DEVELOPMENT, MANUFACTURE AND COMMERCIALIZATION 

2.1         Diligence.   ARCA will use Diligent Efforts to Develop, manufacture
and Commercialize at least one (1) Licensed Product for use in the Field. 

2.2         Development and Commercialization.   ARCA has sole and full control,
authority and responsibility for conducting, funding and pursuing all aspects of the Development and Commercialization of ARC 2172 and Licensed Products throughout the world, so long as ARCA uses Diligent Efforts with respect thereto. ARCA may, at
its discretion, contract with or grant sublicenses to Third Parties in connection with the exercise of its rights with regard to the Development and Commercialization of ARC 2172 and Licensed Products. 

2.3         Abandonment of Development Compounds.   ARCA may determine that
Development of ARC 2172 should be abandoned. If ARCA decides to abandon Development of ARC 2172, and this Agreement is terminated pursuant to Section 9.1, then Archemix will have the right to continue such Development either by itself or with a
Third Party. 
  

 10. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 2.4         Regulatory Affairs.  
With respect to ARC 2172, at its discretion ARCA will prepare, file and own all right, title and interest in Regulatory Filings and Regulatory Approvals relating to ARC 2172. 

2.5         Manufacturing.   ARCA will be responsible for manufacturing and
supplying ARC 2172 and Licensed Products for Development and Commercialization and for making all decisions with respect thereto in its sole discretion including, without limitation, decisions relating to process development work to support quality
assurance, improving manufacturing/cost efficiency and commercial scale-up manufacturing. For clarity, ARCA shall have final decision making authority to fulfill its regulatory responsibilities over all steps of the manufacturing process (including
bulk, finish and fill, labeling and packaging, lot release and management of contractors and subcontractors). The Parties recognize that ARCA may use Third Parties to conduct some or all of ARCA’s manufacturing responsibilities hereunder, and
ARCA will have sole decision making authority for contracting with any such Third Parties. 
  

	3.	LICENSES AND RELATED RIGHTS 

3.1         Commercialization License.   Archemix hereby grants to ARCA an
exclusive (even as to Archemix), worldwide, sublicensable license under the Licensed Technology and Licensed Patent Rights, to Develop, Commercialize, make, have made, use, have used, sell, have sold, lease, offer for sale or lease, import and
export ARC 2172 and Licensed Products within the Field. 
 3.2         License Grant
upon Termination of the Collaboration.   Upon termination the license grants between the Parties of this Agreement shall be governed under Section 9 of this Agreement. 

3.3         License Limitations.   Notwithstanding any provision hereof to the
contrary, (a) Archemix does not grant to ARCA a license to the SELEX Technology or SELEX Inventions and ARCA hereby covenants that it will not practice any SELEX Technology or SELEX Inventions Controlled by Archemix and (b) ARCA hereby
covenants that it will not practice any of the rights granted hereunder to any of the Licensed Patent Rights or Licensed Technology or use, make, have made, import, sell, have sold, or offer for sale ARC 2172 or Licensed Product for a purpose other
than that expressly permitted in Sections 3.1 and 3.2 hereof. For clarity, ARCA shall have no right under this Agreement to use, make, have made, import, sell, have sold, and/or offer for sale: (w) any Radio Therapeutic Aptamer; (x) any
Aptamer that is not ARC 2172; (y) any non-therapeutic use of ARC 2172, including, but not limited to, In Vitro Diagnostics and/or other diagnostic uses, use of an Aptamer as a reagent or use of an Aptamer in or as a non-therapeutic service; or
(z) ARC 2172 in conjunction with a second nucleic acid component, where the additional nucleic acid component is used to affect or terminate the activity of ARC 2172. 

3.4         Exclusivity.   During the Term of this Agreement, Archemix
shall not independently or with a Third Party [ * ]. 
  

 11. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 3.5         Sharing of Data. 

(a)         During the Term of this Agreement, ARCA will (i) have reasonable access
to all Program Technology (including, without limitation, all raw data) as it is generated and (ii) provide Archemix with written updates twice a year describing in reasonable detail ARCA’s Development and Commercialization activities
hereunder. 
 (b)         The Parties’ access to Program Technology and
ARCA Technology after the termination of the Agreement shall be governed by Section 9.2(a) and Section 6.1. 

3.6         Grantback.   Notwithstanding anything in this Agreement to the
contrary, and subject to Section 3.4, ARCA hereby grants to Archemix a non-exclusive, paid-up, royalty-free license to any ARCA Program Technology and ARCA Patent Rights covering such ARCA Program Technology that generically relates to and
covers the manufacturing, formulation, methods of use and/or processing of Aptamers (such Patent Rights hereinafter referred to as “Generic IP”). Archemix shall have the right to practice the Generic IP and to grant sublicenses to
the Generic IP to Third Parties who have a license from Archemix to Archemix technology and/or intellectual property solely in order to permit Archemix or such Third Party to research, discover, make, have made, keep, use, sell and/or have sold,
import or export Aptamers which are not subject to ARCA’s exclusive rights hereunder. For clarity, the rights granted to Archemix by ARCA under this Section 3.6 are limited to the claims to Generic IP and no rights are granted under other
claims in any patent or patent application of ARCA that contains the claim(s) which is (are) Generic IP. 

3.7         Sublicenses.   ARCA has the right to subcontract its Development and
Commercialization responsibilities under this Agreement (and grant any necessary sublicenses in connection therewith) without obtaining the consent of Archemix; provided, that, ARCA shall at all times remain primarily responsible and liable for all
such activities. 
 With respect to each sublicense granted hereunder: (a) such sublicense shall be subject to all the
material terms and conditions of the Agreement as applicable; (b) the scope of such sublicense shall be limited to performing Development or Commercialization activities hereunder; (c) ARCA shall be liable to Archemix as if ARCA is
exercising such sublicensed rights itself under this Agreement; and (d) ARCA shall provide, upon written request by Archemix, reasonable assurance that its sublicensees are bound by confidentiality, indemnity, reporting, audit rights, access to
data, and information and inventions assignment obligations substantially the same as those set forth in this Agreement. ARCA shall promptly provide notice to Archemix of any sublicense granted pursuant to this Section 3.7. 

3.8         No Other Rights.   No licenses other than as expressly provided
herein are granted by either Party to such Party’s Technology or Patent Rights. 
  

	4.	COMPENSATION 

4.1         Payments for Licensed Products. 

 

 12. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 (a)         Milestone Payments.  
ARCA shall pay to Archemix the milestone payments as set forth below, which shall be due and payable within ten (10) business days of the occurrence of the event for the first Licensed Product. For clarity, each milestone payment is due
only once, regardless of the number of Licensed Products Developed or Commercialized under this Agreement. 
  

							
	 	  	 Milestone Event
	  	Payment
Amount	 
	 [ * ]
	  	[ * ]	  	$	  	[ * ] 
	 [ * ]
	  	[ * ]	  	$	  	[ * ] 
	 [ * ]
	  	[ * ]	  	$	  	[ * ] 
	 [ * ]
	  	[ * ]	  	$	  	[ * ] 
	 [ * ]
	  	[ * ]	  	$	  	[ * ] 
	 [ * ]
	  	[ * ]	  	$	  	[ * ] 
		  	Total  	  	$	  	[ * ] 

(b)         Royalties. 

(i)         ARCA shall pay Archemix royalties on Net Sales of Licensed Products at the
royalty rates set forth below: 
  

			
	 Portion of Net Sales of Each Licensed Product

during Each Calendar Year
	  	Royalty Rate
		
	 Up to $ [ * ]
	  	[ * ]%
		
	 The portion of Net Sales that is greater than $ [ * ] and less than or equal to $ [ * ]
	  	[ * ]%
		
	 The portion of Net Sales that is greater than $ [ * ] and less than or equal to $ [ * ]
	  	[ * ]%
		
	 The portion of Net Sales that is greater than $ [ * ] and less than or equal to $ [ * ]
	  	[ * ]%
		
	 The portion of Net Sales that is greater than $ [ * ]
	  	[ * ]%

(ii)         Third Party Royalties.   ARCA shall be responsible for any
and all royalties due to a Third Party in connection with the Development of ARC 2172 and/or Commercialization of any Licensed Product (the “Third Party Royalty”), except that Archemix shall be responsible for all royalties due to
ULEHI for payments made by ARCA to Archemix 
  

 13. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
with respect to all Licensed Products. Archemix hereby warrants that the only Third Party Royalty obligation of which Archemix is aware that exists as of the Effective Date of this Agreement is
set forth in the ULEHI Agreement. 
 (iii)         Royalty Adjustment and
Term.   The royalty amounts set forth above shall be due on a Licensed Product-by-Licensed Product and country-by-country basis for so long as a Valid Claim of (a) Licensed Patent Rights cover the manufacture, use or sale of such
Licensed Product in such country or (b) ARCA Patent Rights that cover ARCA Program Technology cover the manufacture, use or sale of such Licensed Product in such country. In the event that no such Valid Claim exits, the royalty amounts set
forth above, which shall be due on a country-by-country basis, shall be reduced by [ * ] ( [ * ]%) on a Licensed Product-by-Licensed Product and country-by-country basis until the [ * ] ( [ * ]) anniversary of the first commercial sale of such
Licensed Product in such country if such anniversary has not yet occurred. 

(iv)         Royalty Report and Payment.   Commencing with the first commercial
sale of a Licensed Product by ARCA or its licensees or sublicensees, ARCA or its licensees or sublicensees making such sales shall make quarterly written reports to Archemix within sixty (60) days after the end of each calendar quarter (the
“Royalty Period”), stating in each such report, by Licensed Products and by country, the number, description and aggregate Net Sales in U.S. dollars of such Licensed Products sold during such Royalty Period by ARCA and its
licensees or sublicensees, respectively. The report shall also show: (A) the calculation of Net Sales made by ARCA and the royalty payments due to Archemix on such Net Sales for such Royalty Period; (B) the calculation of Net Sales made by
ARCA’s licensees or sublicensees, the amount of sublicense revenue and royalty received from such licensees or sublicensees and the royalty payments due to Archemix on such sublicensee Net Sales for such royalty period; (C) the amount of
taxes, if any, withheld to comply with applicable law; and (D) the exchange rates used in calculating the payments due to the other Party, which exchange rates shall comply with Section 4.1(b)(vi) below. Simultaneously with the delivery of
each such report, ARCA or its licensee or sublicensee making such sales shall pay to Archemix the total royalties, if any, due to Archemix for such Royalty Period. If no royalties are due, ARCA or its licensee or sublicensee making such sales shall
so report. 
 (v)         Blocked Currency.   In each country where
the local currency is blocked and cannot be removed from the country, royalties arising from sales made in that country shall be paid in the country in local currency by deposit in a local bank designated by Archemix, unless the Parties otherwise
agree. 
 (vi)         Foreign Exchange.   Conversion of sales
recorded in local currencies to U.S. dollars will be performed using an exchange rate for conversion of the foreign currency into U.S. dollars, at the average rate of exchange for the calendar quarter to which such payments relate, quoted for
current transactions for buying U.S. dollars, as reported in The Wall Street Journal for the last business day of the week before such payment is due, except as provided in Section 4.1(b)(v). 

 

 14. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 4.2         Payment Method.   All
payments due under this Agreement shall be made by bank wire transfer in immediately available funds to an account designated by the receiving Party. All payments hereunder shall be made in U.S. dollars from the United States. 

4.3         Taxes.   Each Party shall pay any and all taxes levied on account of
all payments it receives under this Agreement. If laws or regulations require that taxes be withheld, the paying Party will: (a) deduct those taxes from the remittable payment; (b) pay the taxes to the proper taxing authority; and
(c) send evidence of the obligation together with proof of tax payment to the receiving Party within thirty (30) days following that tax payment. 
  

	5.	RECORDS; AUDITS 

Both Parties shall keep complete, true and accurate books of accounts and records for the purpose of determining the payments to be made under this
Agreement. Such books and records shall be kept for at least three (3) years following the end of the calendar quarter to which they pertain. Such records will be open for inspection during such three (3) year period by independent
accountants, solely for the purpose of verifying payment statements hereunder. Such inspections shall be made no more than once each calendar year, at reasonable time and on reasonable notice. If any errors that favor the inspected Party are
discovered in the course of such inspection, then within thirty (30) days after its receipt of the inspection report, the inspected Party shall pay the inspecting Party those amounts (plus interest equal to the Prime Lending Rate as published
in the Wall Street Journal on the day preceding the inspection plus two hundred (200) basis points; provided, however, that in no event shall such rate exceed the maximum annual interest rate permitted under applicable law) that the
inspecting Party would have received in the absence of such errors. If any errors that favor the inspecting Party are discovered in the course of such inspection, then within thirty (30) days after its receipt of the inspection report, the
inspecting Party shall pay the inspected Party those amounts. Inspections conducted under this Article 5 shall be at the expense of the inspecting Party, unless a variation or error that favors the inspected Party exceeding five percent (5%) of
the amount stated for any year covered by the inspection is established in the course of such inspection, whereupon all costs relating to the inspection for such period will be paid promptly by the inspected Party. 

 

	6.	INFORMATION, INVENTIONS AND INTELLECTUAL PROPERTY 

6.1         Ownership. 

(a)         Patent Rights and Technology.   Subject to Section 6.1(b), all
Patent Rights will be the property of the inventing Party, provided that all Joint Patent Rights will be jointly owned by the Parties with each Party having full rights to use and license same subject only to the licenses expressly granted and the
terms set forth herein. In all cases, inventorship shall be determined according to United States Patent law. 

(b)         SELEX Inventions and SELEX Technology.   Notwithstanding anything
to the contrary herein, the SELEX Inventions and SELEX Technology shall be the 
  

 15. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
property of Archemix. ARCA shall and hereby does assign to Archemix all of ARCA’s right, title and interest in and to all SELEX Inventions and SELEX Technology. 

(c)         Technology.   Subject to Section 6.1(b), ownership of all
unpatented Technology is and will be the property of the Party who created it. 

(d)         Further Acts.   Each Party shall perform such additional actions
necessary to affect the intent of this Section 6.1, and shall reasonably cooperate with the other Party in doing so. 

6.2         Patent Prosecution and Maintenance. 

(a)         ARC 2172 and Compound Patent Rights.   For so long as ARCA has an
exclusive license hereunder to ARC 2172, ARCA has the right to pursue worldwide filing, prosecution and maintenance of ARC 2172 Patents or Compound Patent Rights using mutually acceptable outside counsel. ARCA will be solely responsible for all
costs incurred in this Section 6.2(a). ARCA will keep Archemix apprised of all prosecution matters, and will provide a copy of all official correspondence to Archemix, and ARCA will consider any comments in good faith from Archemix and
incorporate them to the extent possible. ARCA shall file, prosecute and maintain the ARC 2172 Patents and Compound Patent Rights in Archemix’ name using reasonably diligent efforts including filing, prosecuting and maintaining the ARC 2172
Patents and Compound Patent Rights, at a minimum, in the countries listed on Exhibit A. If in the exercise of diligent efforts ARCA decides to not pursue prosecution or maintenance of any such Patent Rights control of such Patent Rights shall be
transferred to Archemix at no cost. For purposes of this Agreement, “ARC 2172 Patents” means the following United States Patent Applications and their counterparts throughout the world to the extent not SELEX Inventions or SELEX
Technology: U.S. Patent Application Serial No. 60/711,768 and Serial No. 60/808,590. 

(b)         SELEX Technology and SELEX Inventions.   Archemix shall have the
sole right but not the obligation to file, prosecute and maintain Patent Rights on SELEX Technology or SELEX Inventions, at its own expense. 

(c)         Archemix Technology.   Except as set forth in Section 6.2(a),
Archemix shall have the sole right but not the obligation to file, prosecute and maintain Patent Rights on Archemix Background Technology and Archemix Program Technology, at its own expense, including without limitation all Patent Rights in and to
the SELEX Portfolio. 
 (d)         ARCA Background Technology.   ARCA
shall have the sole right but not the obligation to file, prosecute and maintain Patent Rights claiming ARCA Background Technology, at its own expense. 

(e)         ARCA Program Technology.   ARCA shall have the first right but not
the obligation to file, prosecute and maintain Patent Rights claiming ARCA Program Technology at its own expense. If, at any time, ARCA elects not to pursue patent protection for, or 

 

 16. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
maintenance of, any ARCA Program Technology, Archemix shall have the right to pursue patent protection for such Technology at Archemix’s sole expense. 

(f)         Joint Patent Rights.   Archemix has the first right, but not the
obligation, to pursue worldwide patent protection of all Joint Technology not covered by Section 6.2(a) above. The Parties will be jointly (on a fifty/fifty (50/50) basis) responsible for all costs incurred pursuant to this
Section 6.2(f). If Archemix elects to pursue such patent protection, it will use outside counsel mutually acceptable to the Parties. Archemix will keep ARCA apprised of all prosecution matters, and will provide a copy of all official
correspondence to ARCA. Archemix will consider in good faith any comments from ARCA and incorporate them to the extent possible. If, at any time, Archemix elects to not pursue patent protection for, or maintenance of, any such Joint Patent Rights,
control of such Joint Patent Rights shall be transferred to ARCA at no cost. For clarity, Patent Rights claiming any SELEX Technology or SELEX Invention are governed by Section 6.2(b) and not this Section 6.2(f). 

(g)         Information and Cooperation.   Each Party that has
responsibility for filing and prosecuting any Patent Rights under this Section 6.2 (a “Filing Party”) shall: (a) regularly provide the other Party (the “Non-Filing Party”) with copies of all patent applications filed
hereunder for Program Technology and other material submissions and correspondence with the patent offices, in sufficient time to allow for review and comment by the Non-Filing Party; and (b) to the extent practicable, provide the Non-Filing
Party and its patent counsel with an opportunity to consult with the Filing Party and its patent counsel regarding the filing and contents of any such application, amendment, submission or response, and the advice and suggestions of the Non-Filing
Party and its patent counsel shall be taken into consideration in good faith by such Filing Party and its patent counsel in connection with such filing. Each Filing Party shall pursue in good faith all reasonable claims and take such other
reasonable actions, as may be requested by the Non-Filing Party in the prosecution of any Patent Rights under this Section 6.2; provided, however, if the Filing Party incurs any additional expense as a result of any such request, the Non-Filing
Party shall be responsible for the cost and expenses of pursuing any such additional claim or taking such other activities. In addition, ARCA (a) agrees that if Archemix claims any action taken under Section 6.2 would be detrimental to
Patent Rights covering Archemix Background Technology (including without limitation the SELEX Portfolio), Archemix shall provide written notice to ARCA and the Parties shall, as promptly as possible thereafter, meet to discuss and resolve such
matter and, if they are unable to resolve such matter, the Parties shall refer such matter to a mutually agreeable outside patent counsel for resolution. 
  

 17. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 6.3         Enforcement of Patent Rights.

 (a)         Notice.   If a Third Party is apparently infringing any
Patent Right to which exclusive licenses are granted under this Agreement, the Party first obtaining knowledge of such a claim shall immediately provide the other Party notice of such claim and the related facts in reasonable detail. 

(b)         Enforcement Responsibility.   ARCA, as exclusive commercial
licensee, has the first right, but not the obligation, to solely enforce all Compound Patent Rights against any actual or suspected Third Party infringer in the Field. Such enforcement will be in ARCA’s own name and entirely under its own
direction and control, and ARCA may settle any such action, proceeding or dispute by license, subject to the remainder of this Section 6.3(b). ARCA will be solely responsible for all costs incurred in this Section 6.3(b). 

(i)         Enforcement by ARCA.   Archemix will, upon ARCA’s
request, reasonably assist ARCA in any action or proceeding being prosecuted by ARCA under this Section 6.3(b) if so requested, and shall lend its name to such actions or proceedings if reasonably requested by ARCA or required by applicable
law. ARCA shall reimburse Archemix for the documented external costs Archemix reasonably incurs in providing such assistance as specifically requested in writing by ARCA. Archemix shall have the right to participate and be represented in any such
suit by its own counsel at its own expense; provided, that, ARCA shall retain overall responsibility for the prosecution of such suit or proceedings in such event. No settlement of any such action or proceeding which restricts the scope, or
adversely affects the enforceability, of an Archemix Patent Right, or which could be reasonably expected to have a material adverse financial impact on Archemix, may be entered into by ARCA without the prior written consent of Archemix, which
consent shall not be unreasonably withheld, delayed or conditioned. 
 (ii)        
Enforcement by Archemix.   If ARCA elects not to settle or bring any action for infringement described in this Section 6.3(b) and so notifies Archemix, including following any request by Archemix to do so, then Archemix may
settle or bring such action at its own expense, in its own name; provided, however, that Archemix agrees not to so settle or bring such action for infringement upon ARCA’s request based on ARCA’s good faith reasonable determination
that it is not in the best interest of the Parties to so settle or bring such action for infringement. In the case where Archemix proceeds to settle or bring an action for such infringement, the following shall apply. ARCA shall reasonably assist
Archemix in any action or proceeding being prosecuted if so requested, and shall lend its name to such actions or proceedings if requested by Archemix or required by applicable law. Archemix shall reimburse ARCA for the documented external costs
ARCA reasonably incurs in providing such assistance as specifically requested in writing by Archemix. ARCA shall have the right to participate and be represented in any such suit by its own counsel at its own expense; provided, that, Archemix
shall retain overall responsibility for the prosecution of such suit or proceedings in such event. No settlement of any such action or proceeding which restricts the scope, or adversely affects the enforceability, of a Licensed Patent Right
hereunder, or which could be reasonably expected to 
  

 18. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
have a material adverse financial impact on ARCA, may be entered into by Archemix without the prior written consent of ARCA, which consent shall not be unreasonably withheld, delayed or
conditioned. 
 (iii)         Withdrawal.   If either Party
brings an action or proceeding under this Section 6.3(b) and subsequently ceases to pursue or withdraws from such action or proceeding, it shall promptly notify the other Party and the other Party may substitute itself for the withdrawing Party
under the terms of this Section 6.3(b). 
 (iv)        
Damages.   In the event that either Party exercises the rights conferred in this Section 6.3(b) and recovers any damages or other sums in such action, suit or proceeding or in settlement thereof, such damages or other sums
recovered shall first be applied to all out-of-pocket costs and expenses incurred by the Parties in connection therewith, including, without limitation, attorneys fees. Except as otherwise provided in this Section 6.3(b), each Party will bear
its own expenses with respect to any suit or other proceeding against an infringer. If such recovery is insufficient to cover all such costs and expenses of both Parties, it shall be shared in proportion to the total of such costs and expenses
incurred by each Party. If after such reimbursement any funds shall remain from such damages or other sums recovered, such funds shall be divided as follows: (i) as to ordinary damages based on lost sales or profit, ARCA shall retain such funds
and Archemix shall receive payment equivalent to payments that would have been due to Archemix under this Agreement had the infringing sales that ARCA lost to the infringer been made by ARCA; and (ii) as to special or punitive damages, the
Party that brought the enforcement action at its expense shall be entitled to receive eighty percent (80%) of the amount of such special or punitive damages and the other Party shall receive twenty percent (20%) of the amount of such
special or punitive damages. 
 (c)         Archemix Background Technology and SELEX
Technology and SELEX Inventions.   Archemix shall have the sole right but not the obligation to enforce Patent Rights on SELEX Technology and SELEX Inventions and, subject to Section 6.3(b), on Archemix Background Technology.

 (d)         ARCA Patent Rights.   ARCA shall have the sole right
but not the obligation to enforce ARCA Patent Rights. 
 6.4         Defense of Third
Party Claims. 
 ARCA will have the first right to defend any claims by a Third Party alleging infringement of any Third Party Patents or
misappropriation of any Third Party trade secrets in connection with the Development, manufacture or Commercialization of ARC 2172 or a Licensed Product by ARCA, its Affiliates, sublicensees, contractors or consultants. ARCA may, at its sole option,
settle any such claim; provided, that, such settlement does not, or will not have any material adverse effect on Archemix. 
  

	7.	CONFIDENTIALITY 

  

 19. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 7.1         Nondisclosure of Confidential
Information.   All Technology and other information disclosed by one Party to the other Party pursuant to this Agreement that is marked or otherwise identified as “confidential” or “proprietary” shall be
“Confidential Information” of the disclosing Party. Confidential Information also includes all Technology and other information developed by either Party in carrying out this Agreement and disclosed to the other Party, or disclosed
by either Party under the Original Agreement or the Restated Agreement, which agreements are superseded by this Agreement. The Parties agree that during the Term, and for a period of five (5) years thereafter, a Party receiving Confidential
Information of the other Party will: (a) maintain in confidence such Confidential Information to the same extent such Party maintains its own proprietary industrial information of similar kind and value; (b) not disclose such Confidential
Information to any Third Party without prior written consent of the disclosing Party, except as otherwise permitted in this Article 7; and (c) not use such Confidential Information for any purpose except those permitted by this Agreement.

 7.2         Exceptions.   The obligations in Section 7.1 shall
not apply to information that the receiving Party can show by competent written proof: 

(a)         Is publicly disclosed by the disclosing Party, either before or after the
Confidential Information is disclosed to the receiving Party hereunder; 

(b)         Was known to the receiving Party, without obligation to keep it confidential,
before disclosure of the Confidential Information by the disclosing Party; 

(c)         Is subsequently disclosed to the receiving Party by a Third Party lawfully in
possession thereof and without obligation to keep it confidential; 

(d)         Has been published by a Third Party; or 

(e)         Has been independently developed by the receiving Party without the aid,
application or use of the Confidential Information. 
 7.3         Authorized
Disclosure. 
 (a)         A Party may disclose the Confidential Information
belonging to the other Party to the extent such disclosure is reasonably necessary in the following instances, in each case, to the extent consistent with the terms of this Agreement: 

 

	 	(i)	Filing or prosecuting Patent Rights; 

  

	 	(ii)	Making Regulatory Filings; 

  

	 	(iii)	Prosecuting or defending litigation; 

  

	 	(iv)	Complying with applicable governmental regulations; 

  

 20. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 (v)        Conducting business discussions
with Third Parties who potentially or actually enter into a Partnering Agreement with ARCA and who have signed confidentiality agreements consistent with this Article 7; and 

(vi)        Making disclosures, in connection with the performance of this Agreement, to
Affiliates and actual or prospective licensees, sublicensees, contractors, research collaborators, employees, consultants, or agents, each of whom before disclosure must be bound by similar obligations of confidentiality and non-use at least
equivalent in scope to those set forth in this Article 7. ARCA and its sublicensees may also publicly disclose clinical data for use in connection with the marketing of Licensed Products in accordance with the customary practice of the
pharmaceutical industry. 
 (b)        The Parties acknowledge that the terms of
this Agreement shall be treated as Confidential Information of both Parties. Such terms may be disclosed by a Party to investment bankers, investors, and potential investors, lenders and potential lenders and other sources and other potential
sources of financing, licensees and potential licensees, acquirer or merger partners and potential acquirer or merger partners and Gilead and University License Equity Holdings, Inc. In addition, a copy of this Agreement may be filed by either Party
with the Securities and Exchange Commission if such filing is required by law or regulation. In connection with any such filing, such Party shall endeavor to obtain confidential treatment of economic and trade secret information, and shall provide
the other Party with the proposed confidential treatment request with reasonable time for such other Party to provide comments, which comments shall be reasonably considered by the filing Party. 

7.4        Publicity.   The Parties agree that the public announcement of
the execution of this Agreement shall be made pursuant to a press release approved by the Parties. Any other publication, news release or other public announcement relating to this Agreement or to the performance hereunder, shall also be reviewed
and approved by both Parties; provided, however, that any disclosure which is required by law as advised by the disclosing Party’s counsel may be made without the prior consent of the other Party, although the other Party shall be given prompt
notice of any such legally required disclosure and to the extent practicable shall provide the other Party an opportunity to comment on the proposed disclosure. 

7.5        Publications.   Subject to Section 7.3, each Party agrees
to provide the other Party the opportunity to review any proposed abstracts, manuscripts or presentations (including verbal presentations) which relate to ARC 2172 at least thirty (30) days before its intended submission for publication and
agrees, upon request, not to submit any such abstract or manuscript for publication until the other Party is given a reasonable period of time to secure patent protection for any material in such publication as appropriate and as governed by Article
6. Both Parties understand that a reasonable commercial strategy may require delay of publication of information or filing of patent applications. The Parties agree to review and consider delay of publication and filing of patent applications under
certain circumstances. Neither Party shall have the right to publish or present Confidential Information of the other Party, which is subject to Section 7.1, without the other Party’s written consent. Nothing contained in this
Section 7.5 
  

 21. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
shall prohibit the inclusion of information necessary for a patent application, so long as the Non-Filing Party is given a reasonable opportunity to review and comment on the information to be
included before submission of such patent application. Following termination of the Agreement, a Party that continues to develop or commercialize a Licensed Product as an Archemix Product or ARCA Product, as the case may be, may publish results of
studies of such Licensed Product without prior consultation with the other Party. 
  

	8.	TERM 

 Subject to Article
9, the term during which this Agreement is in effect (the “Term”) commences on the Effective Date and expires at such time as all obligations of the Parties to make payments pursuant to Article 4 for all Licensed Products have
ended, unless earlier terminated in accordance with the provisions of Article 9 below. 
  

	9.	TERMINATION 

9.1        Termination of Agreement. 

(a)        Termination for Material Breach.   Either Party may terminate
this Agreement, on a Licensed Product by Licensed Product basis, if the other Party has materially breached or defaulted in the performance of any relevant obligations under this Agreement or failed to use Diligent Efforts in the performance of any
relevant obligations under this Agreement, and the non-breaching Party has provided written notice to the other Party specifying the basis for the termination. For a failure to make a payment set forth in Article 4, the allegedly breaching Party
shall have ten (10) days to cure such breach. For all breaches other than a failure to make a payment set forth in Article 4, the allegedly breaching Party shall have sixty (60) days to either cure such breach or, if cure cannot be
reasonably effected within such sixty (60) day period, to deliver to the other Party a plan for curing such breach that is reasonably sufficient to effect a cure within ninety (90) days from receipt of the notice of breach. If the
breaching Party does not cure the breach before the expiration of ten (10), sixty (60) or ninety (90) days, as applicable, after receipt of the written notice specifying the basis for termination, the Agreement shall terminate upon the
expiration of the ten (10), sixty (60) or ninety (90) day period, as applicable. If the Parties cannot agree as to whether a breach exists, the dispute shall be resolved pursuant to Article 12, and no termination shall be effective until
the matter is so resolved. In the event that either Party files for protection under bankruptcy laws, makes an assignment for the benefit of creditors, appoints or suffers appointment of a receiver or trustee over its property, files a petition
under any bankruptcy or insolvency act or has any such petition filed against it which is not discharged within sixty (60) days of the filing thereof, then the other Party may terminate this Agreement effective immediately upon written notice
to such Party. 
 (b)        Voluntary Termination Other Than for Material
Breach.   For reasons other than Archemix’s material breach of its obligations under this Agreement pursuant to Section 9.1(a) ARCA may terminate this Agreement, on a Licensed Product by Licensed

  

 22. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
Product basis, or terminate the Agreement in its entirety, in its discretion upon sixty (60) days prior written notice to Archemix. 

9.2        Effects of Termination. 

(a)        Development of Products. 

(i)        ARCA Product.   If this Agreement is terminated by ARCA, in whole or
in part, for Archemix’s material breach under this Agreement pursuant to Section 9.1(a), upon the effective date of such termination, any Licensed Product then under Development or being Commercialized shall cease to be a Licensed Product
and will automatically become a “ARCA Product.” Promptly after the effective date of such termination: (A) Archemix shall assign to ARCA all of Archemix’s right, title and interest in and to all Compound Technology and all
Regulatory Documentation, Regulatory Filings and Regulatory Approvals, to the extent relevant to the Development and/or Commercialization of such ARCA Product in the Field and any trademarks for such product; (B) Archemix shall provide ARCA
with at least two (2) accurate and legible copies (including both paper and electronic copies, where available) of all such Technology as defined in Section 1.59 related the Development and/or Commercialization of such ARCA Product;
(C) upon ARCA’s written request and to the extent Archemix has the right to do so, Archemix shall assign to ARCA all agreements with Third Parties that are specific for the Development and/or Commercialization of such ARCA Product; and
(D) Archemix shall no longer have access to future ARCA Technology that is related to such ARCA Product. ARCA shall be free to develop and commercialize such ARCA Product and to collaborate with any Third Parties on such endeavors,
notwithstanding any Patent Rights of Archemix which would prevent such actions and subject only to Section 9.2(b)(i)(1). 

(ii)      Archemix Product.   If this Agreement is terminated by Archemix, in
whole or in part, pursuant to Section 9.1(a) for ARCA’s material breach under this Agreement, or by ARCA pursuant to Section 9.1(b) (voluntary termination), upon the effective date of such termination, any Licensed Product then under
Development or being Commercialized shall cease to be a Licensed Product and will automatically become an “Archemix Product.” Promptly after the effective date of such termination: (A) ARCA shall assign to Archemix all of
ARCA’s right, title and interest in and to the ARCA Technology, Regulatory Documentation, Regulatory Filings and Regulatory Approvals, to the extent relevant to the Development and/or Commercialization of such Archemix Product in the Field and
any trademarks for such product; (B) ARCA shall provide Archemix with at least two (2) accurate and legible copies (including both paper and electronic copies, where available) of all ARCA Technology as defined in Section 1.59 related
to the Development and/ or Commercialization of such Archemix Product; (C) upon Archemix’s written request and to the extent ARCA has the right to do so, ARCA shall assign to Archemix all agreements with Third Parties that are specific for
the Development or Commercialization of such Archemix Product; and (D) ARCA shall no longer have access to future Program Technology that is related to such Archemix Product. Archemix shall be free to develop and commercialize such Archemix
Product and to collaborate with any Third Parties on 
  

 23. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
such endeavors, notwithstanding any patent rights of ARCA which would prevent such actions and subject only to Section 9.2(b)(i)(2). 

(b)        Royalties and Payments on ARCA Products and Archemix Products. 

(i)        Royalty Rate and Payments Upon Termination.   If this
Agreement is terminated with respect to any ARCA Product or Archemix Product pursuant to Section 9.1(a) or (b) after the achievement of the [ * ] Milestone, then the Parties shall pay to each other royalties as set forth below, and
the procedures set forth in Sections 4.1(b)(iii) through (vi) shall apply to both Parties (in the case when Archemix is the royalty paying Party, such provisions shall apply to Archemix correlatively). Otherwise no royalty shall be due to a
Party hereto with respect to Archemix Products or ARCA Products. 

(1)        With respect to ARCA Products, ARCA (a) shall pay to Archemix a royalty
equal to [ * ] percent ( [ * ]%) of the Net Sales of such ARCA Products and (b) shall be solely responsible for any Third Party Royalty; and 

(2)        With respect to Archemix Products, Archemix (a) shall pay to ARCA a
royalty equal to [ * ] percent ( [ * ]%) of the Net Sales of such Archemix Products and (b) shall be solely responsible for any Third Party Royalty. 

(c)        Manufacturing. 

(i)        If this Agreement is terminated by ARCA, ARCA shall, or shall make the Third
Party manufacturer, as necessary, immediately provide to Archemix all process and manufacturing technology, material and data and either transfer or provide access to regulatory filings sufficient to enable Archemix or its Third Party designee to
produce and supply Archemix’s requirements of ARC 2172 or Licensed Product. ARCA shall cooperate with Archemix with respect to such transfer so as to permit Archemix to begin manufacturing and supplying its own requirements as soon as possible,
including without limitation assigning any Third Party manufacturing agreement to Archemix and providing technical advice (including reasonable advice provided at the site of the new manufacturer). In addition, ARCA shall provide, or take such
action as necessary to make the then current Third Party manufacturer provide, a right of reference and access to Archemix to all of ARCA’s or the Third Party manufacturer’s appropriate regulatory filings for the manufacture of such
Licensed Product. 
 (ii)      Transition Period.   In an event ARCA terminates
the Agreement pursuant to Section 9.1(b) and Archemix desires to carry on the Development and Commercialization of any Licensed Product or ARC 2172, ARCA shall remain obligated to its responsibilities under the Development Plan, and the
Commercialization Plan, at the cost of Archemix, until it transitions to Archemix such responsibilities, but in any event such period shall last no longer than ninety (90) days. Promptly following such termination, the Parties shall agree upon
and implement a plan for effecting such transition. 
  

 24. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 (d)        Other Effect of Termination;
Completion of Clinical Trials.   In any event, termination of this Agreement shall not relieve the Parties of any liability which accrued hereunder before the effective date of such termination nor preclude either Party from pursuing
all rights and remedies it may have hereunder or at law or in equity with respect to any breach of this Agreement nor prejudice either Party’s right to obtain performance of any obligation. 

(e)        Partnering Agreement.   If Archemix terminates this Agreement under
Section 9.1(a) and ARCA has a Partnering Agreement in effect as of the effective date of such termination, the Partnering Agreement will automatically be assigned to Archemix, and pursuant to the Partnering Agreement the Third Party will be
entitled to take an assignment of any and all rights of ARCA under any manufacturing agreement with a third party supplier of the Licensed Product(s) that is(are) the subject of the Partnering Agreement. 

9.3        Survival.   In the event of expiration or termination of this
Agreement, the following provisions of this Agreement shall survive for the period of time set forth in the applicable Section or Article, or if no period is specified, in perpetuity or the maximum amount of time permitted under applicable law:
Sections [ * ]. 
  

	10.	REPRESENTATIONS AND COVENANTS 

10.1     Mutual Authority. 

(a)        ARCA represents and warrants to Archemix that: (i) it has the authority
and right to enter into and perform this Agreement; and (ii) to the best of its knowledge the execution, delivery and performance of this Agreement by ARCA will not conflict in any material fashion with the terms of any other agreement to which
it is or becomes a Party or by which it is or becomes bound. 

(b)        Archemix represents and warrants to ARCA that: (i) it has the authority
and right to enter into and perform this Agreement; and (ii) to the best of its knowledge the execution, delivery and performance of this Agreement will not conflict in any material fashion with the terms of any other agreement to which it is
or becomes a Party or by which it is or becomes bound, specifically including, without limitation, the Gilead-Archemix Agreement, the URC License Agreement, the ULEHI Agreement, and the SomaLogic Agreements. 

10.2     Performance by Affiliates. The Parties recognize that each Party may perform some or all of
its obligations under this Agreement through Affiliates. Each Party shall remain responsible and be guarantor of the performance by its Affiliates of any of the obligations under this Agreement and shall cause its Affiliates to comply with the
provisions of this Agreement in connection with such performance. In particular, if any Affiliate of a Party participates in Development under this Agreement: (a) the restrictions of this Agreement which apply to the activities of a Party with
respect to Development Compounds shall apply equally to the activities of such Affiliate; (b) the Party affiliated with such Affiliate shall assure, and hereby guarantees, that any intellectual property developed by such Affiliate shall be
governed by the provisions of this Agreement (and subject to the licenses set forth in Articles 8) as if such intellectual property 

 

 25. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
had been developed by the Party; and (c) the Party affiliated with such Affiliate shall assure, and hereby guarantees, that such Affiliate shall abide by the confidentiality obligations set
forth in Article 10 as if such Affiliate were such Party. 
 10.3     Receipt, Review and Understanding
of Relevant Licenses. 
 (a)        As required under Section [ * ]
of the URC License Agreement, the Parties to this Agreement each hereby acknowledge and reference Gilead’s obligations under Articles [ * ] of the URC License Agreement for the benefit of URC. In addition, the Parties to this Agreement
understand that, in accordance with Section [ * ] of the URC License Agreement, [ * ] with the [ * ] to and [ * ] to the [ * ] of the [ * ], except as [ * ]. 

(b)        ARCA represents and warrants that prior to the execution of this Agreement,
ARCA received and reviewed the URC License Agreement and the Gilead-Archemix Agreement. ARCA further represents and warrants that after receipt and review of the URC License Agreement and the Gilead-Archemix Agreement, ARCA acknowledges and believes
that the URC License Agreement and the Gilead-Archemix Agreement state that: (i) Archemix’s rights in the Archemix Patents may revert to Gilead or the UTC if Archemix, its Affiliates and all assignees and sublicensees cease reasonable
efforts to Develop and Commercialize ARC 2172 and Licensed Products utilizing the Archemix Patents; (ii) in the event of any termination of the URC License Agreement, the sublicenses granted to ARCA hereunder shall remain in full force and
effect in accordance with Section 3.4 of the URC License Agreement so long as ARCA is not then in breach of this Agreement and agrees to be bound to UTC as a licensor under the terms and conditions of this Agreement; and (iii) in the event
of any termination of the Gilead-Archemix Agreement, the sublicenses granted to ARCA hereunder shall remain in full force and effect in accordance with Section 2.3 of the Gilead-Archemix Agreement so long as ARCA agrees to be bound to Gilead as
a licensor under the terms and conditions of this Agreement and provided, that, if the termination of the Gilead-Archemix Agreement arises out of the action or inaction of ARCA, Gilead, at its option, may terminate such sublicense. In accordance
with the representations and warranties made in accordance with this Section 10.3, ARCA hereby agrees to conform to the obligations and restrictions imposed upon it as a sublicensee under the Gilead-Archemix Agreement. 

(c)        Archemix represents and warrants that it acknowledges and believes that the
URC License Agreement and the Gilead-Archemix Agreement state that: (i) in [ * ] of any [ * ] of the [ * ], the [ * ] to [ * ] in [ * ] and [ * ] in accordance with [ * ] so long [ *
] in [ * ] of this [ * ] and [ * ] to be [ * ] to [ * ] the [ * ] and [ * ] of this [ * ]; and (ii) in [ * ] of any [ * ] of the [ * ] to [ * ] in this [
* ] in [ * ] in accordance with [ * ] so long [ * ] to be [ * ] to [ * ] as a [ * ] the [ * ] and [ * ] of this [ * ] and [ * ], that, if the [ * ] of the [ * ]
of the [ * ] or [ * ] of [ * ], at its [ * ] such [ * ]. In accordance with the [ * ] and [ * ] this Section 10.3, [ * ] to the [ * ] as a [ * ] under the [ * ] under
the [ * ] and as a [ * ] to the [ * ]. 
 10.4    Disclosure. Archemix
represents and warrants that, to the best of its knowledge as of the Effective Date, except as disclosed by Archemix to ARCA prior to the Effective Date, 

 

 26. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
the practice by ARCA of its rights under this Agreement with regard to the Development and Commercialization of ARC2172 only does not infringe any Valid Claim of any issued patent owned or
Controlled by any Third Party. If Archemix becomes aware of any Valid Claim owned or controlled by a Third Party that may be infringed by the manufacture, use or sale of ARC 2172 in the Field during the Term, Archemix will notify ARCA. 

 

	11.	INDEMNIFICATION AND LIMITATION OF LIABILITY 

11.1     Indemnification. 

(a)        Archemix shall indemnify, defend and hold harmless ARCA, its Affiliates, their
respective directors, officers, employees and agents, and their respective successors, heirs and assigns (collectively, the “ARCA Indemnitees”), against all liabilities, damages, losses and expenses (including, without limitation,
reasonable attorneys’ fees and expenses of litigation) (collectively, “Losses”) incurred by or imposed upon the ARCA Indemnitees, or any one of them, as a direct result of claims, suits, actions, demands or judgments of Third
Parties, including without limitation personal injury and product liability claims (collectively, “Claims”), (i) arising in the exercise by Archemix of rights pursuant to Section 9.2 hereof, or (ii) arising out of
Archemix’s breach of a material obligation under, or representation or warranty contained in, this Agreement or Archemix’s gross negligence or willful misconduct with respect to the performance of its responsibilities hereunder, in all
cases except to the extent arising from a breach of this Agreement by, or the gross negligence or willful misconduct of, ARCA, its Affiliates, licensees or sublicensees. 

(b)        ARCA hereby agrees to defend and hold harmless Archemix and its directors,
officers, agents and employees (the “Archemix Indemnitees”) from and against any and all Losses resulting from any Claims brought by a Third Party against the Archemix Indemnitees: (i) based on any breach by ARCA of a
material obligation under, or a representation or warranty contained in, this Agreement; (ii) based on the possession, Development, manufacture, use, offer for sale, sale or other Commercialization, distribution, administration, storage or
transport of ARC 2172, a Licensed Product or a ARCA Product by ARCA, its Affiliates, licensees or sublicensees, or (iii) based on the gross negligence or willful misconduct of ARCA, its Affiliates, licensees or sublicensees, in the performance
of this Agreement. 
 (c)        In the event that an Archemix Indemnitee or a
ARCA Indemnitee, as the case may be, is seeking indemnification under Section 11.1, it shall inform the indemnifying Party of a claim as soon as reasonably practicable after it receives notice of the claim, shall permit the indemnifying Party
to assume direction and control of the defense of the claim (including the right to settle the claim solely for monetary consideration), and shall cooperate as requested by the indemnifying Party (at the expense of the indemnifying Party) in the
defense of the claim. 
  

 27. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 11.2     Limitation of Liability.   EXCEPT AS
EXPRESSLY PROVIDED IN SECTION 11.1, IN NO EVENT SHALL EITHER PARTY, ITS DIRECTORS, OFFICERS, EMPLOYEES, AGENTS OR AFFILIATES BE LIABLE TO THE OTHER PARTY FOR ANY INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY OR CONSEQUENTIAL DAMAGES, WHETHER BASED UPON A
CLAIM OR ACTION OF CONTRACT, WARRANTY, NEGLIGENCE, STRICT LIABILITY OR OTHER TORT, OR OTHERWISE, ARISING OUT OF THIS AGREEMENT. 

11.3     Warranty Disclaimer.   EXCEPT AS OTHERWISE EXPRESSLY PROVIDED IN THIS
AGREEMENT, NEITHER PARTY MAKES ANY WARRANTY WITH RESPECT TO ANY TECHNOLOGY, GOODS, SERVICES, RIGHTS OR OTHER SUBJECT MATTER OF THIS AGREEMENT, INCLUDING WITHOUT LIMITATION ANY WARRANTY OF MERCHANTABILITY OR OF FITNESS FOR A PARTICULAR PURPOSE OR
NON-INFRINGEMENT OF THIRD PARTY RIGHTS. IN ADDITION, ARCHEMIX MAKES NO WARRANTIES AS TO THE VALIDITY OR ENFORCEABILITY OF THE LICENSED PATENT RIGHTS. 

11.4     Third Party Beneficiaries.   To the [ * ] that [ * ] and/or [ * ] by the [ * ] and [ * ] of
this [ * ] to any [ * ] or [ * ] by a [ * ], the [ * ] and [ * ] as [ * ] Section 11.1 [ * ] to [ * ] and [ * ]. 
  

	12.	DISPUTE RESOLUTION 

12.1     Disputes.   The Parties recognize that disputes as to certain matters may from time
to time arise during the term of this Agreement that relate to either Party’s rights or obligations hereunder. It is the objective of the Parties to establish procedures to facilitate the resolution of disputes arising under this Agreement in
an expedient manner by mutual cooperation and without resort to litigation. To accomplish this objective, the Parties agree to follow the procedures set forth in this Article 12 if and when a dispute arises under this Agreement. Either Party may
formally request resolution of a dispute by providing written notice to the other Party. The Parties will refer any such dispute to the Chief Executive Officers of the Parties for attempted resolution by good faith negotiations within thirty
(30) days. In the event the Chief Executive Officers are not able to resolve the dispute within such period, either Party may then invoke the provisions of Sections 12.2 through 12.13. 

12.2     Arbitration for Disputes.   Any dispute not resolved pursuant to Section 12.1
may be submitted by either Party for final and binding arbitration in accordance with the terms of this Agreement by JAMS. The arbitration will be conducted in New York, New York under the rules then in effect for JAMS, except as provided herein,
and the Parties consent to the personal jurisdiction of the United States federal courts, for any case arising out of or otherwise related to this arbitration, its conduct and its enforcement. Any situation not expressly covered by this Agreement
shall be decided in accordance with such rules of JAMS. 
 12.3     Arbitrator for Dispute
Resolution. 
  

 28. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 (a)        Subject to Section 12.3(b),
the arbitrator shall be one (1) neutral, independent and impartial arbitrator selected from a pool of retired federal judges to be presented to the Parties by JAMS. Failing the agreement of the Parties as to the selection of the arbitrator
within thirty (30) days, the arbitrator shall be appointed by JAMS within the subsequent 30 days. 

(b)        Upon the written request of either Party before the commencement of the
arbitrator’s duties pursuant to this Article 12, there shall be three (3) arbitrators rather than one (1). If such request is made before the selection of an arbitrator pursuant to Section 12.3(a), then within thirty (30) days
after such request each Party shall select one (1) neutral, independent and impartial arbitrator from the pool of retired federal judges presented to the Parties by JAMS and within thirty (30) days thereafter those two (2) arbitrators
shall select the third (3rd) arbitrator from such
pool. If such request is made after the selection of an arbitrator pursuant to Section 12.3(a), then within thirty (30) days after such request each Party shall select one (1) additional arbitrator from the pool from which the first
arbitrator was selected. 
 12.4     Governing Law for Dispute Resolution.  
Resolution of all disputes and any remedies relating thereto, shall be governed by and construed under the substantive laws of the State of New York, without regard to conflicts of law rules that would provide for application of the law of a
jurisdiction outside New York. 
 12.5     Rules of Procedure.   The Parties shall
be entitled to discovery as provided in the Federal Rules of Civil Procedure and the local rules of the Federal District Court in the Southern District of New York, provided, however, that all discovery shall be conducted expeditiously within the
time limit set by the arbitrators selected pursuant to Section 12.3. At the hearing, the Parties may present testimony (either by live witness or deposition) and documentary evidence. Each Party shall have the right to be represented by
counsel. 
 12.6     Rules of Evidence.   The Federal Rules of Evidence shall apply
to any and all matters submitted to final and binding arbitration under this Agreement. 
 12.7    
Decision.   The power of the arbitrator to fashion procedures and remedies within the scope of this Agreement is recognized by the Parties as essential to the success of the arbitration process. The arbitrator shall not have the
authority to fashion remedies which would not be available to a federal judge hearing the same dispute. The arbitrator is encouraged to operate on this premise in an effort to reach a fair and just decision but shall fashion such rules and
procedures to best approximate Federal rules and procedures except with respect to procedural time limits and delays (which shall be set by the arbitrator pursuant to Section 12.5). Reasons for the arbitrator’s decisions should be complete
and explicit. A full transcript and record of the proceedings as well as written decisions including all determinations of law and fact shall be provided for the appellate process. The written reasons should also include the basis for any damages
awarded and a statement of how the damages were calculated. Such a written decision shall be rendered by the arbitrator following a full comprehensive hearing no later than twelve (12) months following the selection of the arbitrator as
provided for in Section 12.3. 
  

 29. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 12.8     Award. 

(a)        The award shall be paid in U.S. dollars free of any tax, deduction or offset;
and any costs, fees or taxes incident to enforcing the award shall, to the maximum extent permitted by law, be charged against the Party resisting enforcement. 

(b)        If as to any issue the arbitrator should determine under the applicable law
that the position taken by a Party is frivolous or otherwise irresponsible or that any wrongdoing they find is in callous disregard of law and equity or the rights of the other Party, the arbitrator shall also award an appropriate allocation of the
adversary’s reasonable attorney fees, costs and expenses to be paid by the offending Party, the precise sums to be determined after a bill of attorney fees, expenses and costs consistent with such award has been presented following the award on
the merits. 
 (c)        Each Party agrees to abide by the award rendered in
any arbitration conducted pursuant to this Article 12, and agrees that a judgment of any Federal District Court having jurisdiction may be entered upon the final award and that other courts may award full faith and credit to such judgment in order
to enforce such award. 
 (d)        The award shall include interest from the
date of any damages incurred for breach of the Agreement, and from the date of the award until paid in full, at a rate fixed by the arbitrator. 

(e)        With respect to money damages, nothing contained herein shall be construed to
permit the arbitrator(s) or any court or any other forum to award punitive, consequential or exemplary damages. By entering into this agreement to arbitrate, the Parties expressly waive any claim for punitive or exemplary damages. The only damages
recoverable under this Agreement are compensatory damages. For clarity, the foregoing shall not be interpreted to limit or to expand the express rights specifically granted in this Agreement. 

12.9     Costs.   Except as set forth in Section 12.8, each Party shall bear its own
legal fees. The arbitrator shall assess his or her costs, fees and expenses against the Party losing the arbitration unless he or she believes that neither Party is the clear loser, in which case the arbitrator shall divide his or her fees, costs
and expenses according to his or her sole discretion. 
 12.10   Injunctive Relief.   Provided
a Party has made a sufficient showing under the rules and standards set forth in the Federal Rules of Civil Procedure and applicable case law, the arbitrator shall have the freedom to invoke, and the Parties agree to abide by, injunctive measures
after either Party submits in writing for arbitration claims requiring immediate relief. 
 12.11  
Confidentiality for Dispute Resolution.   The arbitration proceeding shall be confidential and the arbitrator shall issue appropriate protective orders to safeguard each Party’s Confidential Information. Except as required by
law, no Party shall make (or instruct the arbitrator to make) any public announcement with respect to the proceedings or decision of the arbitrator without prior written consent of each other Party. The existence of any dispute

  

 30. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
submitted to arbitration, and the award, shall be kept in confidence by the Parties and the arbitrator, except as required in connection with the enforcement of such award or as otherwise
required by applicable law. 
 12.12   Survivability.   Any duty to arbitrate under this
Agreement shall remain in effect and be enforceable after termination of the contract for any reason. 

12.13   Jurisdiction.   For the purposes of this Article 12, the Parties acknowledge their diversity
(ARCA having its principal place of business in Colorado and Archemix having its principal place of business in Massachusetts). 

12.14   Patents and Trademarks.   Any dispute, controversy or claim relating to the scope, validity,
enforceability or infringement of any Compound Patent Rights covering the manufacture, use, importation, offer for sale or sale of any Licensed Product or of any ARCA trademarks, Archemix trademarks, or trademark rights related to any Licensed
Product shall be submitted to a court of competent jurisdiction in the country in which such Patent or trademark rights were granted or arose. 

(a) 
  

	13.	MISCELLANEOUS 

13.1     Entire Agreement; Amendment.   This Agreement, including the Exhibits attached
hereto and the expressly referenced provisions of the other agreements referenced herein, sets forth the complete, final and exclusive agreement between the Parties, and this Agreement sets forth all the covenants, promises, agreements, warranties,
representations, conditions and understandings between the Parties hereto and supersedes all prior agreements and understandings between the Parties, including without limitation the Original Agreement and the Restated Agreement. There are no
covenants, promises, agreements, warranties, representations, conditions or understandings, either oral or written, between the Parties other than as are set forth in this Agreement. No subsequent alteration, amendment, change or addition to this
Agreement shall be binding upon the Parties unless reduced to writing and signed by an authorized officer of each Party. 

13.2     Bankruptcy. 

(a)        All rights and licenses granted under or pursuant to this Agreement, including
amendments hereto, by each Party to the other Party are, for all purposes of Section 365(n) of Title 11 of the U.S. Code (“Title 11”), licenses of rights to intellectual property as defined in Title 11. Each Party agrees during
the term of this Agreement to create and maintain current copies or, if not amenable to copying, detailed descriptions or other appropriate embodiments, to the extent feasible, of all such intellectual property. If a case is commenced by or against
either Party (the “Bankrupt Party”) under Title 11, then, unless and until this Agreement is rejected as provided in Title 11, the Bankrupt Party (in any capacity, including debtor-in-possession) and its successors and assigns
(including, without limitation, a 
  

 31. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
Title 11 Trustee) shall, at the election of the Bankrupt Party made within sixty (60) days after the commencement of the case (or, if no such election is made, immediately upon the request
of the non-Bankrupt Party) either: (i) perform all of the obligations provided in this Agreement to be performed by the Bankrupt Party including, where applicable and without limitation, providing to the non-Bankrupt Party portions of such
intellectual property (including embodiments thereof) held by the Bankrupt Party and such successors and assigns or otherwise available to them; or (ii) provide to the non-Bankrupt Party all such intellectual property (including all embodiments
thereof) held by the Bankrupt Party and such successors and assigns or otherwise available to them. 

(b)        If a Title 11 case is commenced by or against the Bankrupt Party and this
Agreement is rejected as provided in Title 11 and the non-Bankrupt Party elects to retain its rights hereunder as provided in Title 11, then the Bankrupt Party (in any capacity, including debtor-in-possession) and its successors and assigns
(including, without limitations, a Title 11 Trustee) shall provide to the non-Bankrupt Party all such intellectual property (including all embodiments thereof) held by the Bankrupt Party and such successors and assigns or otherwise available to them
immediately upon the non-Bankrupt Party’s written request therefore. Whenever the Bankrupt Party or any of its successors or assigns provides to the non-Bankrupt Party any of the intellectual property licensed hereunder (or any embodiment
thereof) pursuant to this Section 13.2, the non-Bankrupt Party shall have the right to perform the obligations of the Bankrupt Party hereunder with respect to such intellectual property, but neither such provision nor such performance by the
non-Bankrupt Party shall release the Bankrupt Party from any such obligation or liability for failing to perform it. 

(c)        All rights, powers and remedies of the non-Bankrupt Party provided herein are
in addition to and not in substitution for any and all other rights, powers and remedies now or hereafter existing at law or in equity (including, without limitation, Title 11) in the event of the commencement of a Title 11 case by or against the
Bankrupt Party. The non-Bankrupt Party, in addition to the rights, power and remedies expressly provided herein, shall be entitled to exercise all other such rights and powers and resort to all other such remedies as may now or hereafter exist at
law or in equity (including, without limitation, under Title 11) in such event. The Parties agree that they intend the foregoing non-Bankrupt Party rights to extend to the maximum extent permitted by law and any provisions of applicable contracts
with Third Parties, including without limitation for purposes of Title 11: (i) the right of access to any intellectual property (including all embodiments thereof) of the Bankrupt Party or any Third Party with whom the Bankrupt Party contracts
to perform an obligation of the Bankrupt Party under this Agreement, and, in the case of the Third Party, which is necessary for the development, registration and manufacture of licensed products; and (ii) the right to contract directly with
any Third Party described in subsection (i) above to complete the contracted work. Any intellectual property provided pursuant to the provisions of this Section 13.2 shall be subject to the licenses set forth elsewhere in this Agreement
and the payment obligations of this Agreement, which shall be deemed to be royalties for purposes of Title 11. 
  

 32. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 13.3     Force Majeure.   Both Parties shall be
excused from the performance of their obligations under this Agreement to the extent that such performance is prevented by force majeure and the non-performing Party promptly provides notice of the prevention to the other Party. Such excuse shall be
continued so long as the condition constituting force majeure continues and the non-performing Party takes reasonable efforts to remove the condition. For purposes of this Agreement, force majeure shall include conditions beyond the control of the
Parties, including, without limitation, an act of God, voluntary or involuntary compliance with any regulation, law or order of any government, war, civil commotion, labor strike or lock-out, epidemic, failure or default of public utilities or
common carriers, destruction of production facilities or materials by fire, earthquake, storm or like catastrophe; provided, however, the payment of invoices due and owing hereunder shall not be delayed by the payer because of a force majeure
affecting the payer, unless such force majeure specifically precludes the payment process. 

13.4     Notices.   Any notice required or permitted to be given under this Agreement shall
be in writing, shall specifically refer to this Agreement and shall be deemed to have been sufficiently given for all purposes if (a) mailed by first class certified or registered mail, return receipt requested, postage prepaid,
(b) express delivery service providing evidence of receipt or (c) personally delivered. Unless otherwise specified in writing, the mailing addresses of the Parties shall be as described below. 

 

			
	For ARCA:	  	ARCA biopharma, Inc.
		  	8001 Arista Place, Suite 200
		  	Broomfield, CO 80021
		  	Fax: 720-208-9261
		  	Attention: CEO
		  	Copy: Legal Department
		
	For Archemix:	  	Archemix Corp.
		  	300 Third Street
		  	Cambridge, MA 02142
		  	Fax: (617) 621-9300
		  	Attention: Legal Department

13.5     Consents Not Unreasonably Withheld or Delayed.   Except as expressly stated to the
contrary, whenever provision is made in this Agreement for either Party to secure the consent or approval of the other Party, that consent or approval shall not unreasonably be withheld or delayed, and whenever in this Agreement provisions are made
for one Party to object to or disapprove a matter, such objection or disapproval shall not unreasonably be exercised. 

13.6     Maintenance of Records.   Each Party shall keep and maintain all records required by
law or regulation with respect to Licensed Products and shall make copies of such records available to the other Party upon reasonable request. 
  

 33. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 13.7     United States Dollars.   References in
this Agreement to “Dollars” or “$” shall mean the legal tender of the United States of America. 

13.8     No Strict Construction.   This Agreement has been prepared jointly and shall not be
strictly construed against either Party. 
 13.9 Assignment.   Except as otherwise specifically provided
to the contrary in this Agreement, neither Party may assign or transfer this Agreement or any rights or obligations hereunder without the prior written consent of the other; provided, that, a Party may make such an assignment without the other
Party’s consent to an Affiliate or in conjunction with a merger, acquisition, or sale of all or substantially all of the assets of such Party to which this Agreement pertains. Any assignment or attempted assignment by either Party in violation
of the terms of this Section 13.9 shall be null and void and of no legal effect. 
 13.10  
Counterparts.   This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

13.11   Further Actions. Each Party agrees to execute, acknowledge and deliver such further instruments, and to
do all such other acts, as may be necessary or appropriate in order to carry out the purposes and intent of this Agreement. 

13.12   Severability.   If any one or more of the provisions of this Agreement is held to be invalid or
unenforceable by any court of competent jurisdiction from which no appeal can be or is taken, the provision shall be considered severed from this Agreement and shall not serve to invalidate any remaining provisions hereof. The Parties shall make a
good faith effort to replace any invalid or unenforceable provision with a valid and enforceable one such that the objectives contemplated by the Parties when entering this Agreement may be realized. 

13.13   Ambiguities.   Ambiguities, if any, in this Agreement shall not be construed against any Party,
irrespective of which Party may be deemed to have authored the ambiguous provision. 
 13.14  
Headings.   The headings for each Article and Section in this Agreement, and in the Exhibits, have been inserted for convenience of reference only and are not intended to limit or expand on the meaning of the language contained in
the particular Article or Section. 
 13.15   No Waiver.   Any delay in enforcing a
Party’s rights under this Agreement or any waiver as to a particular default or other matter shall not constitute a waiver of such Party’s rights to the future enforcement of its rights under this Agreement, excepting only as to an express
written and signed waiver as to a particular matter for a particular period of time. 
 13.16   Tax
Treatment and Tax Structure Disclosure.   Notwithstanding anything herein to the contrary, any Party to this Agreement (and any employee, representative, or other agent of any Party to this Agreement) may disclose to any and all
persons, without limitation of 
  

 34. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 
any kind, the tax treatment and tax structure of the transactions contemplated by this Agreement and all materials of any kind (including opinions or other tax analyses) that are provided to it
relating to such tax treatment and tax structure; provided, however, that such disclosure may not be made to the extent a lack of disclosure is reasonably necessary to comply with any applicable federal or state securities laws. For the purposes of
the foregoing sentence: (a) the “tax treatment” of a transaction means the purported or claimed federal income tax treatment of the transaction; and (b) the “tax structure” of a transaction means any fact
that may be relevant to understanding the purported or claimed federal income tax treatment of the transaction. 

13.17   Independence.   Subject to the terms of this Agreement, each Party shall manage its own
activities and resources, acting independently and in its individual capacity. The relationship between ARCA and Archemix is that of independent contractors and neither Party shall have the power to bind or obligate the other Party in any manner,
other than as is expressly set forth in this Agreement. 
  

 35. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 IN WITNESS WHEREOF, the Parties have
executed this Agreement in duplicate originals by their proper officers as of the date and year first above written. 
  

									
	ARCA BIOPHARMA, INC.	 		 	ARCHEMIX CORP.
					
	BY:	 	/S/ MICHAEL BRISTOW  	 		 	BY:	 	/S/ JOHN A. HARRE        
					
	NAME:  	 	MICHAEL BRISTOW      	 		 	NAME:  	 	JOHN A. HARRE              
					
	TITLE:	 	CEO                        	 		 	TITLE:	 	GEN. COUNSEL                

 

 36. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 EXHIBIT A 

REGIONAL OFFICES OR COUNTRIES IN WHICH 

PATENT APPLICATIONS ARE TO BE NATIONALIZED 

OR OTHERWISE PROSECUTED, FILED AND MAINTAINED 

[ * ]
  

 [ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the
Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 EXHIBIT B 

Coagulation Cascade Proteins 

[ * ] 
  

 2. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended. 

 EXHIBIT C 

Criteria for Short Acting Characteristics of Aptamers 

For purposes of this Agreement, an Aptamer is a “Short Acting Coagulation Cascade Aptamer” if the Aptamer has [ * ]  

[ * ] 
  

 3. 

[ * ] = Certain confidential information contained in this document, marked by brackets, is filed with the Securities and Exchange Commission pursuant to
Rule 24b-2 of the Securities Exchange Act of 1934, as amended.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00177-of-00352.parquet"}]]